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Abstract 
The principal aims of the work presented in this thesis were to investigate the 
biochemical properties and protein compositions of nasal secretion (NS) from healthy 
cattle and to document changes in the protein expression in NS from diseased and 
vaccinated cattle using advanced proteomic methods.  
 
Bovine respiratory disease (BRD) is the principal source of economic loss for the cattle 
industry throughout the world. Even though it has been studied extensively, it still 
remains the number one cause of disease and death in cattle. Although the 
etiopathogenesis of BRD is multifactorial and complex, all of the pathogens have the 
common route of infection which is intranasal. Thus, NS is potentially a valuable source 
of biological sample in the detection of biomarkers for BRD.  
 
Therefore, a method for the collection of substantial volumes of NS from cattle was 
developed in this study to establish a reference range of analytes that are present in 
the NS of healthy cattle. Biochemical profiles of NS from a group of 38 healthy Holstein-
Friesian cows revealed high alkaline phosphatase (AP) activity of up to 2392 IU/L which 
is 15.7 fold higher compared to AP activity in serum reference ranges. 
 
This study further investigated the source of the high AP activity in bovine NS. 
Histochemical analysis using AP specific staining confirmed the localization of the AP 
enzyme activity to epithelial cells and serous glands of the nasal mucosa. Advanced 
molecular methods were used to determine the characterization of nasal AP.  The 
analysis at mRNA levels from nasal mucosa by endpoint RT-PCR and PCR product 
sequencing confirmed that the AP was locally produced and is identical at the 
nucleotide level to the non-specific AP splice variant gene (ALPL) found in bovine liver, 
bone and kidney. Investigation using isoelectric focussing (IEF) confirmed that AP was 
produced locally at a high level in nasal epithelium demonstrating that novel AP 
isoenzymes in NS had pIs in the same range as those of the nasal mucosa extracts (pH 
4.8-6.2) but were clearly different from the extracts of other tissues. The differences in 
IEF migration of the AP extracts is likely to be due to post translational modifications 
(PTMs) such as glycosylation or phosphorylation which would be areas worthy of future 
research.  
 
Preliminary proteomic investigation of NS from healthy cattle using 1D gel 
electrophoresis, 2D gel electrophoresis and ESI-MS/MS analysis putatively identified 10 
major proteins in NS consisting of 7 vascular proteins and other glandular and cellular 
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proteins such as lactoferrin, an anti-bacterial protein commonly present in mucosal 
secretions, odorant binding protein known to have a role in scent recognition and 
glutathione-S-transferase, an enzyme capable of detoxifying noxious compounds.  
 
The final objective was therefore to compare the nasal proteins from healthy, disease 
and vaccinated group of animals using 2D difference gel electrophoresis (DiGE). The 
experimental model used for this investigation was an immunisation study against 
bovine malignant catarrhal fever (MCF).  It was concluded that quantitative proteomics 
technology such as DiGE identified and measured changes in nasal protein expression in 
response to MCF and following vaccine protection. 
 
In conclusion, this research has contributed to the scientific knowledge regarding the 
biochemical properties and protein compositions that is present in bovine NS. In 
addition, the research also explored the use of proteomic technologies as a novel tool 
to analyse protein expression and identify possible biomarkers in NS. This thesis is an 
important step forward for a better understanding of bovine NS, and thus provides a 
basis for future studies involving bovine NS by way of providing reference data and 
alternative source of biological sample.    
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1.1 Bovine respiratory disease and its impact on the cattle 
industry 
1.1.1  Background 
Bovine respiratory disease (BRD) is a general term for respiratory disease in cattle 
caused by a range of factors, singly or in combination. Of cattle diseases, BRD has the 
greatest economic impact towards the cattle farming industry and till this date 
pneumonia is a leading cause of loss to the cattle industry in the United States and 
Europe (Griffin, 1997 and Ackermann et al., 2010). An estimated 1.9 million animals 
(Nicholas and Ayling, 2003 and Nicholas, 2011) are affected by BRD each year in the UK 
cattle industry with costs estimated at around £60 million annually (NADIS, 2007). Costs 
associated with BRD prevention, treatment, morbidity, and mortality have been 
estimated from US$13.90 (Snowder et al., 2006) to US$15.57 (Faber et al., 1999) per 
head. Annual losses to the US cattle industry are estimated to approach 1 billion dollars, 
whereas preventative and treatment costs are over 3 billion dollars annually (Griffin, 
1997 and Jones and Chowdhury, 2007). 
Bovine respiratory disease affects the upper respiratory tract causing inflammation of 
various tissues such as pharyngitis, rhinitis, tracheitis and bronchitis and/or lower 
respiratory tract prompting the development of pneumonia.  Respiratory pathogens can 
cause serious outbreaks of acute pneumonia in neonatal, weaned and growing calves. 
Whereas chronic infection leads to debilitation, decreased performance, and the need 
to protect the welfare of these animals suffering from the disease often leads to the 
early culling of the animals. In addition, another major worry are the usage of numerous 
and unregulated antimicrobial drugs which subsequently leads to the growing concern 
on the issues of antibiotic resistance. The needs to enhance effective immune responses 
are needed because of the high incidence of pneumonia in cattle, ubiquity of 
respiratory pathogens, and the general expectation by end consumers for producers to 
use antibiotics less frequently.  
The bovine respiratory tract immune response is sophisticated and shaped by anatomic 
and cellular features unique to cattle, management practices, and interactions with 
specific microbial pathogens. Vaccines can effectively enhance resistance to some 
pathogens, but not all (Kasimanickam, 2010).  Until recently, more attention now has 
been given to early detection of BRD onset through the understanding of the host innate 
immune response towards disease and factors that could increase innate immune 
activity. In spite of the advances in managerial practices, vaccines, and clinical 
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treatments, pneumonia still remains a widespread problem and ways to enhance host 
resistance to pathogen colonization and pneumonia are much required. 
1.1.2  Predisposing factor 
There are a variety of factors and conditions that predispose cattle to respiratory 
disease. Cattle have anatomic and cellular differences from humans and other species 
and are managed in herds all of which increases susceptibility to microbial pathogens. In 
healthy animal, the upper respiratory tract is colonized by a variety of bacterial 
pathogens that are inhaled and replicate in the tonsillar crypts and nasal mucin 
(Ackermann et al., 2010). Colonization of these organisms within regions of the upper 
respiratory tract mucosa may occupy micronutrients and receptor sites resulting in 
reduced colonization by pathogens. In an old study from 1964, Collier and Rossow have 
reported that the bacterial isolates from trachea and lung were colonized by only 
commensal microflora such as Pseudomonas sp., Bacillus sp., Streptomyces sp., 
Micrococcus sp. and Streptococcus sp..  However, Allen et al. (1991) demonstrated the 
presence of M. haemolytica, P. multocida, H. somni, M. bovis, and M. bovirhinis, 
Bacillus spp., Streptomycetes sp., and Neisseria spp. in nasopharyngeal swabs of 
healthy calves.  
One of the most important predisposing features involving the respiratory system of the 
cattle is the anatomic structure of the respiratory airways. Cattle have a relatively long 
tracheobronchial tree that increases the amount of dead space volume in comparison to 
pigs, dogs and horses (Kirrchvink, 2008). The increased of dead space affects the 
amount of fresh oxygen that can be delivered to lung and increases the risk of alveolar 
hypoventilation with partial obstruction. Although the increased dead space in cattle 
may not affect respiratory tract immunity directly, it might allow increase in the 
surface area for particles deposition and increased transit time of inhaled vapours, 
gases and aerosolized materials. 
There are several environmental factors and managerial issues that were known to 
interrupt the respiratory tracts immunity. These include transportation, weaning, 
humidity, air exchange, lighting, sounds, overcrowding, changes in social structure, 
precipitation, fluctuations in temperature, changes in feedstuffs, feedlot floor 
conditions, and other microbial agents. Minor changes to these predisposing factors 
could even prompting distress to the animals, affecting even the basic aspects of the 
immune system and subsequently predisposing them to BRD. 
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1.1.3  Aetiology  
Bovine respiratory disease is a complex infectious disease caused by the interaction of 
several pathogenic microbial agents. These include viruses that have a tendency to 
infect immunocompromised lung which includes bovine herpesvirus-1 (BHV-1), bovine 
adenovirus A–D, bovine respiratory syncytial virus, bovine coronavirus, infectious bovine 
rhinotracheitis (IBR), bovine parainfluenza virus 3 (PI-3), bovine viral diarrhoea virus 
(BVDV)  and bovine viral diarrhea virus 1 and 2. Many herds of cattle have been reported 
to have been colonized by Mycoplasma spp. including bovis, dispar, bovirhinis which 
involve in inhibiting the function of ciliated respiratory epithelial cells (Booker et al., 
2008 and Gabinaitiene et al., 2011 and Gautier-Bouchardon et al., 2014). Upon early 
viral infections, toxins such as 3-methyl indole or other immunosuppressive conditions 
would increase replication of other bacterial pathogens such as M. haemolytica, P. 
multocida, H. somni, A. pyogenes and Chlamydiaceae. These bacteria could colonize 
the tonsil and at the mucous of the nasal meatus and sinuses (Ackermann et al., 2010 
and Love et al., 2014). Following any stresses, these pathogenic microbes shall actively 
increase in replication which subsequently leads to spreading the area of colonization.  
Many recent studies on BRD have focused on BVDV. These viruses are classified into 
genotype 1 and genotype 2 (Ridpath et al., 1994). Within the 2 genotypes, a further 
division into cytopathic and non-cytopathic strains is made based on the presence or 
absence of effects in vitro. In cattle with a history of BRD, BVDV non-cytophathic 
biotypes were isolated more often than cytopathic biotypes, and BVDV1 non-cytopathic 
biotypes were isolated more frequently than BVDV2 genotypes (Fulton et al., 2000). 
Moreover, BVDV1 genotypes were isolated more frequently than type 2 genotypes from 
necropsy of calves with fibrinous pneumonia (Fulton et al., 2003). 
1.1.4  Endotoxin - Lipopolysaccharide 
Pasteurellaceae comprise a large family of Gram-negative Proteobacteria. Members 
ranging from important pathogens such as Manhaemia sp., Pasteurella sp. and 
Haemophilus sp. that causes BRD or live as commensals on mucosal surfaces of cattle, 
especially in the upper respiratory tract.  Lipopolysaccharide widely known as endotoxin 
is the major component of the outer membrane of these Gram-negative bacteria, 
contributing greatly to the structural integrity of the bacteria, and protecting the 
membrane from certain kinds of chemical attack.  Lipopolysaccharide also increases the 
negative charge of the cell membrane and helps stabilize the overall membrane 
structure. It is of crucial importance to Gram-negative bacteria, which would causes 
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bacteriolysis if the LPS are removed. Lipopolysaccharide is a major constituent of the 
outer leaflet of the bacterial cell membrane and a single bacterial cell contains 
approximately 3.5 x 106 LPS molecules, which are essential for growth and stability of 
the bacterium (Rietschel et al., 1994). 
 
Lipopolysaccharide typically consists of a hydrophobic domain known as lipid A, a non-
repeating core oligosaccharide, and a distal polysaccharide or O-antigen. The full length 
of the LPS molecule is shown in Figure 1.1 (Raetz, 1990). The lipid A moiety is composed 
of two phosphorylated glucosamine saccharides links with at least six fatty acids. Kotani 
et al. (1985) and Galanos et al. (1985) have reported that lipid A is the toxic part of the 
molecule causing effects in vivo after injection of a chemically synthesized lipid A into 
rabbits and mice.  Schromm et al. (2000) have shown that the two phosphate groups 
attaching to the saccharides are essential for the toxic effects of lipid A. Removal of 
even one phosphate group would result in the formation of monophosphoryl lipid A 
(MPLA), subsequently causing significant reduced in bioactivity of LPS (Schromm et al., 
2000 and Gangloff et al., 2005). 
 
The inner core of the LPS molecule consists of two or three 2-keto-3-deoxyoctonic acid 
(KDO) sugars and 3 heptose sugars. Raetz, (1990) have reported that LPS structure 
consisting only 1 KDO sugar and the lipid A moiety is sufficient for the bacteria to 
maintain growth and stability. On the other hand, the outer core compartment contains 
common sugars with more structural diversity than the inner core.  It is composed of 
three sugars with one or more sugars covalently bound as side chains. The O-antigen is 
composed of a polymer of oligosaccharides with repeating units of three sugars. The 
structure of this repeating unit distinguishes a bacterial strain within a serotype, which 
indicates pathogenicity of the antigen. 
 
The abundance of recent genomic data has made it possible to study LPS assembly in 
diverse Gram-negative bacteria, including those important pathogens that cause BRD in 
cattle. The most important finding in the field of endotoxin biology since 1990s has 
been the identification of the plasma membrane protein toll-like receptor 4 (TLR4) as 
the lipid A signalling receptor of animal cells which involved in the innate immunity 
mechanism (Beutler, 2002 and Mani et al., 2012). 
  
 
 
 
 
 
 
 
 
 
 
Figure 1.1:  Simplified structure of LPS from Gram-negative bacteria such as E. coli.  
Lipopolysaccharide contains a distal O-specific polysaccharide region, a core polysaccharide region divided into outer and inner core and an 
interior lipid A moiety through which LPS is inserted into the cell membrane. The O- polysaccharide region is highly variable and contains 
approximately 10 to 25 repeated units (n) and is made up of common hexose sugars. Outer core polysaccharide contains common hexose sugars 
such as glucose (Glu) and galactose (Gal), whereas inner core polysaccharide contains unusual sugar such as 3-deoxy-D-manno-octulosonic acid 
(KDO). Lipid A structure is explained in the text. P = phosphate; GlcN = N-acetyl glucosamine; Hep = Heptose 
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1.1.5  Diagnostic tests for bovine respiratory disease 
Respiratory disease in the cattle industry continues to be a major cause of clinical 
disease, mortality, production loss, and reduced carcass quality. In addition to the 
initial examination of live affected animals and obtaining a history, due to the various 
predisposing factors and aetiologies involved in causing BRD, this disease has 
overlapping clinical manifestations. Hence, pathologic and laboratory investigations for 
the discovery of lesions and detection of the aetiology are often required in those cases 
for which a specific diagnosis is required. A specific diagnosis is useful to direct 
antimicrobial therapy, vaccination programs, and biosecurity practices. 
1.1.5.1  Classical assessment 
For many decades, common methods for detecting morbid cattle include visual 
assessment once or twice daily by the farmers or veterinarian, with cattle displaying 
various signs including nasal or ocular discharge, depression, lethargy, emaciated body 
condition, laboured breathing, or any combination of these, being removed from pens 
for further evaluation. Symptomatic animals with a rectal temperature ≥40°C are 
usually considered morbid and given treatment. Perino and Apley (1998) defined a 
clinical scoring system shown in Table 1.1.  According to their protocol, animals with a 
rectal temperature of ≥40°C and a clinical score of ≥1 should receive therapeutic 
treatment.  Due to this subjective nature of such assessment, detection of animals with 
BRD is not always accurate. Wittum et al. (1996) have reported that pulmonary lesions 
indicative of BRD were present at slaughter in 68% of steers that were not treated for 
BRD, whereas lesions were present in 78% of treated steers. 
Likewise, Thompson et al. (2006) reported his findings in South African slaughter houses 
that 42.8% of all cattle had lung lesions at slaughter, and of the cattle with lung lesions 
at slaughter, 69.5% of them had never received treatment for BRD. Noffsinger and 
Locatelli (2004) have reported that the failure to detect morbid animals using current 
protocols for diagnosis may be related to psychological behaviour, in that when the 
animals perceive the cattle handlers as predators; they will mask the signs of weakness 
such as depression and lameness. Therefore, development and implementation of 
quantitative measures to detect BRD is critical, and several possible candidates will be 
discussed in the subsequent sections (Duff and Gaylyean, 2007). 
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Score Assessment 
 
0 
 
Normal animal 
1 Noticeable depression without apparent signs of weakness 
2 Marked depression with moderate signs of weakness without a significantly 
altered gait 
3 Severe depression with signs of weakness such as a significantly altered gait 
4 Moribund and unable to rise 
Table 1.1:  Clinical scoring system used to assess general health of cattle.  
Clinical score of ≥1 requires therapeutic intervention. 
 
1.1.5.2  Laboratory tests 
Laboratory tests are often used to confirm BRD cases however, most laboratory test 
procedures require time and expertise to complete, which limits their value. Field tests 
would be highly desirable but such tests are not widely available, often cost-prohibitive, 
and little data and studies are available to evaluate their efficacy.  Establishing the 
causative agents of BRD would assist in correct treatment. A study by DeRosa et al. 
(2000) have shown that nasal swab cultures contained the same species of bacteria as 
trans-tracheal swab cultures 96% of the time and nasal swab cultures were the same 
with the organism causing disease in 70% of the calves lung tested in that study. A nasal 
swab which is easy to sample and process could routinely be performed in the field to 
identify the species of microbes responsible for causing bacterial pneumonia and 
selection of antibiotic treatments (DeRosa et al., 2000), since antibiotic susceptibility 
usually similar between the paired isolates for most of the antibiotics used to treat BRD.  
Isolation of bacteria from cases of respiratory disease can be done from nasal, 
nasopharyngeal, or tracheal swabs; trans-tracheal wash or bronchoalveolar lavage fluids 
(BAF); or lungs at necropsy. The use of these samples to determine the cause of 
pneumonia in a living animal and herd health status if from necropsy samples can 
provide data that can be helpful for the clinician. However, there are several drawbacks 
which affecting this test. Mainly, all bovine respiratory bacterial pathogens can be 
members of the normal upper respiratory flora, and identification of one or more of 
such bacteria does not necessarily indicate that an organism is the cause of the disease 
or lesion. Another arising issue would be when bacterial isolation from an obvious 
clinical case of bacterial pneumonia is negative due to the usage of antimicrobial 
therapy. 
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The use of nasal, nasopharyngeal, trans-tracheal, or BAL cultures in live animals as a 
replacement for lung culture is less than perfect. DeRosa et al. (2000) have shown that 
when bacterial isolates from nasal and tracheal samples from cattle were compared, 
there was 96% correlation between the bacterial species recovered from the 2 sites. 
When isolates were genetically tested with ribotyping and antimicrobial sensitivity, only 
70% of the nasal and tracheal samples were similar, indicating that multiple strains of 
individual bacterial species are carried in the respiratory tract of cattle.  In another 
study by Godinho et al. (2005), M. haemolytica and M. bovis were isolated from deep 
nasopharyngeal swabs collected prior to euthanasia and another from the lungs 
collected by lung lavage and from tissue samples at necropsy were compared 
genetically. It was reported that there was 86% correlation between URT and LRT 
isolates of M. haemolytica and 100% correlation for M. bovis isolates. 
Serological tests such as virus neutralization test (VNT) measures antibodies that 
interfere with viral infection therefore, provide a functional indication of antibody 
efficacy against the causative virus whereas the enzyme-linked immunosorbent assays 
(ELISA) results, in contrast, provide only indication that antibodies bind to the virus, 
and those antibodies may bind portions of the virion that are not essential for viral 
invasion of host cells. In addition to the assays described, toxin-neutralization assays 
can be used for certain bacteria that secrete toxins. Gentry and Srikumaran (1991) and 
Aulik et al. (2010) have reported the use of this test in detecting bovine antibodies to 
M. haemolytica leukotoxin.  
The direct fluorescent antibody test (FA) is a laboratory test that uses fluorescent dye–
tagged, agent-specific antibodies to detect the presence of infectious agents (Jerome, 
2010). Most BRD viruses may be identified in tissues by FA testing. However, a drawback 
to the FA test is that samples cannot be stored or archived for long due to rapid decay 
of the dye activity. 
Immunohistochemistry (IHC) has become an important diagnostic tool in veterinary 
diagnostic laboratories. Narita et al., 2000 has demonstrated the potential use of IHC 
for identification of bovine herpes virus in cells obtained from bovine BAL. IHC is also 
frequently used to detect BVDV antigen in skin biopsies (Njaa et al., 2000 and Grooms 
and Keilen, 2002). Furthermore, DuBois et al. (2000) have shown that IHC test seems 
reliable where calves recently vaccinated with modified live vaccines have not caused 
false positives. However, skin biopsy samples cannot be pooled, hence increasing costs 
of diagnosis. Larson et al. (2005) suggested using RT-PCR on pooled blood samples from 
30 animals, followed by an IHC test only on animals represented in the pooled samples 
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that returned positive assay results. This 2-test strategy might be cost effective, but it 
would increase the lag time in detecting PI BVDV calves and increase the time they 
would be able to infect other cattle. 
Viral isolation (VI) tests by diagnostic laboratories have utilized the attempt to grow 
virus in cell cultures from diagnostic samples (Jerome, 2010). The VI tests use 
susceptible cell cultures for inoculation and incubation periods. During incubation, 
evidence of virus replication may be observed visually under the microscope as 
cytopathic effects (CP). VI from blood leukocytes or serum also can be used to identify 
persistent infection (PI) BVDV animals. However, although the time to complete these 
tests varies among laboratories, generally the process could take more than 10 days to 
provide a definitive result. This is because for initial incubation usually is takes 7 days, 
and if no CP or antigen is detected, a second incubation is used. A downside to VI in cell 
cultures is that 2 passages are used, taking at least 2 weeks before a test is called 
negative.  Moreover, not all viruses show cytopathology, such as non-cytopathic BVDV, 
hence other detection methods are used to verify the virus presence such as antigen 
detection by fluorescent antibody, ELISA, or IHC. Thus, there is growing use of 
molecular diagnostic tests such as polymerase chain reaction (PCR). 
1.1.5.3  Molecular diagnostics and others 
One of the most common uses of molecular technology in microbiology is for detection 
of pathogen DNA or RNA, identification of bacterial genera, species and subspecies as 
well as viral genotyping (Veir and Lapin, 2010). These technologies allow laboratories to 
rapidly identify bacteria without the requirements of additional time consuming 
biochemical tests. In the case of P. multocida, capsular type of A, B, D, E, or F can be 
determined without cumbersome enzymatic digestion techniques (Shayegh et al., 2009; 
Stahel et al., 2009 and Taylor et al., 2010). Similarly, molecular techniques are used for 
identifying BVDV types 1 and 2 (Letellier and Kerkhofs, 2003 and Kosinova et al., 2007). 
In a conventional PCR, a known genetic region is amplified in a thermo cycler using 
polymerase to produce an amplified segment of nucleic acid. Those products are then 
compared to known positive controls using gel electrophoresis or sequenced and 
compared to published sequence for the specific agent. For RNA viruses, a reverse 
transcriptase enzyme reaction is required. The PCR product is directly visualized using 
agarose gel electrophoresis with dyes such as ethidium bromide. These gel-based PCR 
assays are qualitative, indicating only presence or absence of visualized product of the 
amplification. 
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For the last decade, real-time PCR has largely taken over molecular diagnostics, 
including molecular tests used in veterinary diagnostic laboratories. The most common 
sequence-specific oligonucleotide probe format used in diagnostic real-time PCR is the 
dual labelled Taq Man probe consisting of a fluorescent reporter dye coupled at the 59- 
end and a quenching dye at the 39-end (Jerome, 2010). When the probe is intact, the 
close proximity of the quenching dye prevents the emission of the fluorescent dye. 
However, during PCR primer extension the DNA polymerase enzyme digests any bound 
Taq Man probe, separating the 2 dyes. The reporter dye is no longer suppressed by the 
quencher dye and may now emit a fluorescent signal. The principle behind the 
quantitative real-time PCR (qPCR) is that during thermo cycling PCR amplification will 
begin sooner in specimens containing a higher infectious agent nucleic acid load 
compared to a specimen with a lower infectious agent load. 
Schaefer et al. (2005) suggested that infrared thermography might be valuable for 
detection of BRD. Similarly, the use of radio frequency implants containing temperature 
probes may allow for early detection of diseases that elevate body temperature (Reid 
and Dahl, 2005). Though the studies on these 2 methods have not been verified for the 
accuracy in separating healthy and morbid animals, if successful the use of 
technological approaches might assist in the early detection of BRD cases. 
Pathologic and laboratory investigations are necessary in situations in which a specific 
diagnosis or identification of the cause is required. Laboratory analysis of clinical 
samples can be a highly effective means of refining the clinical diagnosis in situations 
where the benefits of diagnosis outweigh the costs of acquiring and analysing blood, NS, 
trans-tracheal wash, bronchoalveolar lavage or lung biopsy samples. Elements of each 
diagnostic approach may hold merit in evaluating BRD in cattle, and the diagnostic path 
will vary depending on the goals of the farmer and veterinarian. The benefits and 
limitations of all the diagnostic tests mentioned in this chapter is summarize in Table 
1.2 (Fulton and Confer, 2012). 
 
 Test Use Positive Negative 
 
Serology 
 
Antibody detection 
 
Detect vaccine responses and past infections. 
 
 
 
Titres do not necessarily infer resistance and are not able to 
differentiate vaccine-induced antibodies from infection-acquired 
antibodies. 
 
Culture — nasal, nasopharynx, trachea, BAL Detect bacteria and  viruses Demonstrate the presence of colonization or active infection. Positive culture does not necessarily mean lung infection or 
causative for disease. Times for results to be obtained are days to 
weeks. 
Culture — lung lesion Detect bacteria and  viruses Require active replication of the agent in the tissue at time 
of death, so isolation usually indicates that high 
concentrations are in tissue. Antimicrobial resistance can be 
determined. 
Sensitivity is not great and may miss true positives due to 
concurrent infections and antimicrobial therapy. Times for results 
to be obtained are days to week. 
Immunohistochemistry — lung lesion Detects antigen in lung lesion One can localize the infectious agent within the lesion. 
Strong evidence that infectious agent is related to disease. 
Sensitivity and specificity depend on available monospecific 
immune serum or monoclonal antibodies to specific infectious 
agent. 
In-situ hybridization — lung lesion Detects region of genome of agent 
in lesion 
One can localize the infectious agent within the lesion. 
Strong evidence that infectious agent is related to disease. 
Depends on known, pathogen-specific genomic region for 
development of specific oligonucleotide primers. 
Single PCR — nasal, nasopharynx, trachea, BAL swabs or 
collection 
Detects genetic material of agent 
in sample 
Provides specific evidence that infectious agent is in or 
recently has been in a sample. 
Cannot differentiate subclinical or incidental concurrent infection 
from natural exposure or vaccination. Does not always detect 
infectious material. Cannot determine antimicrobial resistance. 
Single PCR — lung lesion from supernatant of tissue 
homogenate 
Detects region of agent genome Potential evidence of specific infectious agent is associated 
with disease. 
May not represent causative infectious agent within diseased 
tissue or differentiate natural infection versus MLV vaccine. 
Multiplex PCR — nasal, nasopharynx, tracheal, BAL swab 
or collection 
Detects region of several agents’ 
genomes 
With a single test, potential evidence of one or more 
infectious agent associated with disease can be determined. 
Test provides more information than single PCR. 
May not represent causative agents within diseased tissue or 
differentiate natural infection versus MLV vaccine. 
Multiplex PCR — lung lesion from supernatant Detects region of several agents’ 
genomes 
With a single test, potential evidence of 1 or With a single 
test, potential evidence of one or more infectious agent 
associated with disease can be determined. Test provides 
more information than single PCR. 
May not represent causative agents within diseased tissue or 
differentiate natural infection versus MLV vaccine. 
Table 1.2:  Comparison of uses of diagnostic tests along with their strengths and limitation (adapted from Fulton and Confer, 2012).  
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1.1.6  Diagnostic biomarkers 
Metabolic and elemental compounds including glucose, phosphorus, low density 
lipoprotein (LDL), lactate, valine, and iron are known to be the biomarkers of viral 
infection and disease outcome (Aich et al., 2009). Some innate immune protein 
molecules have potential use is assessing respiratory tract physiological activity and the 
severity and outcome of clinical disease.   
During the initial tissue insult of the disease, a set of reactions result in the release of 
soluble mediators termed the acute phase response (Baumann and Gauldie, 1994). Many 
studies have shown that acute phase proteins (APP) are clinical markers of pneumonia 
severity.  Several APP have been measured in cattle with BRD, including fibrinogen, 
haptoglobin (Hp), serum amyloid-A (SAA), α-1-acid glycoprotein, ceruloplasmin, α-2-
macoglobulin, and C-reactive protein (Carter et al., 2002), and APP are altered by 
transportation in newly weaned calves (Arthington et al., 2003).  
Haptoglobin and SAA assessment in ruminants has been recognised as a valuable marker 
of disease in these species. Serum amyloid-A, Hp, alpha 1-acid glycoprotein produced by 
liver in response to IL-1 and TNF alpha are produced by ruminant during pneumonia 
(Eckersall and Conner, 1988; Conner et al., 1989 and Wittum et al., 1996). Haptoglobin 
has even been identified in broncho-alveolar lavage fluid from calves with experimental 
Pasteurellosis (Katch et al., 1999), although they have concluded that the Hp in the 
lavage fluid was resulted from leakage from the circulation across the blood-lung 
barrier.  Wittum et al. (1996) suggested that Hp concentration was unrelated to the 
severity of the case or the need for treatment in feedlot cattle however subsequent 
results suggest that Hp may have value for assessing morbidity (Carter et al., 2002). 
Wittum et al. (1996) and Carter et al. (2002) has also reported that Hp was of value in 
assessing treatment efficacy and Berry et al. (2004) has suggested that serum Hp 
concentrations may be useful in predicting the number of treatments required by 
calves. Serum amyloid-A and Hp can differentiate acute and chronic pneumonia and 
alterations in Hp and apolipoprotein A1 are associated with viral infections (Aich et al., 
2009).  Furthermore, Godson et al. (1996) work on APP in BRD have shown that Hp 
concentration ranged from undetectable in the serum of most calves prior to challenge, 
to greater than 1 mg/ml in over one-third of the calves at the height of disease.  
Additionally, the concentration of Hp was associated significantly with other measures 
of the severity of disease. 
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1.2  Host response to respiratory diseases 
1.2.1  Immunobiology of upper respiratory tract 
The URT includes the nasal mucosa, sinuses, pharynx, larynx, trachea and bronchi. Air 
inhaled by animal would encounter resistance to flow in the nasal cavity and induces a 
turbulent flow pattern (Alexandersen et al., 2003). Boyton and Openshaw (2002) have 
demonstrated that this phenomenon could deflect and traps aerosolized particles larger 
than 10 µm in the inhaled air against the nasal mucosal lining and subsequently able to 
be eliminated by swallowing. Other foreign particles or organism larger than 5 µm but 
less than 10 µm would frequently be able to escape the defences of the nasal cavity and 
were deposited on a ciliated epithelial area that layering from the whole nasal 
turbinate to the terminal bronchioles.  
Epithelial layer is consisting of glandular cells that are responsible for the release of 
mucus when stimulated by any disturbance of the turbulence flow of secretion which 
capable to entrap the inhaled foreign materials (Boyton and Openshaw, 2002). 
Succeeding that would be the vital role of the cilia that impede the adherence and 
entry of foreign bodies especially pathogens into the LRT by beating in a co-ordinated 
mode to propel the inhaled material towards the pharynx for swallowing (Zhang and 
Sanderson, 2003). For microorganism to overcome these local host defences and 
subsequently causing tissue disruption, attaching to host epithelial cells is vital for the 
beginning of a disease to develop. Bischof et al. (2008) have shown that M. mycoides 
the causative agent of contagious bovine pleuropneumonia have to first attach to calf 
nasal epithelial cells to achieve a cytotoxicity rate of approximately 90%. Another 
finding by Al-Haddawi et al. (2000) also shown that P. multocida attaches to microvilli 
and the mucous layer of respiratory epithelium through its fimbriae. Following 
attachment, P. multocida and its toxic secretions would rupture the cilia membrane 
resulting epithelial cells to become necrosis and slough off (Al-Haddawi et al., 1999).   
1.2.2  Composition of bovine nasal secretion 
On the event when the functional integrity of the epithelial layer has been 
compromised by damage and inflammation, the immunological barrier would be unable 
to stop infection. Further defence mechanisms are required to prevent invasion of 
pathogen into the LRT thus maintaining lung sterility and the onset septicaemia. 
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Nasal secretion (NS) derived from the epithelial cells secrete antimicrobial peptides and 
proteins (AMPs) forms a vital role in stopping further microbial invasion and 
proliferation. The NS include IgA being the most prevalent immunoglobulin, proteases, 
cathelicidins, lysozyme, lactoferrin, surfactant proteins, defensins, and lactoperoxidase 
which produce superoxide free radicals to destroy bacteria (Ganz and Weiss, 1997). 
These antimicrobial properties are capable to prevent the development of respiratory 
diseases in cattle and their response to epithelial compromise and microbial invasion in 
an experimental challenge study shall be discussed in Chapter 6. A scheme summarizing 
the primary function of protein commonly found in mammalian NS, which also provides 
insight into nasal mucosa defence mechanisms is reported in Figure 1.2. 
 
 
 
 
Figure 1.2:  Bovine nasal mucosa and sources of secreted proteins.  
Mucosa is the protective barrier between air and the tissues. Mucins are secreted by epithelial 
goblet and glandular mucous cells. Glandular serous cells secrets antimicrobial proteins that 
could bind to the mucins. Serous cells also bear the polymeric immunoglobulin receptor that 
transports locally synthesized IgA dimers across serous cells and exocytoses them as secretory 
IgA (Casado et al., 2005). Vascular permeability fills the interstitial spaces with plasma. Mucus 
together with the function of serous secretion traps and kills invading pathogens forming mucus 
raft. Ciliary action sweeps mucus raft away from nostril hence creating an innate protection in 
the nasal mucosa. 
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1.2.2.1  Immunoglobulins 
In addition to providing lubrication, the submucosal gland's predominant role in the 
upper airways is to provide a first line of defence for the mucosa. It has long been 
accepted that antibody at mucous surfaces often plays a key role in preventing initial 
establishment and penetration of pathogens. Immunoglobulin A (IgA) masks inhaled 
foreign material and protect the mucosa by preventing epithelial adherence, infiltration 
and by augmenting toxin neutralisation.  Specific immunoglobulin G (IgG) acts as an 
opsonin to promote the uptake of bacterial like P. multocida by alveolar macrophages 
(Reynolds, 1991). 
Earlier studies conducted in respiratory tract have established that a prominent local 
IgA system in mammalian is located mainly in the upper reaches of the respiratory 
tract, with a virtual absence around the alveolar region where antibody would appear to 
be entirely of humoral origin. In cattle and sheep, the relative abundance of IgA 
presents in the NS (Mach and Pahud, 1971 and Morgan et al., 1981) in contrast to IgG 
presents in abundance in brochoalveolar lavages.  McBride et al. (1999) have also 
demonstrated that immunoglobulins present in respiratory secretions with IgA are 
confined to the URT while IgG is more prevalent in the alveoli following M. haemolytica 
infection. The study is also consistent with the study conducted thirty years ago by 
Morgan  et al. (1981) where IgA was shown to be the major immunoglobulin in upper 
respiratory tract secretions of ruminants as it is in other species studied (Morgan et al., 
1981). In addition, several studies conducted on neutralizing activity in the NS of cattle 
following either natural or intranasal exposure to live PI-3 virus or mixed live vaccine 
comprising PI-3 and IBR viruses is almost exclusively associated with IgA (Morein, 1970 
and Mukkur et al., 1975). 
In bovine NS, IgA is present at a higher concentration than IgG.  The immunoglobulins 
present in bovine NS, are either produced locally by cells of the lymphocyte known as 
the plasma cells or are derived from the blood plasma and transferred across the 
epithelium from the interstitial fluid compartment by selective or passive processes. 
Raphael et al. (1988) have demonstrated that the nasal glands in particular the serous 
cells process and secrete secretory IgA, the major immunoglobulin of not only the 
respiratory tract, but the entire mucosal immune tract.  In contrast, it could be 
summarized that the serum proteins albumin, non-secretory IgA, and IgG enter nasal 
secretions through two mechanisms. The first is by increased extravasation from blood 
vessels into interstitial fluid and transport across the respiratory epithelium into the 
nasal cavity; or secondly by passage across specialized capillary fenestrae, uptake by 
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the submucosal glands, and transport into the glandular lumen, thus entering the nose 
as a component of glandular secretions (Raphael et al., 1989 and Meredith et al., 1989). 
1.2.2.2  Proteases 
Proteases control cellular reactions in animal at the cellular level via the cleavage of 
protein substrates. Metallo and serine proteases are two large families of proteases and 
are characterized by their catalytic type and their active site residues (Page and Di 
Cera, 2008). However, there is not much study conducted on the exact role of protease 
signalling in innate and adaptive immunity in animal. 
Metalloproteases are the most diverse of the four main protease types, with more than 
50 families classified to date (Visse and Nagase, 2003). Matrix metalloproteases (MMP) 
are a group of endopeptidase that depend on zinc as a cofactor able to degrade the 
extracellular matrix of lung tissue. Recent evidence has shown the role of macrophage-
derived MMP (MMP-2) in the pathogenesis of pulmonary sarcoidosis (John et al., 2002). 
Macrophages were also found to secrete MMP-9 in a dose-dependent manner in response 
to a mycobacterial infection in vitro with immune-regulatory cytokines interferon-
gamma (IFN-γ), IL-4 and IL-10 able to stop the bacterial-induced MMP production by 
reducing the amount of tumour necrosis factor-α (TNF-α) available to the macrophages 
(Quiding-Jarbrink et al., 2001). The specific mechanism of lung pathology caused by 
MMP is unknown but it is believed that MMP facilitate the migration of inflammatory 
cells and extracellular matrix remodelling (Obayashi, 2011 and Lee et al., 2003). 
Serine proteases are widely distributed in nature and found in all kingdoms of cellular 
life as well as many viral genomes.  They control a wide variety of physiological and 
pathological processes in animal and human, including tissue remodelling and local 
immunity against infection (Shpacovitch et al., 2008). Regulation of proteolysis induced 
by these serine proteases is essential to prevent self-induced damage. Hence, there are 
specialized serine protease inhibitors known as serpins which are broadly distributed 
(Silverman et al., 2001 and Heutinck et al., 2010). Serpins play a critical role in T 
lymphocyte mediated immunity. However intracellular pathogens may use serpins to 
inhibit the same proteases cell in order to escape T cell immunity (Ashton-Rickardt, 
2013). However, the evolution of proteases appears to be advantageous to pathoges as 
it enables them to avoid destruction and opsonisation of IgA and IgG by degrading these 
immunoglobulins.  
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1.2.2.3  Cathelicidin 
While humans and mice each possess a single cathelicidin, other species such as cattle 
and pigs express many different cathelicidins (Ramanathan et al., 2002). In cattle, 
Whelehan et al. (2014) have revealed seven protein-coding cathelicidin genes, with 6 of 
the 7 protein-coding genes were expressed in leukocytes extracted from milk of high 
somatic cell count (SCC) and another was expressed across several sites in the mammary 
gland.  Although all cathelicidins are produced as a precursor consisting of an N-
terminal signal peptide which is a highly conserved prosequence (Zaiou et al., 2002), it 
is the presence of the evolutionarily conserved prosequence that assigns an 
antimicrobial to the cathelicidin class (Zanetti et al., 2000). 
Cathelicidin peptides generally exhibit broad-spectrum antimicrobial activity against a 
range of Gram-positive and Gram-negative bacteria (Zanetti, 2005). Certain 
cathelicidins are effective at killing common respiratory bacterial isolates of S. aureus, 
E. faecalis or P. aeruginosa that are resistant to conventional antibiotic therapy 
(Zanetti et al., 2002). Cathelicidins also show inhibitory activity against certain fungi 
like C. albicans (López-García et al., 2005), parasites like C. parvum (Giacometti at al., 
2003) and certain enveloped viruses like Respiratory Syncytial Virus (RSV) causing LRT 
infection in human (Currie et al., 2013). Cathelicidins act as a rapid bactericidal protein 
where in most cases is believed to be involved in intercalation of the peptides within 
the bacterial membrane to disrupt membrane integrity (Gutsmann et al., 2001), 
although certain cathelicidins such as porcine PR-39 reach intracellular targets to block 
the bacterial protein synthesis (Boman et al., 1993). 
The study of cathelicidin functions in human was well documented extends to other 
aspects of immunity and tissue repair. The only human cathelicidin (LL-37) has been 
shown able to bind and neutralize bacterial LPS, preventing the induction of 
inflammatory mediators from monocytes and endothelial cells subsequently inhibiting 
the development of endotoxemia in vivo (Sawa et al., 1998 and Ciornei et al., 2003). 
LL-37 was also shown involve in promoting wound repair by recruitment of leukocytes to 
the site of infection (Scott et al., 2002). Bactericidals were also effectively amplified by 
phagocytosis and increasing production of additional cathelicidin by the activated 
neutrophils (Turner et al., 1998) and mast cells (Di Nardo et al., 2003). 
Cathelicidins are widely distributed within the skin and respiratory tract such as at the 
bronchial epithelial cells (Schrumpf et al., 2012) and other mucosal epithelial tissues 
(Dürr et al., 2006). Furthermore, secretions such as NS, saliva and sweat (Thienhaus et 
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al., 2011; Murakami et al., 2002a and Murakami et al., 2002b), are capable to  serve as 
an important multi-functional effectors of innate immunity. 
1.2.2.4  Lactoferrin and lysozyme 
The major antimicrobial proteins lactoferrin and lysozyme invariably found in NS in 
human and animals. The iron-binding protein lactoferrin, has been demonstrated to 
occur in saliva, nasal secretions, tears, bronchial mucus, hepatic bile, pancreatic juice, 
seminal fluid, female cervical mucus and urines (Masson et al., 1966). It functions by 
inhibiting bacterial growth by promoting iron-restricted conditions and agglutinating the 
bacteria (Skerrett, 1994). These iron-binding properties are of value in the defence of 
epithelial surfaces against most of bacterial infections. However, an earlier study by 
Sparling (1983) has shown that P. multocida an important bacteria causing BRD in cattle 
are capable to overcome the effects of lactoferrin and utilises this protein as a source 
of iron.   
Flemming and Allison in 1922 have reported the presence of lysozymes in human NS and 
its ability to kill bacteria by targeting their cell wall.  Later, Kelly et al. (1982) have 
able to demonstrate that this enzyme able to specifically hydrolyse the peptidoglycan 
layer of the bacteria cell wall. In general, lysozymes cleaves the β-1,4 glycosidic bond 
between N-acetyl-muramic acid C-1 and N-acetylglucosamine C-4 ( Pahud et al., 1983). 
All lysozymes catalyse the same reaction hence there is a structural homology seen in 
different organisms such as having molecular mas of around 15 kDA and having high 
isoelectric point. It is well established that majority of the bacteria possess 
peptidoglycan. Therefore the ability of lysozyme having the bactericidal properties 
against these bacteria is probably due to an early destabilization of the cell wall outer 
membrane.  
Raphael et al. (1989) have demonstrated by histochemical analysis of the nasal 
turbinate tissue and revealed lactoferrin and lysozyme localize within the serous cells of 
submucosal glands, hence providing evidence that both of these proteins are strictly 
glandular products within the nasal mucosa indicating that they are produced and 
secreted from the glands. 
1.2.2.5  Surfactant proteins 
Surfactant proteins are a family of collagenous carbohydrate binding proteins released 
by psuedostratified ciliated cells, type II and Clara cells into the airway and/or alveolar 
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lumen and have very potent antimicrobial and immunomodulatory roles (Wright, 1997 
and Pastva et al., 2007). Surfactant protein A (SP-A) and D (SP-D) can bind and 
inactivate microbial agents. Grubor et al. (2006) have demonstrated that both of these 
proteins have a carbohydrate recognition domain (CRD) that binds to mannose residues 
of microbial pathogens. Once bound, the pathogen and surfactant protein complex can 
aggregate and be taken up by alveolar macrophages thus inhibiting adherence to 
epithelial lining. Once released, SP-A can activate macrophages and enhance 
macrophage uptake and killing of microbial pathogens. In addition, SP-A present within 
the alveolar lumen liquid can be taken up by the pulmonary lymphatic drainage system 
and enter the blood (Poulsen and McGuirk, 2009). 
1.2.2.6  Defensin 
Cationic peptides form a significant part of the phagocytes oxygen-independent 
antibacterial system.  Defensins (α and β) are an important part of the multifactorial 
defence against pathogens in barrier organs like the nasal mucosa (Thienhaus et al., 
2011). These important cysteine-rich peptides actively involved in the innate immunity 
and anti-microbrial defence mechanism by way of binding to  the bacterial cell 
membrane and neutralising the virulent effects of the bacteria (Yang et al., 2001). 
These peptides have been subjected to crystallisation and nuclear magnetic resonance 
exhibiting a distinct hydrophobic and charged region that allowing them to invade the 
phospholipid membrane thus assisting bacteriolysis. This ability is attributed to the 6 
cysteine of each peptide that forms a circular molecule, stabilised by intramolecular 
bonds and creating ion-permeable channels in the membrane (Patrick and Larkin, 1995). 
In addition, their broad-spectrum bactericidal effects are non-specific and apply to both 
Gram-positive and Gram-negative bacteria (Takemura et al., 1996 and Nakajima et al., 
2003) as well as modulating infections of both enveloped and non-enveloped viruses 
(Ding et al., 2009). These effector molecules have also been associated in the release of 
chemokines (IL-8) by airway epithelial cells (van Wetering et al., 2002) and 
degranulation of mast cells realising histamine (Befus et al., 1999) hence providing 
evidence for their involvement in the inflammatory response. 
 
1.2.3  Endotoxins as activators of innate immunity 
Lipopolysaccharide is the major pathogen-associated molecular pattern (PAMP) having 
potent pro-inflammatory properties toward many cell types (Drake et al., 1993).  They 
are found in the cell wall of Gram-negative bacteria and in cattle as in other mammals, 
are recognized by the TLR4 in conjunction with the serum protein, lipopolysaccharide-
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binding protein (LBP), and the CD14 co-receptor.  CD14 binds to the LBP-LPS complex 
(Figure 1.3) and since CD14 lacks a transmembrane domain which is an accessory 
receptor complex (TLR4 and MD2) is required to initiate a cell signal transduction 
(Wright et al., 1990 and Schumann, 1992). 
Lipid A is an essential part of the LPS consist of a glucosamine based phospholipid that 
makes up the outer monolayer of the outer membranes of most Gram-negative bacteria 
(Rietschel et al., 1994 and Zähringer et al., 1999).  Most types of lipid A molecules are 
detected at pico molar levels by an ancient receptor of the innate immune system 
present on macrophages and endothelial cells of animals (Aderem and Ulevitch, 2000 
and Medzhitov and Janeway, 2000). The receptor now identified as TLR4 (Poltorak et al. 
1998, Hoshino et al., 1999), is a membrane covering protein that is distantly related to 
the IL1 receptor (Aderem and Ulevitch, 2000 and Medzhitov and Janeway, 2000).  Lipid 
A activation of TLR4 in macrophages triggers the biosynthesis of diverse mediators of 
inflammation, such as TNF-α and IL1-β (Beutler and Cerami, 1989) and activates the 
production of co-stimulatory molecules required for the adaptive immune response 
(Medzhitov et al., 2000).  In mononuclear and endothelial cells, lipid A also stimulates 
tissue factor production (Drake et al., 1993 and Li et al., 1998).  
In cattle and other mammals, the interaction of lipid A with TLR4 likely involves other 
proteins, including not only the phosphatidylinositol glycan-linked surface protein CD14 
(Yang et al., 1996 and Nemchinov et al., 2006) but also the soluble accessory protein 
MD2 (Lizundia et al., 2008). MD2 is associated with TLR4 on the cell surface and enables 
TLR4 to respond to LPS, thus providing a link between the receptor and LPS signalling 
(Dziarski and Gupta, 2000). It is essential for the correct intracellular distribution, cell 
surface expression, and LPS recognition of TLR4. This may be a target for neutralizing 
the toxic effects of endotoxin.  
In contrast, TLR2 appears to be less specific than TLR4 in that it is activated by diverse 
ligands, including bacterial lipoproteins and peptidoglycan fragments (Lien et al., 1999). 
This is though MD2 enables TLR2 to respond to non-activating LPS and lipid A, and 
enhances TLR2-mediated responses to Gram-negative and Gram-positive bacteria, the 
association with TLR2 is weaker than with TLR4 (Dziarski and Gupta, 2000).  TLR6 may 
function together with TLR2 to recognize a subset of bacterial membrane proteins and 
lipopeptides (Hajjar et al., 2001). Whereas TLR3 is activated by double-stranded RNA 
(Alexopoulou et al., 2001), and TLR5 is activated by bacterial flagellum (Hayashi et al., 
2001). 
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1.2.4  Systemic acute phase response  
Systemic response in cattle during BRD or infections involving the respiratory normally 
associated with fever, pain, endocrine and metabolic alterations in serum protein 
concentrations characterised by the production of APP. The major APPs in cattle are 
mainly Haptoglobin (Hp), serum amyloid A (SAA), Ceruloplasmin (Cp) and Alpha-1 acid 
glycoprotein (AGP).  Additionally, cytokines mainly IL-1, IL-6 and TNF-α produced by 
monocytes and macrophages activated by pathogens responsible for increasing the 
systemic acute phase response (APR). 
The APR is an important feedback to avoid further destruction to the site of injury. It 
restricts the growth of and elimination of the pathogens as well as to remove damaged 
tissue and activate the process of restoring homeostasis.  The APR essentially is a non-
specific immune response succeeded by a specific immune response (Hirvonen et al., 
1999). Under the effect of IL-1 and TNF-α and especially IL-6, hepatocytes increase the 
synthesis of APP which is a group of plasma glycoproteins which could increase in 
concentration up to 25% in response to tissue damage. The rate of increase depends on 
the type of APP and it is varies among species of animal. These proteins can function as 
Figure 1.3:  Lipopolysaccharide signalling cascade.  
Signalling LPS recognition is facilitated by LBP and CD14, and is mediated by TLR4/MD2 receptor 
complex. 
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mediators, modulators, scavengers, inhibitors and immune-modulator during 
inflammation. Haptoglobin and SAA are two major APP related with different disease or 
pathological condition in cattle while Cp and AGP is a moderately responding APP. 
These proteins have shown to be sensitive and reliable markers for inflammation in 
cattle (Horadagoda et al., 1999).  
1.2.4.1  Haptoglobin 
The protein Hp were first documented by Bremner in 1964 showing that this protein is 
virtually undetectable in the plasma of healthy calves, able to reach up to 1 mg per ml 
during inflammation. In ruminants, there is particularly a strong Hp response to 
infection, with the concentration in the circulation increasing up to 100-fold or more, 
hence measuring of this protein could be important in assessing the health status and 
outcome of cattle to BRD.  
In addition, Bremner (1964) has also reported that the serum Hp levels decrease during 
haemolysis due to an increased uptake of Hp-haemoglobin complexes by the hepatic 
system where they were later recycled. Haptoglobin-haemoglobin complexes were 
detected in 0.6% of clinically healthy cattle, however were found in most of the cows 
diagnosed with bacterial infection (Spooner and Miller, 1971). Haptoglobin acts as an 
effective antimicrobial property by rendering the iron present in haemoglobin for 
bacteria proliferation. Based on this ability, Eckersall et al. (1999) have shown that Hp 
detection is a useful diagnostic test for the detection of inflammatory disorders in 
animals. 
1.2.4.2  Serum amyloid A 
Serum amyloid A is a precursor of amyloid A with a molecular weight of approximately 
9–14 kD, is an apoprotein and one of the important serum acute phase reactive proteins 
in cattle (Husebekk et al., 1988 and Takahashi et al., 2009).  Boosmann et al. (1989) 
have shown that bovine SAA, increases 100-fold in cattle inoculated experimentally with 
E. coli LPS toxins. Other experimental studies have measured the SAA response in cattle 
following inoculation of pathogens associated with BRD like M. haemolytica 
(Horadagoda et al., 1993), bovine respiratory syncytial virus (BRSV) (Heegaard et al., 
2000) and P. multocida (Hodgson et al., 2005). Serum amyloid-A was observed to be a 
sensitive APP that reacts faster than Hp following infections (Alsemgeest et al., 1994 
and Horadagoda et al., 1994). 
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1.2.4.3  Alpha-1 glycoprotein 
Alpha-1 glycoprotein is a highly glycosylated protein which build up by about 45% 
carbohydrate. This sugar is the composition of the glycan residues known to alter during 
an acute phase response (Fournier et al. 2000). AGP is considered to be a natural anti-
inflammatory and immune-modulatory agent. It has also been suggested that AGP is 
required to maintain capillary permeability (Fournier et al. 2000). Concentration of AGP 
is known to increase in several cattle disease including pneumonia, mastitis and 
following subcutaneous inoculation of M. haemolytica in calves (Walker et al., 1994). 
Plasma concentrations of AGP rise in a slower rate following tissue injury in cattle in 
compare to other APP (Conner et al., 1988). In addition, AGP is also one of the most 
important drug binding proteins in plasma with important pharmacokinetic implications 
(Huang and Ung 2013) hence provide a way to monitor responsiveness to antibiotic often 
use in treatment of BRD cases. It exhibits a moderate acute phase response in most 
species and is more likely to be associated with chronic conditions.  
 
1.2.4.4  Ceruloplasmin 
Ceruloplasmin is a protein of the α-2 globulin fraction, a glycoprotein containing six 
copper (Cu) atoms and nine sialic acid (N-acetylneuraminic acid) residues per molecule 
(Frieden, 1980). It is a ferroxidase enzyme that is the major copper-carrying protein in 
the blood and plays a role in iron metabolism (Lovstad, 2006). In cattle, plasma Cp 
activities are dependent on liver Cu reserves, with lowered activities reflecting a 
depletion of these reserves to maintain Cu homeostasis (Paynter, 1982). 
 
Ceruloplasmin has been evaluated as a marker of animal health and welfare (Skinner, 
2001).  Several studies in cattle indicate its diagnostic use with applications in many 
disease conditions (Sheldon et al., 2002, Laven et al., 2007 and Szczubial et al., 2008).  
The levels of Cp were measured to observe the effect of copper deficiency on response 
of calves to a respiratory disease challenge with live infectious bovine rhinotracheitis 
virus (IBRV) followed by intratracheal administration of P. hemolytica (Gengelbach et 
al., 1997). Another respiratory challenge study done on calves have shown that the 
concentrations of Cp in the serum increase during induced pneumonic pasteurellosis, 
with the highest concentrations observed 2 and 4 hours after the inoculation (Fagliari et 
al., 2003).  
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1.3  Alkaline phosphatase  
1.3.1  Introduction 
Alkaline phosphatase (AP; EC 3.1.3.1), has been continuously and extensively 
investigated in veterinary medicine for more than 70 years. Throughout that period, 
observations of the disease-related changes in AP activity in animal plasma and other 
bodily fluid provided a constant stimulus to explain the related pathology and extend 
the range of diagnostic applications.  
The knowledge of the structure and function of AP has increased greatly in recent 
years. The importance of phosphate transfer in an animal biological system is reflected 
by the ubiquity of phosphate compounds. Phosphate containing compound covers many 
biologically important tasks, such as being essential intermediary metabolites, genetic 
materials, maintenance of homeostasis and reservoirs of biochemical energy 
(Westheimer, 1987). Due to the low reaction rates of phosphate ester hydrolyse, hence 
a catalyst is essentially required. The superfamily of enzymes called phosphatase has 
biochemical machinery enabling it to hydrolyse phosphoesters rapidly under mild 
cellular conditions. 
Alkaline phosphatase hydrolyses non-specifically phosphate monoesters at alkaline pH to 
produce inorganic phosphate and an alcohol (Coleman and Gettins, 1983).  Figure 1.4 
describes the AP reaction. It catalyses the cleavage of a phosphate groups from a 
variety of compounds, including Ribonucleic Acid (RNA) and DNA and the artificial 
substrates (Wilson and Walker, 2000). Alkaline phosphatase also catalysis trans-
phosphorilation of phosphate esters and hydrolysis, where in the presence of a 
phosphate acceptors, AP transfers phosphate to alcohol to form another phosphate 
monoester, thereby recycling inorganic phosphate within the living cells. Free inorganic 
phosphate is required for the uptake and the participation in biochemical reactions 
(Coleman, 1992).  Interestingly, the final hydrolysis product, inorganic phosphate is also 
a strong competitive inhibitor of the enzyme, and when it is bound to the active site, it 
fills its entire volume (Stec et al., 2000). In addition, due to its catalytic efficiency, AP 
is also widely used in molecular biology labs, especially for manipulation of nucleic 
acids. During the DNA cloning activity of AP is used for removal of 5’ phosphates. The 
use of a dephosphorylated vector is required to prevent it from reclosing on itself (self-
ligation), and to favour it’s insertion into a DNA fragment that has 5’ phosphates still 
present. Also AP is widely used for the removal of 5’ phosphates from DNA and RNA 
prior to labelling with radioactive phosphate (Wilson and Walker, 2000). 
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Figure 1.4:  Schematic representation of the reaction mechanism of AP. 
  
1.3.2  Regulation and distribution 
As its name suggests, the tissue-nonspecific gene is widely expressed in the bovine 
tissues, in contrast to the localized expression of the intestinal genes or the placental 
genes seen in human and pig.  At this moment, there are two structural genes encoding 
bovine AP have now been sequenced (Hua et al., 1985 and Weissig et al., 1993) and 
mapped to bovine chromosomes (Zimin et al., 2009). The tissue-nonspecific AP gene, 
expressed in osteoblasts, hepatocytes, kidney and other cells, is located at 124,938,738 
<- 124,999,046 covering 99.29 centisomes on Chromosome 2. Bovine IAP as the name 
implies expressed by the enterocytes is encoded by a locus on chromosome 2, at 
108,882,752 -> 108,932,683 covering 86.53 centisomes in legth (biocyc.org). The 
sequence homology between the tissue nonspecific AP and intestinal gene is 67% (Figure 
1.5). 
While the main features of the catalytic mechanism are conserved comparing 
mammalian and bacterial APs, mammalian APs have higher specific activity and Km 
values; have a more alkaline pH optimum display lower heat stability,  membrane-
bound and are inhibited by L-amino acids and peptides through an uncompetitive 
mechanism. These properties, however, differ noticeably among the different 
mammalian AP isoenzymes and are likely to reflect very different in vivo functions. 
Table 1.3 summarizes the nomenclature, tissue distribution and some of the functions 
of human and bovine AP isoenzymes.  Importantly, APs have homology to a large 
number of other enzymes and are part of a superfamily of enzymes having some 
overlapping catalytic properties and substrate specificities. 
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Figure 1.5:  Comparison of nucleotide sequence similarity between the 
bovine ALPL gene and bovine ALPI gene. 
  
 Accession 
numbers 
Sequence 
length 
Mass (Da) Protein 
names 
 
Common names Tissue distribution General function 
Human 
genes 
ALPL 
 
 
NM_000478 
 
 
524a 
447b 
469c 
 
 
57,305 
48,909 
51,045 
 
 
TNAP 
 
 
Alkaline phosphatase 
liver/bone/kidney isonzyme; 
Alkaline phosphatase, tissue-
nonspecific isoenzyme ;TNSALP 
 
 
 
Skeletal tissues, liver, 
kidney 
 
 
Bone mineralization 
ALPI NM_001631 528 56,812 IAP Intestinal-type alkaline 
phosphatase; IALP 
 
Small intestine, 
influenced by fat feeding  
Intestinal absorption 
ALPP NM_001632 535 57,954 PLAP Placental alkaline phosphatase; 
PLALP 
Syncytio-trophoblast,  
a variety of tumours 
 
Unknown 
ALPP2 
 
NM_031313 532 57,377 GCAP Germ cell alkaline phosphatase; 
GCALP 
Testis, malignant 
trophoblast 
Unknown 
 
 
Cattle 
genes 
ALPL 
 
NM_176858 
 
524 
 
57,193 
 
TNAP 
 
Alkaline phosphatase 
liver/bone/kidney isoenzyme; 
Alkaline phosphatase, tissue-
nonspecific isoenzyme ;TNSALP 
 
 
Skeletal tissues, liver, 
kidney 
 
Bone mineralization, response to 
vitamin D,  
ALPI NM_173987 533 57,100 IAP Intestinal-type alkaline 
phosphatase; IALP 
 
Small intestine Zinc ion binding, 
dephosphorylation 
Table 1.3:  Summary of the gene nomenclature, accession numbers, sequence length, mass, common names, tissue distribution and function for the 
human and cattle AP isoenzymes.  
Data were tabulated from www.uniprot.org. a-b represents 3 different AP tissue non-specific isoenzymes in human. 
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1.3.3  Coding and isoenzyme 
The constructed crystal structure of the placental isoenzyme in human and subsequently 
modelling of the three-dimensional core structures of the mammalian APs has enabled 
scientist to differentiate features of the animal enzymes that differ from those of the 
bacterial enzymes (Kim and Wyckoff, 1989). Most of the studies conducted have now 
accepted that AP is a homodimeric metalloenzyme with 449 amino acid residues, 30Å 
apart and 3 distinct metal binding sites for one magnesium and two zinc ions. The 
active site is located in a pocket created by the termination of a number of helices and 
sheets that is open to the surface (Kim and Wyckoff, 1991). Interestingly, this 
heterodimeric type of AP is also found in bovine pre-attachment embryos (McDougall et 
al., 2002) and cancer cells (Le Du and Millán, 2002).  
The synthesis of this glycoprotein begins in the cytoplasm, where the translation 
product of AP gene (phoA) is folded into the trypsin insensitive monomeric precursor 
(Akiyama and Ito, 1993), which is later transported to the periplasmic space, where it 
spontaneously dimerises and binds metal ions (Martin et al., 1999). Disulphide bridges 
play an important role in correct protein folding and stability (McCammon et al., 1976). 
A major property of bovine APs that is important in terms of structure is the large 
variability in catalytic activity displayed in this species, which have 10–100-fold higher 
kcat values than E. coli AP (Murphy et al., 1995). Besman and Coleman (1985) have 
demonstrated the existence of two IAP isozymes in the cow intestine which is calf IAP 
and adult bovine IAP, by sequencing the amino termini of chromatographically purified 
AP fractions. 
Sequence assessments (Kim and Wyckoff, 1990) between the mammalian APs and the E. 
coli AP, for which the 3 dimensional structures is known (Sowadski et al., 1985) have 
indicated that they conform to the basic α/β architecture of the E. coli enzyme with a 
highly-conserved central β-sheet. However, the eukaryotic enzymes possess highly 
variable loops and major insertions with no equivalents in the E. coli structure (Millan, 
1992). These variable regions are in some instances associated with unique properties of 
the mammalian APs, such as uncompetitive inhibition (Hummer and Millan, 1991; 
Hoylaerts and Millan, 1991 and Hoylaerts et al., 1992) and binding to extracellular 
proteins (Van Amersfoort et al., 2003). These regions may be responsible for other novel 
AP isoenzyme later discovered in this study, which could have specific functions such as 
LPS dephosphorylation. 
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Alignment and comparison of amino acids sequences between bovine and human APs 
were given in Figure 1.6 and the percentage of similarity were tabulated in Table 1.4. 
The phylogenetic tree was constructed for and presented at Figure 1.7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Bovine TNAP Bovine IAP 56% a 
Human TNAP 90% 55%  
Human IAP 60% 78%  
Human PLALP 56% 74%  
Human GCAP 57% 75%  
Table 1.4:  Identical percentage of amino acid sequence alignment between bovine and 
human APs.  
a The homology of bovine TNAP and IAP amino acid sequence are 56%. 
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Figure 1.6:  Comparison of amino acid sequences of bovine TNAP (P09487), bovine 
IAP (P19111), human TNAP (P05186), human IAP (P09923), human PLALP (P05187) 
and human GCAP (P10696).  
Amino acid properties having similarity were highlighted in dark grey. 
 
 
 
 
 
Figure 1.7:  Phylogenetic tree between bovine and human APs.  
Bovine TNAP (P09487), bovine IAP (P19111), human TNAP (P05186), human IAP (P09923), human PLALP (P05187) and human GCAP (P10696). 
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1.3.4  Alkaline phosphatase and lipopolysaccharides  
AP is abundantly expressed at locations where possible endotoxin producing microbes, 
like M. haemolytica or P. multocida, may enter the systemic circulation via the 
respiratory or digestive tract. Exposure of cells that form a barrier between the host’s 
internal milieu and the external environment to LPS result in upregulation of AP, 
suggesting that AP also serves a role in the natural defense system against an LPS insult 
(Koyama et al., 2002; Hayama et al., 2002; Koyama et al., 2004 and Vaishnava and 
Hooper, 2007). Furthermore, since AP catalyses the hydrolysis of phosphomonoesters 
and expression of AP is induced after the occurrence of LPS, it is strongly believed that 
this enzyme was able to detoxify LPS. Lipid A moiety contains 2 phosphate groups, and 
when one of the molecules might be removed by AP, this would then results in the 
release of inorganic phosphate (Pi) and the formation of monophosphoryl LPS (Poelstra 
et al., 1997a and Poelstra et al., 1997b). Monophosphoryl LPS is less effective than LPS 
to induce an inflammatory response, probably because it is not recognized by one of the 
components of the LPS cell signalling cascade.  
Various studies have reported the promising effects of AP against LPS insult in a variety 
of animal models. A reduction in the inflammatory response induced by LPS could be 
observed in piglets and mice after treatment with bovine IAP (Beumer et al., 2003; van 
Veen et al., 2005 and Fiechter et al., 2011).  Koyama et al. (2002) have shown that rats 
given an oral treatment of LPS have resulted in a prolonged endotoxemia when 
endogenous IAP was inhibited. The relative of AP reducing inflammation and preventing 
mortality on LPS-mediated diseases has been demonstrated in many studies involving 
Gram-negative bacteria insults. A study conducted in mice infected with a lethal dose 
of Gram-negative bacteria has shown that the mortality rate was reduced after 
injection of IAP derives from calves (Beumer et al., 2003).  A study conducted by van 
Veen et al. (2005) has shown how cytokine response and neutrophil influx was seen in 
secondary peritonitis in mice after being attenuated by bovine IAP. Another study by Su 
et al., (2006) shown that sheep injected with faeces into their peritoneal to create 
severe peritonitis and septic shock model, have decreased IL-6 concentrations and 
prolonged survival time after bolus of bovine IAP was administered by intravenous. 
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1.4  Proteomics for the analysis of bovine nasal secretion 
1.4.1  Introduction 
Proteomics, the promising new “omics,” has become an important complementary tool 
to genomics providing novel information and greater insight into veterinary diseases. 
Since the completion of the bovine genome, the interest of the scientific community 
has evolved toward understanding the bovine proteome. The genomic and proteomic 
data will facilitate the understanding of the functions of proteins in human and 
veterinary diseases and the discovery of novel drug target proteins and biomarkers of 
diseases. Hence, highly sensitive analytic techniques are necessary to study the 
complexity of biologic samples.  
Wilkin et al. (1996) invented the word the term “proteome” in the mid-1990s. They 
have described proteome as the entire set of proteins expressed by its genome. 
Proteomics refers to the technical analysis of all the proteins in a given set of 
proteome. The application of gel-based and gel-free proteomics methods to better 
understand bovine response towards diseases and identification of potential disease 
biomarkers has strongly increased in recent years. The key to any proteomics 
experiment is to reduce the complexity of the sample before mass spectrometry (MS) 
analysis.  
The application of proteomic approaches over the last decade has provided new tools 
for clarifying the molecular aspects of physiological states, and for understanding the 
aetiology and pathogenesis of many diseases.  Nevertheless, proteomic studies in 
veterinary medicine, particularly in the bovine species, remain limited compared with 
human medicine. Conventional approaches to the characterization of protein changes in 
complex biological fluids have required the availability of species-specific antibodies for 
the detection and quantification of a given protein. Use of antibody-based strategies 
such as ELISA in biomarker discovery analyses however, limits the identification and 
characterization of novel candidates, as well as the detection of posttranslational 
modifications (PTM) of target proteins (Boehmer and Olumee-Shabon, 2005).  An 
advantage of proteomics in biomarker discovery is the ability to detect a theoretically 
unlimited number of proteins in a given sample without the need for antibodies. 
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1.4.2  Proteome markers associated with pneumonia in cattle 
Proteome based biomarkers are important for early diagnostics in veterinary medicine. 
Biomarker studies on farm animals usually focuses on monitoring animal health and 
welfare and to investigate type and state of disease, for the purpose of ensuring animal 
welfare as well as for monitoring quality and safety of animal products (Bendixen et al., 
2011).  Despite the recognized importance of NS proteins as effectors of pulmonary 
defence and homeostasis, as far as the author aware, no proteomic study has been done 
to determine how they are altered during the disease or other physiological stress 
response. Most of the proteomic work using biological fluid associate with the 
respiratory system were mostly using epithelial lining fluid (EPL). Bronchoalveolar 
lavage is used to sample the EPL also known as brochoalveolar lavage fluid (BALF). In 
human, the application of BALF to the study of lung diseases began since the mid-1970s 
and has contributed greatly to knowledge of local immune-inflammatory responses in 
normal and pathological conditions.  
Proteins thought to function in the pathophysiology of several pulmonary disease states 
have been recently identified using proteomic analyses such as 2-DE (Magi et al., 2006) 
and this approach could further be used to predict markers of BRD susceptibility or 
identify therapeutic targets in cattle. Van der Vliet and Cross (2001) have reported that 
investigation of the ELF by 2-DE has revealed stress dependent alterations in several 
functional groups of proteins including those involved in oxidative stress such as 
superoxide dismutase (SOD) and glutathione peroxidase (GPx)  and the APR like albumin 
and  Hp. Other proteins that were observed in bovine EPL to have significant change 
during stress due to transportation were annexin A1, isocitrate dehydrogenase, 
fibrinogen, heme-binding protein 1 and odorant-binding protein (Mitchel et al., 2008). 
In another proteomic study, Mitchell et al. (2007) have examined the EPL of bovine 
respiratory tract and revealed that, under the influence of dexamethasone, an APR 
occurs with induction of adipocyte-fatty acid binding protein and OBP.  Recent work 
from the same group using DiGE to analyse BALF collected from stressed calves caused 
by weaning and  transportation have found that calves that later would developed 
pneumonia had significantly lower levels of annexin A1, annexin A2, peroxiredoxin I, 
calcyphosin, superoxide dismutase, macrophage capping protein and dihydrodiol 
dehydrogenase 3. They have concluded that the low levels of annexins A1 and A2 found 
to be potential biomarkers of increased the calves’ susceptibility to pneumonia 
(Senthilkumaran et al., 2013). 
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1.4.3  Gel-based proteomics 
1.4.3.1  Protein solubilisation 
Due to the major problem of protein solubility, the majority of electrophoretic protein 
separations are made under denaturing conditions. Therefore, in order to take 
advantage of the high resolution capacity of gel electrophoresis, proteins would be 
completely disaggregated, reduced and solubilised to disrupt molecular interactions also 
to ensure separation into individual polypeptide (Gordon and Jencks, 1963).  
Two types of reagents are used in 2-DE buffers to ensure protein solubility and 
denaturation. The first type, chaotropes such as urea or thiourea were used at multi 
molar concentrations, is able to unfold proteins by weakening non-covalent bonds 
between proteins (Gordon and Jencks, 1963).  The second one is ionic detergents, in 
which SDS (sodium dodecyl sulfate) is the archetype. It is made of a long and flexible 
hydrocarbon chain linked to an ionic polar head. The detergent molecules will bind 
through their hydrophobic hydrocarbon tail to hydrophobic amino acids, subsequently 
promoting denaturing by binding favours amino acid-detergent interactions over amino 
acid-amino acid interactions (Abdallah et al., 2012). 
1.4.3.2  One-dimensional gel electrophoresis  
Gel-based proteomic is the most important and versatile method of global protein 
separation and quantification. One-dimensional gel electrophoresis (1-DE) became the 
most popular method for fast determination of protein Mw and assessing the protein 
purity. This widespread technique is used for many applications mainly preliminary 
comparison of protein composition of different samples, analysis of the number and size 
of polypeptide subunits, western blotting coupled to immune-detection, as a second 
dimension in 2-DE. 
Taking advantage of both gel-based protein and gel-free peptide separation properties, 
1-DE regularly coupled to subsequent analysis in liquid chromatography (LC) prior to MS. 
After protein separation on SDS gel, the entire gel lane is excised and divided into slices 
prior to the proteolytic digestion (Batycka et al., 2006). Later, peptide fractions are 
subjected to a second separation in LC prior to MS/MS analysis. The main aim of this 
technique is to ensure protein solubility during the size separation step and the reduced 
sample complexity prior to LC by means of exposing the harsh ionic detergent of SDS. 
Unfortunately, this however would further reduce the chance of identifying low 
abundant proteins. 
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1.4.3.3  Two-dimensional gel electrophoresis  
Since it was first introduced by O’Farrell in 1975, two-dimensional gel electrophoresis 
(2-DE) has evolved at different levels and became the classical approach of protein 
separation and the method of choice for differential protein expression analysis (Petrak 
et al., 2008 and Chanthammachat et al., 2013). Two-DE separates proteins in the first 
dimension by IEF based on their charge at different pH values, and then in the second 
dimension by size and mass. This technique has an excellent resolving power, and it is 
now possible to visualize over 10,000 spots corresponding to over 1,000 proteins, 
multiple spots containing different molecular forms of the same protein, on a single 2-
DE gel (Svesson et al., 2009). In addition, the use in analysis of post-translational 
modifications including phosphorylation and glycosylation is of paramount importance, 
since their alteration is frequently related with pathological states. However, moderate 
reproducibility and limited detection for hydrophobic proteins such as membrane 
proteins, low abundance proteins, proteins above or below the pore size of the gel as 
well as proteins beyond the pH range of the IPG strips are shortcomings of 2-DE 
(Chevalier, 2010). 
1.4.3.4  Difference gel electrophoresis  
Although no technique has a better resolving power than classical 2-DE, many 
endeavours were made to step forward and make it suitable to study membrane 
proteins (Vertommem et al., 2011), and to overcome the protein ratio errors due to low 
gel-to-gel reproducibility, by the use of difference gel electrophoresis (DiGE; Unlu et 
al., 1997).  
DiGE enables protein detection at sub picomolar levels and relies on pre-electrophoretic 
labelling of samples with one of three spectrally resolvable fluorescent CyDyes (Cy2, 
Cy3, and Cy5). These dyes have an NHS-ester reactive group that covalently attaches to 
the ε-amino group of protein lysines via an amide linkage (Alban et al., 2003). Normally, 
the ratio of dye to protein is designed to ensure that the dyes are approximately 
covering 1-2% of the available proteins where only a single lysine per protein would be 
labelled. Inter gel comparability is achieved by the use of an internal standard usually 
by mixing of all samples in the experiment,  labelled with Cy2 and co-resolved on the 
gels that each contains individual samples labelled with Cy3 or Cy5. Since every sample 
is multiplexed with an equal aliquot of the same Cy2 standard mixture, each resolved 
feature can be directly related to the Cy2-labelled internal standard, and ratios can be 
normalized to all other ratios from other samples and across different gels. This can be 
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done with extremely low technical variability and high statistical power (Alban et al., 
2003 and Karp and Lillley, 2009). 
1.4.3.5  Gel staining and protein identification 
The gel must firstly be immersed in a fixation solution containing acid usually 
phosphoric acid or acetic acid, later with ethanol or methanol as a function of the 
staining protocol selected (Chevalier et al., 2007). Conventional dyes are colloidal 
Coomassie Blue and silver nitrate, at quite different sensitivities: 50, 10 and 0.5 ng of 
detectable protein spots respectively (Neuhoff et al., 1990; Mortz et al., 2001; 
Chevalier et al., 2007; Smejkal, 2004 and Lanne and Panfilov, 2005). Colloidal 
Coomassie blue or fluorescent dyes are recommended for the staining of the preparative 
gel, because they have good compatibility with MS (Ball and Karuso, 2007; Cong et al., 
2008 and Nock et al., 2008). In contrast, Mortz et al. (2001) and Chevalier et al. (2004) 
have reported that silver nitrate will give poor results, even if MS compatible protocols 
are available. Stained protein spots of interest are excised, commonly digested with 
trypsin and analysed by MS, such as peptide-mass mapping by matrix-assisted laser 
desorption/ionization–time-of-flight mass spectrometry (MALDI-TOF MS), and peptide 
sequencing by electrospray ionization tandem mass spectrometry (ESI-MS/MS) (Ong and 
Pandey, 2001). 
1.4.4  Benefits of gel-based proteomics 
1.4.4.1  Characterization of protein isoenzyme 
At present, there is a growing interest by scientists in the area of identifying post-
translational modifications (PTMs) and spliced gene or protein variations (Schulenberg 
et al., 2004 and Ahrer and Jungbauer, 2006). Today, with the option of having 
automatic 'in-gel' digests and identification of peptides with MS, determining protein 
expression in a particular proteome has become a relatively simple task. Most of the 
proteins are identified by either assigning them definitive protein attributes, such as 
peptide masses generated by MALDI-TOF mass spectrometry or with the short amino 
acid sequences generated by tandem MS (Chevalier, 2010). It is clear that when several 
spliced variants are present in a proteome, such approach for protein identification 
mostly characterizes peptides common to all spliced variants.  
In a precedent study conducted by Hirtz et al. (2005), they have shown the used of 2-DE 
separation to analyse alpha-amylase isoform diversity in human saliva exist as a discrete 
purified protein and it is unique to its original proteome. However, the use of 
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electrophoretic features have allowed detail analysis of proteome separation and 
simultaneous hierarchical clustering of the observed peptides in the mass spectra. 
Consequently they have able to define several groups of isoforms present with specific 
sequence characteristics that potentially related with specific biological activities. In 
another recent study by Chevalier et al. (2009), they have shown to use 2-DE separation 
to analyse isoforms and polymers forms of bovine milk proteins where a combination of 
reducing and non-reducing steps to show proteins polymers occurring before and after 
heat treatment of milk. This strategy revealed numerous disulphide-mediated 
interactions and has proposed to analyse reduction or oxidation of milk and dairy 
product proteins. 
1.4.4.2  Reduced gel to gel variation with DiGE 
Unlu et al. first conceived DiGE in 1997 by taking advantages of the structurally protein 
samples, which are later co-separated on a single 2-DE gel (Viswanathan et al., 
2006).The major advantage of DiGE over other gel electrophoresis based systems is that 
it allows the analysis of two or more protein samples simultaneously on a single 2-DE 
(Wheelock et al., 2006; Hrebicek et al., 2007 and Karp et al., 2008). Since the same 
proteins present in two different samples were pre-labelled with two different dyes 
commonly cyanine 3 (Cy3) and cyanine 5 (Cy5), they could be combined and separated 
on the same 2-DE without the loss of the relative protein abundance in the original 
samples. At the end of protein separation, the relative ratio of proteins in the two 
original samples could be readily obtained by comparing the fluorescence intensity of 
the same protein spots under different detection channels using a commercial 
fluorescence gel scanner. 
Since there is only one gel is used in DiGE, and the same proteins from two different 
protein samples co-migrate as single spots, there is no need for superimposition of 
different gels, making spot comparison and protein quantitation much more convenient 
and consistent. This could make DiGE highly amendable for high-throughput proteomics 
applications, providing opportunities to detect and quantify accurately certain proteins, 
such as low-abundance proteins.  DiGE has shown significant advantages over 
conventional 2-DE in a number of applications. Up to three kinds of fluorescent cyanine 
dyes have been employed in DiGE, namely, cyanine 2 (Cy2), Cy3, and Cy5, which allows 
for simultaneous analysis of up to three different protein samples in a single gel.  
However, one of the problems in DiGE lies in the hydrophobicity of the cyanine dyes, 
which label the protein by reacting covalently with surface exposed lysine in the 
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protein, hence lead to the removal of multiple charges from the protein. Therefore, this 
decreases the solubility of the labelled protein, and in some cases may lead to protein 
precipitation prior to gel electrophoresis. To address this problem, minimal labelling is 
generally employed in when using this method. Typically the labelling reaction is 
optimized such that only 1-5% of total lysine in a given protein is labelled. Shaw et al. 
(2003) have developed a new batch of DiGE Cy3 and Cy5 dyes, which label only free 
cysteine in a protein by means of saturation labelling offering more sensitivity than the 
conventional DiGE method. The major weakness however, is that the system only labels 
proteins that contains free cysteine, making only a certain percentage of proteins in a 
proteome not labelled, causing reduced in the detection and characterization of other 
proteins (Arnold and Fröhlich, 2012). 
1.4.4.3  Post translational modifications 
Krishna and Wold, (1993) have reported that there is  more than 200 post translation 
modifications (PTMs) of proteins that provide subtle regulatory control systems within 
the complex molecular machinery of cells and tissues.  Two-DE gel method is suited for 
the detection and identification of PTMs. In most cases, the proteins are modified only 
at a few sites. Therefore, most digestion-derived peptides are exactly the same in the 
unmodified and modified forms of the proteins (Rabilloud, 2002). This ensures correct 
identification of the protein in the databases without requiring much peptide 
sequencing effort. Characterization of PTMs is crucial for biomarker discovery, because 
much of the regulation of the biological activity of proteins is mediated by the 
modification of peptide amino acid residues, including the phosphorylation of serine and 
threonine, and the glycosylation of asparagine, arginine, or tyrosine (Boehmer, 2011a 
and Boehmer, 2011b). 
Detection of PTMs in 2-DE gel usually achieved by detection of altered separation 
parameters (pI and Mw) of that modified proteins. However, although there is always a 
mass alteration, it is generally too small to be detected in the SDS dimension. The only 
exceptions to this rule is the obvious mass increase sometimes encountered in 
phosphorylation and the mass decrease seen when a rather large peptide is cleaved. 
Therefore, the parameter leading to the detection of modifications is most often the pI.  
Unfortunately, this also means in turn that modifications that do not alter the pI such as 
cysteine alkylation or acylation will frequently remain unnoticed. Mass spectrometry 
can define these functional modifications that cannot be predicted from DNA or amino 
acid sequences alone (Mann and Jensen, 2003; Schweppe et al., 2003 and Jensen, 
2004).  PTMs such as phosphorylation, glycosylation, sulfation and acetylation play vital 
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roles in molecular interactions and enzymatic activities.  Yordy and Muise-Helmenicks 
(2000) have reported that protein phosphorylation in human has become a major focus 
of interest for signal transduction pathways and therapeutic targets. 
Determination of the type and precise amino acid location of a particular modification 
is now possible with the use of MS for both mass and ion fragment spectra. Casado 
(2004) have reported several novel proteomic approaches for mapping protein 
phosphorylation including purification of phosphorylated proteins using anti-
phosphotyrosine antibodies, esterification of the amino acid residues with immobilized 
metal affinity chromatography (IMAC) purification, chemical derivatization of the 
phosphorylated proteins, application of phosphoprotein isotope- coded affinity tags to 
enrich low abundance phosphoproteins, identification of phosphoserine and 
phosphothreonine-containing peptides by MS/MS, and protein in gel digestion followed 
by capillary liquid chromatography (capLC-MS/MS). 
1.4.5  Limitations of gel-based proteomic 
1.4.5.1  Low abundance protein 
Low-abundance proteins are seldom noticed or detected on traditional 2-DE maps due 
to the fact that large quantities of abundant soluble proteins usually would obscure 
their detection (Patton, 2002; Yamada et al., 2002; Greenough et al., 2004 and Ahmed 
and Rice, 2005). Most 2-DE based proteomic studies employ a one-extract per gel 
approach and the majority of proteins identified in these studies are in high abundance. 
These low-abundance proteins are considered to be some of the important, including 
regulatory proteins, signal transduction proteins and receptors. Consequently, the 
analysis of low abundance proteins is becoming increasingly common in cellular 
proteomics. The dynamic range of protein concentration can differ considerably 
between biological samples. However, in plasma, the predicted dynamic range of 
proteins is up to 12 orders of magnitude (Chevalier, 2010). Analysis of individually in 
parts not only provides information on protein localization, but also allows detection of 
protein populations that are not detectable in whole cell proteomes (Ahmed and Rice, 
2005).  Generally, it is require to remove abundant proteins from the sample to detect 
the low-abundance proteins.  
The complexity of the serum and plasma proteome presents extreme analytical 
challenges in comprehensive analysis due to the wide variations and dynamic range of 
protein concentrations. Hence, a robust sample preparation usually is required as one of 
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the important steps in the proteome characterization. A specific depletion of high-
abundant proteins from bovine serum and plasma using affinity columns is of particular 
interest to improve dynamic range for proteomic analysis and enable the identification 
of low-abundant plasma proteins (Marco-Ramell and Bassol, 2010). In addition, Smejkal 
and Lazarev (2005) and Hannan et al. (2009) have reported the used of narrow pIs such 
as (2-3 pH units) and very narrow (~1 pH unit) gradients for the first separation that 
enable many more proteins to be resolved. The loading capacity of narrow-range IPGs is 
considerably higher than broad-range IPGs, thus enabling the visualization and 
identification of previously unseen proteins. Sub-fractionation can be used to improve 
the recovery of low-abundance proteins and allow a specific separation between 
abundant or soluble proteins and membrane or low-abundance proteins. For example, 
Nissen et al. (2012) work on bovine colostrum using different fractionation techniques 
each have resulted in detection of unique subsets of proteins where whey production by 
high-speed centrifugation contributed most to detection of low abundant proteins. 
1.4.5.2  High molecular weight protein 
A conventional 2-DE, using SDS-PAGE as second dimension is not practical to visualize 
high-molecular-weight (HMw) proteins. Even with gradient acrylamide gels, it is very 
difficult to obtain a good separation of proteins up to 250 kDa. Alternatively, Yokoyama 
et al. (2009) have shown that HMw proteins and protein-complexes can be analysed 
using agarose gel IEF. Oh-Ishi and Maeda (2007) have also shown that agarose 2-DE is 
sufficiently good at separating HMM proteins with molecular masses up to 500 kDa from 
various diseased tissues and cells. Moreover, this method has successfully used to 
analyse HMw proteins previously from bovine plasma (Dahlbäck and Stenflo, 1981), 
dental enamel (Belcourt et al., 1983) and α-crystallin protein in bovine lens (Kramps et 
al., 1975 and Carver et al., 1996). 
1.4.5.3  Membrane protein 
The resolution of membrane proteins remains an area of considerable concern in gel-
based proteomics because till recently, it is difficult or impossible to effectively resolve 
membrane proteins using 2-DE (Chevallet et al., 1998; Santoni et al., 2000 and Luche et 
al., 2003). Membrane proteins usually are poorly soluble in the detergent or chaotropic 
conditions in IEF, causing proteins samples to be insoluble in gel, subsequently causing 
them to be poorly resolved by IEF and 2-DE.  
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Protein fractionation in combination with the proper solubilizing reagents usually 
produces sample extracts that are highly enriched for membrane proteins. Steps like 
sequential extraction of proteins from a sample by increasing protein solubility is an 
effective strategy for first removing the more abundant soluble proteins and then for 
concentrating the less abundant and less soluble membrane proteins. Macfarlane (1989) 
first described the use of this cationic detergent benzyldimethyl-n-hexadecylammonium 
chloride in first dimension electrophoresis in view to increase the high resolution 
capacity for the purification of proteins from complex mixtures. Later, several studies 
have shown a specific 2-DE method by using the cationic detergent benzyldimethyl-n-
hexadecylammonium chloride in the first and the anionic detergent SDS in the second 
dimension, to analyse membranes proteins in various systems (Dreger et al., 2001 and 
Moebius et al., 2005 and Zahedi et al., 2005). 
1.4.5.4  Alkaline protein 
Basic proteins were difficult to resolve on 2-DE gels. Until today, the most common 
commercially available pH gradients were pH 4-7 and pH 3-10 and these do not provide 
significant alkaline protein resolution (Wildgruber et al., 2002). As more alkaline pH 
range immobilized pH gradients become commercially available, resolution of proteins 
in IPGs up to pH 12 has been demonstrated (Wildgruber et al., 2002). Strongly alkaline 
proteins such as ribosomal and nuclear proteins with closely related isoelectric points 
(pIs) between 10.5 and 11.8 were focused to the steady state by using 3-12, 6-12 and 9-
12 pI ranges (Gorg et al., 1997; Wildgruber et al., 2002 and Drews et al., 2004). 
Furthermore, Altland et al. (1988) and Gorg et al. (1995) have reported that for highly 
resolved two dimensional patterns, different optimization steps with respect to pH 
engineering and gel composition were necessary, such as the substitution of 
dimethylacrylamide (DMAA) for acrylamide and the necessity near the cathode of a 
paper strip soaked with DTT to provide a continuous influx of DTT to compensate for the 
loss of DTT. Similarly, Gorg et al. (1997) have also reported the addition of isopropanol 
to the IPG rehydration solution was required to suppress the reverse electro-endosmotic 
flow which causes highly streaky 2-DE patterns in narrow pH range for IPGs 9-12 and 10-
12. 
1.4.6  Proteomic and biologic discovery 
Identification of biomarker is the first step towards clinical implementation 
(Frangogiannis, 2012). The most important role of proteomics in biologic sample analysis 
is the discovery and validation of biomarkers in disease. These samples include serum, 
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NS, cerebrospinal fluid (CSF), urine, saliva or other biological fluids. The biomarkers are 
generally present in low abundance, and it is necessary to work with high volumes of 
sample. Frantzi et al. (2014) have reported that current MS based proteomics 
techniques favour untargeted approaches in biomarker discovery that could result in a 
substantial increase of novel biomarker candidates.  Petricoin et al. (2002) 
demonstrated that the changes in the patterns of multiple protein expression were 
more helpful than changes in single protein markers.These principles can be applied to 
bovine NS, which could be useful for the detection of biomarker in cattle having BRD or 
other respiratory diseases.  
There were a few studies that use proteomic technology to detect potential biomarkers 
from human nasal lavage fluid (NLF). For example, NFL from workers suffering from 
occupational rhinitis were compared with 2-DE followed by MALDI-TOF before and after 
a 2-hour exposure to dimethylbenzylamine (DMBA). They have found palate lung and 
nasal epithelial clone (PLUNC) could be a potential marker for irritation. They have 
reported that the levels of PLUNC in the control group were lower after 2-hour exposure 
compared with that in epoxy workers, where the level was increased 3 to 20 fold after 
exposure to DMBA (Lindahl et al., 2001). Casado et al. (2002) have also shown the use of 
proteomics to confirm several major vascular (albumin, IgG, IgM, α-2-macroglobulin), 
glandular (mucin, lysozyme, lactoferrin), and epithelial (keratins) protein in human NLF. 
They have also concluded that a common finding was the high prevalence of lipocalin 
family proteins, such as PLUNC and apolipoproteins were observed in human NS samples 
(Casado et al., 2002).  Spielman et al. (1995) and later also by Briand et al. (2002) have 
able to identified odorant-binding proteins OBP) in NS. 
The used of proteomics to study protein expressed in human NS have proved to be 
important for the discovery of new biomarkers. Therefore, this technology can be a 
useful tool for the study of bovine NS, enabling the detection of novel biomarker in 
cattle suffering BRD or other respiratory diseases. 
1.5  Aims of study 
A non-invasive sampling technique has been the major choice of collecting biological 
sample from animals due to the time, cost, human safety and animal welfare concern 
commonly seen in experiment involving animals. In this study,  the author believe that 
NS which produced excessively in respiratory disease animal, renders a portal through 
which systemic animal health could be monitored since the secretion is consist of both 
locally synthesized and systemic proteins that could act as novel biomarkers for BRD.  
69 
Chapter 1 
The collection of NS also provides a practical method for obtaining large volume of 
diagnostic samples and repeated sampling without causing stress and pain to the 
animals.  
Hence the aims of the thesis are as follow: Firstly, to develop a method that is practical 
and non-invasive to collect sufficient amount of undiluted bovine NS. Secondly, to 
investigate the bovine NS from healthy animals and establish the normal biochemical 
reference data for bovine NS.  Thirdly, to investigate the source of AP present in NS and 
subsequently characterise and compare them with those AP found in other relevant 
bovine tissues. Fourthly, to determine the genetic expression of NSAP and compared 
with the two known bovine AP gene. Fifthly, bovine NS will be screened for host protein 
involve in innate immunity using novel proteomic techniques. Finally, is to measure the 
changes of protein expression in NS from healthy, disease and vaccinated cattle using a 
quantitative proteomic technique. 
1.6  Thesis outline 
Chapter 2 begins with development and improvement on methods to collect sufficient 
amount of undiluted bovine NS that is practical and easy to perform.  The remainder of 
this chapter first investigate the biochemical profiles of NS from healthy animals and 
then outlines the results in comparison to serum reference. Biochemical results would 
be use to establish a novel standard reference for future work on bovine NS. Preliminary 
proteomic work was also carried out to have a general assessment on the amount of 
protein present in NS.  
Novel findings from the previous chapter direct the study to further characterized nasal 
AP in Chapter 3.  In this chapter, work was focused on investigating the presence of 
nasal AP and understanding the function of AP in bovine NS. Studies was carried out 
using biochemical, histochemical, isoelectric focusing and western blot approaches in 
view to determine the origin of nasal AP in NS.  Additionally, extraction of bovine nasal 
mucosa and work carried out on the tissue was also described.  
Chapter 4 further describes and validates AP gene expression from nasal tissue using 
mixed-methods of molecular biology approaches. This chapter describes in detail the 
technique used such as end point polymerase chain reaction (PCR), quantitative PCR 
(qPCR) and gene sequencing to validate the gene as well as the results of both 
quantitative and qualitative analysis. The main aim of this work was to determine the 
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origin of nasal AP at the genome level and compare the findings with bovine liver (non-
intestinal) and intestinal AP. 
Chapter 5 is split into three consecutive parts, focusing mainly on using proteomic as a 
novel tool to investigate NS from healthy animal. In the first part, protein in NS were 
separated using a gel based proteomic approach mainly  2-DE which combines 
isoelectric focusing, separating proteins according to their isoelectric point, and then by 
means of SDS-PAGE, which separates them further according to their molecular mass. In 
the second part, the next typical steps of gel-based proteomics for both the 2-DE gels 
and preliminary proteomic work on 1-DE gels from Chapter 2 are spots/bands 
visualization and evaluation, expression analysis and finally protein identification by 
mass spectrometry (MS). In the last part, the chapter shall analyse and describe the 
nasal proteins identified and its possible function. 
In Chapter 6, experiments were performed to compare and analyse the nasal proteins 
between healthy, disease and vaccinated cattle using the latest gel based proteomic 
approach - Difference gel electrophoresis (DiGE). Following experiments, the MS 
analysis results would be discussed concentrating on how the host response towards 
treatments and the changes occurs in NS proteins in the three different physiological 
conditions. The remainder of this chapter shall discuss the benefits and limitation of 
this method used. 
Chapter 7 summarises the main findings of the research presented in this thesis and 
includes limitations and recommendations for future research.  
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Biochemical profiling of healthy bovine nasal secretion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
72 
Chapter 2  
 
2.1  Introduction 
In the 1920s Fleming (1922) discovered the intrinsic antimicrobial properties of human 
NS and attributed them to lysozyme. Since then most of the NS studies in humans have 
mainly focused on the understanding of mucosal host defence against pathogens, as in 
common colds of either virus or bacterial origin and other respiratory diseases including 
hospital-associated infections (Rossen et al., 1965; Kim et al., 1983; Kaliner, 1991; 
Kluytmans et al., 1997; and Blackbourn et al., 1997).     
An early study conducted by Long et al. (1933) at John Hopkins University had students 
and laboratory workers blow their nose upon a piece of non-absorbent brown paper and 
smearing the discharge on a glass slide, showing that macrophages, epithelial cells and 
polymorphonuclear leukocytes dominate the constituents of the human NS in early 
upper respiratory tract infections. McCormick et al. (1972) studied the acute phase of 
respiratory infection with NS obtained from military personnel by repeatedly flushing 5 
ml of sodium chloride solution into each nostril, which was then forcibly expelled into a 
sterile container until a total of 100 ml was collected from both nostrils. This study 
revealed that the increment of IgA level during acute phase of infection derived from 
both serum and local production, mainly released by the IgA synthesizing plasma cells 
(Serum derived IgA) and glandular type epithelial cells (Secretory IgA) in the respiratory 
mucosa.  
More recently a study described the collection of human NS by chemical stimulation 
with methacholine chloride using an atomizing dosimeter and vacuum-aided suction 
(Cole et al., 1999). They were able to identify several known antimicrobial proteins and 
peptides in NS such as statherins and defensins. However the major antimicrobial 
proteins that were present in NS were lysozymes and lactoferrin. Over many years, 
different techniques have been developed and used to collect this secretion. Several 
techniques such as nasal lavage, brush, nasal scraping or microsuction have been 
described for the collection of NS in human and animal models. However most of the 
methods have been poorly validated and findings were directly influenced by the 
method of collection (Watelet et al., 2004).  Furthermore many of the techniques used 
were not applicable to an animal model. 
Apart from the common techniques of diagnosing the severity of respiratory disease by 
taking history and clinical signs evaluation, biochemical analysis of the NS may be able 
to characterize the presence and severity of specific inflammatory responses, confirm 
the release of cytokines and mediators, detect acute phase responses and/or allow 
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assessment of response to treatment and vaccination. The NS closely reflects the 
inflammatory and immunological responses within the nasal mucosa (Watelet et al., 
2004).  Among the major components of the NS from human are mediators of adaptive 
immunity including IgA and IgG. These are both produced by plasma cells adjacent to 
the submucosal glands (Meredith et al., 1989). The immunoglobulins act in the mucosa 
to prevent the attachment and invasion of pathogenic organisms.  Mediators of innate 
mucosal host defence are also found in NS and include substances that selectively 
disrupt bacterial cell walls and membranes, sequester microbial nutrients, or act as 
traps for microbial attachment (Cole et al., 1999). These include two major 
antimicrobial proteins of human NS, lysozyme and lactoferrin and other known 
antimicrobial proteins and peptides such as statherin, secretory phospholipase A2, and 
defensins, believed to contribute to the total antimicrobial properties. However there 
has been an increased used of electrophoresis technique to study the protein content of 
human NS (Cole et al., 1999). 
The application of NS sample for the diagnosis of respiratory diseases in veterinary 
species is not common. Unlike in humans, the clinical biochemistry of NS from animal 
species has not been well characterised but could provide useful indicators of immune 
function and status. There is evidence that the nasal, bronchial and alveolar secretions 
have many similar properties in terms of their composition (Lindahl et al., 1995). 
However, unlike bronchial and alveolar secretions which are usually collected as lavage 
fluid with inevitable dilution, NS can easily, as shown in this chapter, be collected in an 
undiluted form from cattle but previously there was no suitable and practical method to 
collect NS from animals. Moreover, probably due to the very small volume of NS samples 
collected using nasal swabs, many studies conducted by using swabs  mostly focus on 
the detection of pathogens and antimicrobial sensitivity  testing (Storz et al., 1996; 
DeRosa et al., 2000; Seker et al., 2009; de Souza Figueiredo et al., 2010 and Klem et 
al., 2014). Therefore, the use of swabbing to collect NS is not sufficient for the study of 
host response towards diseases with tests such as biochemical and immunological 
analyses which usually require samples of a higher volume. 
 
The biochemical composition of NS could provide a useful matrix for investigation and 
potentially provide information for the study of any respiratory diseases in cattle and 
other species. However before bovine NS could be assessed for use as a biological fluid 
to be examined for diagnosis, it is necessary to determine a baseline of the biochemical 
composition of the fluid in normal healthy cattle.  Similarly there is a need to develop a 
viable technique for NS collection that is non-invasive, well standardized, reproducible 
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and able to provide sufficient volume for multiple investigations, allowing analysis of NS 
to serve as a valuable fluid for future investigation. 
 
2.1.1  Aims of Study 
The aims of the work presented in this chapter were to: 
 
1. Provide a viable collection system for normal NS from healthy cattle with 
minimal invasive procedures.  
 
2. Establish a biochemical, enzymological and immunological profile of bovine NS 
from healthy animals giving reference range values for this fluid. 
 
3. Investigate the proteins present in NS using one-dimensional gel electrophoresis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
75 
Chapter 2  
 
2.2  Materials and methods 
2.2.1  Animals 
Thirty eight Holstein-Friesian cows aged 2-5 years were convenience sampled from a 
herd of 90 lactating cows from University of Glasgow Cochno Farm. The animal 
experiments were carried out with the approval of the University of Glasgow MVLS 
College Ethics Committee and complied fully with the Home Office of Great Britain and 
Northern Ireland “Animals (Scientific Procedures) Act 1986”. Clinical examination was 
performed to ensure the cows were clinically healthy and free from respiratory disease. 
2.2.2  Bovine nasal secretion 
2.2.2.1  Collection of nasal secretion 
The cows were restrained in a cattle crush during the procedure. A commercially 
available tampon measuring 4 cm in length was inserted into one nostril and slid gently 
in an upwards and backwards direction about 5-8 cm deep and left in place for up to 15 
min (Figure 2.1A). The tampon was then removed from the nostril by gently pulling on 
the attached string (Figure 2.1B) and weighed as a measure of the NS uptake before 
being inserted into a modified collecting tube. The cows were observed during 
collection and the tampon would have been removed at the first sign of distress but this 
was not required in any of the samples collected by this method. 
2.2.2.2  Modified collecting tube 
The modified collecting tube consists of a 30 ml universal tube with four holes drilled 
into the bottom of the tube (2 mm diameter drill bit) at the bottom, inserted in a 50 ml 
Falcon tube (Figure 2.2). 
2.2.2.3  Extraction of nasal secretion 
The modified tubes were centrifuged at 700g for 10 min at 4°C. Nasal secretion 
collected at the bottom of Falcon tube (Figure 2.2) were aliquoted into 1.5 ml tubes 
and stored at -80°C until further analysis. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
Figure 2.1:  Collection of bovine NS.  
A) The cows were restrained in a cattle crush during the procedure. A commercially available tampon was inserted into one nostril and slid 
gently in an upwards and backwards direction about 5 – 8 cm deep and then left in place for up to 15 min. B) The tampon was then removed 
from the nostril by gently pulling on the attached string (yellow arrow). 
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Figure 2.2:  Schematic representation of a collecting tube for NS.  
The saturated tampon from nostril was inserted into a modified collecting tube consisted of a 30 ml universal tube with four x 2 
mm holes drilled into the bottom, inserted in a 50 ml Falcon tube. After centrifugation, NS would be collected at the bottom of 
Falcon tube and transferred to 1.5 ml tubes and stored at −80°C until further analysis. 
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2.2.3  Protein quantification 
The total protein content was determined with a Bradford protein assay kit (Sigma-
Chem. Co., Poole, UK) using bovine serum albumin (BSA) as protein standard. This 
method is a rapid and sensitive colorimetric assay for measuring total protein 
concentration utilizing the principle involving the binding of the dye Coomassie Brilliant 
Blue to protein in an acidic solution and its concomitant absorbance shift from 465 nm 
to 595 nm. The elevated absorbance at this wavelength reflects the increased binding of 
protein to Coomassie blue and in a relationship where the absorbance is proportional to 
the protein concentration.  
Ultrapure water (10 µl) was used as a blank and a similar volume of each BSA standards; 
0.25, 0.5, 1.0, 1.5, 2.0 (mg/ml) were compared to 10 µl of each sample at an 
appropriate dilution. Samples of NS were diluted at 1/20 and sample from tissue 
extracts (Chapter 3) were diluted at 1/40 in ultrapure water.  Incubation of the protein 
mixture was conducted at RT for 5 min following addition of 250 µl Bradford reagents 
and mixing on a shaker for approximately 15 sec. The absorbance was read on a 
FLUOstar OPTIMA spectrophotometer at 595 nm (BMG Labtech, Aylesbury, UK). The 
details of Bradford reagents are given in (Appendix 2.1). The protein concentration was 
determined using a standard curve that was plotted by the spectrophotometer 
according to the BSA standards (absorbance versus concentration in mg/ml) and taking 
the dilution factor into consideration. 
2.2.4  Biochemical analysis 
Bovine NS collected from the 38 cows were included in this study. A total of 75 µl of NS 
of each was used to measure the sodium, potassium and chloride concentration using 
the ion selective electrode technique and a total of 10 µl was used from a sampling cup 
consisting of 500 µl of NS sample for measurement of other analytes (urea; creatinine; 
albumin; total protein; calcium; phosphate and total bilirubin).  All biochemical tests 
(Appendix 2.2) were carried out on an Olympus A640 analyser operated by Veterinary 
Diagnostic Services, University of Glasgow.  
2.2.5  Enzymological analysis 
A total of 10 µl of NS was used to measure each of the 3 enzymological compositions 
(AP; AST and GGT) using an Olympus A640 analyser operated by Veterinary Diagnostic 
Nasal secretion 
79 
Chapter 2 
Services, University of Glasgow using the recommended protocol  of the German Society 
for Clinical Chemistry (Büttner, 1976).  
2.2.5.1  Alkaline phosphatase 
Alkaline phosphatase activity was determined by measuring the rate of conversion of p-
Nitrophenyl phosphate (pNPP) to p-Nitrophenol (pNP) in the presence of magnesium ions 
and diethanolamine as phosphate acceptor at pH 9.8. The rate of increase in 
absorbance due to the formation of pNP is measured at 410/480 nm and is directly 
proportional to the AP activity in the sample. 
Reaction principle: 
pNPP + H2O       
AP         Phosphate + pNP 
                                    Mg2+ 
2.2.5.2  Gamma-glutamyl transferase 
Gamma-glutamyl transferase (GGT) catalyses the transfer of the gamma-glutamyl group 
from the substrate, gamma-glutamyl-3-carboxy-4-nitroanlide to glycyglycine, yielding 5-
amino-2-nitrobenzoate. The change in absorbance at 410/480 nm is due to the 
formation of 5-amino-2-benzoate and is directly proportional to the GGT activity in the 
sample. 
Reaction principle: 
L-γ-Glutamyl-3-carboxy-4-nitroanilide + Glycylglycine      γ-GT    L-γ-
Glutamylglycylglycine + 5-amino-2-nitrobenzoate 
2.2.6  Immunological analysis 
The 38 NS samples collected and processed as described in section 2.2.2 were analysed 
for the nasal mucosal antibody contents by measuring the IgA and IgG concentrations. 
2.2.6.1  Reagents and buffers 
General chemicals and buffers (Appendix 2.3) were obtained from Sigma Chem. Co, 
Poole, UK unless otherwise stated. Double distilled water was used throughout. 
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2.2.6.2  Antibody 
Both coating antibodies (bovine specific anti-IgA and IgG) and signal antibodies (sheep 
anti-bovine IgA-HRP and IgG-HRP conjugate) for ELISA quantification were obtained 
from Bethyl Labs, Cambridge, UK. 
2.2.6.3  Immunoglobulin A and G assay procedure 
ELISA plates were coated with 100 µl per well of antibody against IgA or IgG (described 
in section 2.2.6.2) at 1/100 in double distilled water and left at RT (20 - 25°C) for 1 hr.  
The plate was then washed 5 times with ELISA wash buffer to remove any unbound Ig. 
The plate was blocked with 200 µl of blocking solution containing  0.05 M Tris and 0.14 
M NaCl to each well for 30 min at RT. Blocking  prevented subsequent non-specific 
binding of diluted antisera and NS to the well surface.  After washing a further 5 times 
with ELISA wash buffer, 100 µl of NS and standard bovine sera were added in duplicate 
to the antibody coated wells.  
A preliminary optimisation study were carried out where NS were titrated from 1/10 to 
1/10 000, a dilution at 1/2000 being identified as appropriate for the detection of IgA or 
IgG in NS. The standard sera were used at a dilution of 1/100 according to the 
manufacturer’s suggestion.  Plates were washed with 200 µl of ELISA wash buffer and 
100 µl of sheep anti-bovine IgA-HRP or IgG-HRP conjugate (Bethyl labs, Cambridge, UK) 
was added (1/100 000) to each well before incubation for 1 hr at RT.  After washing 5 
times, 100 µl of TMB (3,3′,5,5′-Tetramethylbenzidine) substrate solution was added to 
each well and the plate was incubated in the dark at RT for 15 min.  The reaction was 
stopped by adding 2.5 M H2SO4 and measurement of O.D. were read at 450 nm. 
2.2.7  Immunoglobulin assay validation 
2.2.7.1  Precision 
Reproducibility of the ELISA was demonstrated by intra-assay and inter-assay coefficient 
of variance (CV %). For intra-assay precision, the CV was determined as the mean of CV 
of duplicate results.  Inter-assay precision was determined where CVs were calculated 
from the mean and standard variation (SD) of the NS control samples over 10 times 
during the use of the assay.  
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2.2.7.2  Accuracy 
Linearity experiments are used to assess the compatibility of NS sample to be used for 
assaying Ig concentration. In the absence of purified sample of Ig the accuracy was 
determined by linearity of dilution of 3 NS samples with varying Ig concentration. 
2.2.7.3  Limit of detection  
The limit of detection was determined as the lowest amount of Ig that could be 
distinguished from the zero standards. This was determined as the Ig concentration at 3 
SD away from the mean of the ELISA optical density (mean ± 3 x SD) of the zero 
standard. 
2.2.8  One-dimensional gel electrophoresis 
Ten randomly selected NS collected and processed as described in section 2.2.2 were 
used to analyse the nasal proteome by 1-DE on a Criterion™ electrophoresis system (Bio-
Rad Laboratories, Hemel Hempstead, UK). 
2.2.8.1  Gel and buffers 
Eighteen well Criterion TGX™ Precast Gels 4-15% (Bio-Rad Laboratories, Hemel 
Hempstead, UK) were used for 1-DE. All stock solutions and buffers (Appendix 2.4) were 
prepared according to manufacturer’s instruction manuals (Bio-Rad Laboratories, Hemel 
Hempstead, UK).  
2.2.8.2  Sample preparation 
Prior to 1-DE analysis, protein content was measured as mentioned in section 2.2.3. 
Nasal secretion samples were diluted to 1/20 and mixed with Laemmli Sample Buffer 
(62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% Bromophenol Blue and 5% β-
mercaptoethanol, 710 mM) at a ratio of 1:1 and heated at 95°C for 4 min.  
2.2.8.3  Gel electrophoresis 
Electrophoresis was run using a standard Tris-glycine running buffer on a Criterion™ 
electrophoresis system at 300 V for 20 min.  
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2.2.8.4  Gel staining and image acquisition 
After electrophoresis, gels were stained using colloidal Coomassie blue dye for 1 hour 
according to manufacturer’s instructions (Sigma-Aldrich, Dorset, UK), and initially 
destained in 10% (w/v) acetic acid and 25% (v/v) methanol for 1 min, subsequently the 
destain solution was removed  and replaced with a fresh destain for a further 24 hours. 
Gel images were acquired using a UMAX PowerLookIII scanner (UMAX Technologies Inc., 
CA, USA) under the following settings: transmissive mode, true colour RGB and a 
resolution of 600 dpi. 
2.2.9  Statistical analysis 
Statistical analyses and graphs were performed using Minitab® for windows version 17 
(Minitab® Software Inc., Pennsylvania, USA). Anderson-Darling normality test were used 
to analyse the skewness and distribution of biochemical, enzymological and 
immunological results with a significance level (α) set at 0.05.  
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2.3  Results 
2.3.1  Bovine nasal secretion 
By means of using this technique of collecting NS, 5 to 12 ml of NS was absorbed and 
extracted by centrifugation per tampon from each cow within a sampling period of 10 
min. 
2.3.2  Biochemical results 
Following biochemical analysis, concentrations of total protein, creatinine, albumin and 
all other electrolytes were lower than the serum reference range whereas urea and 
total bilirubin levels were comparable with serum reference ranges (Table 2.1). 
Anderson-Darling statistical test for and histogram for all substrate and electrolyte 
measurements were given in Figure 2.3 – 2.12.  Sodium, calcium and phosphate were 
normally distributed whereas other analytes such as total protein, albumin, potassium, 
chloride, urea, creatinine and total bilirubin were not normally distributed. 
Table 2.1:  Biochemical properties of NS from 38 apparently healthy cattle.  
The values for median and range are presented. 
 
 
Substrate & Electrolyte (unit) 
 
 
Median 
(Range) 
 
Reference Range 
(Bovine serum)a 
    
Urea (mmol/L)  3.1 (1.8 – 6.1) 0 - 8 
Calcium (mmol/L)  1.1 (0.6 - 1.4) 2.2 – 3.3 
Phosphate (mmol/L)  0.8 (0.4 - 1.6) 1.1 – 2.8 
Creatinine (µmol/L)  30 (5 - 61) 53 - 132 
Total bilirubin (µmol/L)  0 (0 - 2) 0 - 8 
Total protein (g/L)  14 (9 - 34) 52 - 84 
Albumin (g/L)  3 (0 - 5) 21 - 34 
Sodium (mmol/L)  60 (18 - 98) 135 - 151 
Potassium (mmol/L) 
Chloride (mmol/L) 
 
2.4 (0.6 – 3.9) 
18.7 (14.2 - 33.7) 
3.2 - 5.8 
96 - 111 
aLaboratory reference range for bovine serum 
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A) 
B) 
Figure 2.3:  Graphs showing distribution of total protein concentration in NS from 
apparently healthy cattle (n=38). Total protein concentration was not normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of total protein concentration for normality check. The mean, SD, 
AD and p-value are presented.   
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Figure 2.4:  Graphs showing distribution of albumin concentration in NS from apparently 
healthy cattle (n=38). Albumin concentration was not normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of albumin concentration for normality check. The mean, SD, AD 
and p-value are presented. 
 
A) 
B) 
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A) 
B) 
Figure 2.5:  Graphs showing distribution of sodium concentration in NS from apparently 
healthy cattle (n=38). Sodium concentration was normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of sodium concentration for normality check. The mean, SD, AD 
and p-value are presented. 
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B) 
A) 
Figure 2.6:  Graphs showing distribution of potassium concentration in NS from apparently 
healthy cattle (n=38). Potassium concentration was not normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of potassium concentration for normality check. The mean, SD, AD 
and p-value are presented. 
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B) 
A) 
Figure 2.7:  Graphs showing distribution of calcium concentration in NS from apparently 
healthy cattle (n=38). Calcium concentration was normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of calcium concentration for normality check. The mean, SD, AD 
and p-value are presented. 
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A) 
B) 
Figure 2.8:  Graphs showing distribution of phosphate concentration in NS from apparently 
healthy cattle (n=38). Phosphate concentration was normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of phosphate concentration for normality check. The mean, SD, 
AD and p-value are presented. 
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B) 
A) 
Figure 2.9:  Graphs showing distribution of chloride concentration in NS from apparently 
healthy cattle (n=38). Chloride concentration was not normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of chloride concentration for normality check. The mean, SD, AD 
and p-value are presented. 
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A) 
B) 
Figure 2.10:  Graphs showing distribution of urea concentration in NS from apparently 
healthy cattle (n=38). Urea concentration was not normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of urea concentration for normality check. The mean, SD, AD and 
p-value are presented. 
92 
Chapter 2 
 
B) 
A) 
Figure 2.11:  Graphs showing distribution of creatinine concentration in NS from apparently 
healthy cattle (n=38). Creatinine concentration was not normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of creatinine concentration for normality check. The mean, SD, 
AD and p-value are presented. 
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A) 
B) 
Figure 2.12:  Graphs showing distribution of total bilirubin concentration in NS from 
apparently healthy cattle (n=38). Total bilirubin concentration was not normally 
distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of total bilirubin concentration for normality check. The mean, 
SD, AD and p-value are presented. 
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2.3.3  Enzymological results 
The mean AP activity in NS was 15.7-fold higher at 80:1259 than the serum reference 
range for AP (Table 2.2) while GGT activity was 2.5-fold higher at 27:67 than the bovine 
serum GGT reference range. However, the other enzyme AST levels were comparable 
with serum reference ranges. Anderson-Darling statistical test and histogram for all 
enzymes were given in Figure 2.13 – 2.15. All enzymes in bovine NS were normally 
distributed. 
 
Table 2.2:  Enymes activity of bovine NS taken from healthy animals (n=38).   
The values for median and range were presented. 
Enzymes (unit)  Median (Range) 
 
Reference Range 
(Bovine serum)a 
    
AP (IU/L)  1155 (144 - 2392) 20 - 80 
AST (IU/L)  97 (50 - 184) 10 - 140 
GGT (IU/L)  68 (28 - 109) 0 - 27 
aLaboratory reference range for bovine serum 
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B) 
A) 
Figure 2.13:  Graphs showing distribution of AP activity in NS from apparently healthy 
cattle (n=38). Alkaline phosphatase activity was normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of AP activity for normality check. The mean, SD, AD and p-value 
are presented. 
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A) 
B) 
Figure 2.14:  Graphs showing distribution of AST activity in NS from apparently healthy 
cattle (n=38). Aspartate transaminase activity was normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of AST activity for normality check. The mean, SD, AD and p-value 
are presented. 
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A) 
B) 
Figure 2.15:  Graphs showing distribution of GGT activity in NS from apparently healthy 
cattle (n=38). Gamma-glutamyl transferase activity was normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of GGT activity for normality check. The mean, SD, AD and p-
value are presented. 
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2.3.4  Immunological analysis 
The concentrations of IgA and IgG in bovine NS were 0.5 – 2.0 g/L and 0.2 - 1.9 g/L 
respectively (Table 2.3). Anderson-Darling statistical test and histogram for both 
immunoglobulins were given in Figure 2.16 and 2.17.  Immunoglobulin A concentration 
was normally distributed whereas IgG concentration was not normally distributed. 
Table 2.3: Imunoglobulin A and G concentrations in bovine NS taken from apparently healthy 
cattle (n=38). 
The values for median and range are presented. 
 
 
 
 
 
 
 
 
 
 
Immunoglobulins (unit)  Median (Range) 
 
Reference Range 
 
    
IgA (g/L) 
IgG (g/L) 
 
1.2 (0.5 – 2.0) 
0.5 (0.2 - 1.9) 
1.8 - 3.9 a 
0.1 - 0.7 b 
a Morgan et al., 1981; b Duncan et al., 1972 
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B) 
A) 
Figure 2.16:  Graphs showing distribution of IgA concentration in NS from apparently 
healthy cattle (n=38). The IgA concentration was normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of IgA concentration for normality check. The mean, SD, AD and 
p-value are presented. 
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B) 
A) 
Figure 2.17:  Graphs showing distribution of IgG concentration in NS from apparently 
healthy cattle (n=38). The IgG concentration was not normally distributed. 
A) Anderson-Darling (AD) test for normality with p-value <0.05 is considered not normally 
distributed and B) Histogram of IgG concentration for normality check. The mean, SD, AD and p-
value are presented. 
 
101 
Chapter 2 
2.3.5  Assay optimisation 
Throughout the optimisation procedure for Ig assays, a wide range of NS dilutions were 
tested (Figure 2.18) however a dilution at 1/2000 was implemented for the detection of 
IgA or IgG in NS as this gave the steepest standard curve. The standard sera were used 
at a dilution of 1/100 according to the manufacturer’s suggestion and the standard 
curves used were given at Figure 2.19.  Figure 2.20 show the linearity of mean pooled 
NS samples (n=38) in comparison with IgA and IgG standard curve.   
2.3.6  Assay validation 
2.3.6.1  Intra and Inter-assay precision  
The intra-assay CV for IgA and IgG assays were 10.2% and 8.5% respectively which was 
calculated as the mean of duplicate samples (n=38). The inter-assay values, means and 
the calculated CVs which were 14.2% and 23.9% for IgA and IgG respectively. The 
control CVs were 8.1% and 15.3% for IgA and IgG respectively.  
2.3.6.2  Accuracy 
Serial dilution of NS samples was used to assess the assay accuracy. The samples show 
linearity then plateau at low dilution and are parallel to standard curve (Figure 2.20).  
Diluted sample concentrations were taken from the linear portion of the curve as it is 
the most precise and accurate area of the curve. 
2.3.6.3  Limit of detection 
The minimum detection limit significantly different from the blank samples was taken 
as the Ig concentration at 3 SD from the mean of blank sample (n=4). This resulted in a 
limit of detection of 0.34 and 0.45 for IgA and IgG in NS respectively. 
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Figure 2.18:  Optimisation of bovine NS concentration for ELISA.  
The effect of NS dilutions at 1/1000; 1/2000; 1/4000 and 1/8000 on the A) IgA and B) IgG 
standard curve.  Nasal secretion sample diluted at 1/2000 was chosen to analyse Ig 
concentration.  
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Figure 2.19:  Standard curve used for analysis of A) IgA and B) IgG concentration obtained 
from bovine reference serum diluted at 1:100 
 
A) 
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Figure 2.20:  Linearity of mean NS samples at 1:2000 dilution (n=38) for analysis of A) IgA 
and B) IgG concentration.  
Standard curve from serum diluted at 1:100 included for comparison. 
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2.3.7  Preliminary proteomic investigation on nasal secretion from 
apparently healthy cattle using one-dimensional gel 
electrophoresis  
Ten NS samples from apparently healthy cattle were randomly selected from the 38 
samples by random number generator (http://www.randomnumbergenerator.com) for 
preliminary proteomic investigation. Prior to one-dimensional gel electrophoresis (1-
DE), the protein concentration for each sample was determined by Bradford assay and 
the results are presented in Table 2.4. The separation of protein from NS from healthy 
animals on 1-DE is shown in Figure 2.21.  
Visual inspection of the polyacrylamide gel lanes revealed consistent migratory profiles 
between all of the samples. A total of 13 distinct protein bands were visible following 1-
DE separation and were labelled a to k as shown in Figure 2.21.  Apart from band a to c, 
which is only clearly visible in sample 4, 7 and 8 no clear difference in terms of 
presence or absence of protein bands were observed within the samples.  
The identity of the bands in the NS was examined by the proteomic investigation fully 
described in Chapter 5. In this initial investigation protein identification was based on 
published Mw of protein in other biological fluids, notably bovine serum (Lavin et al., 
2013) where an initial presumed identification was possible (Table 2.5). By comparison 
of the protein bands with MW marker, several proteins commonly present in NS were 
predicted. Albumin, commonly found in many body secretions, was predicted at ~65 kDa 
(band f), whereas immunoglobulins were predicted at around 55 kDa (band g) and 23 
kDa (band k) for antibody fragments of heavy chain and light chain respectively.  
Further characterisation of protein separated by SDS-PAGE is described in section 5.2.8 
– 5.2.10. 
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Nasal secretion no. 
(n=10) 
Total protein 
(g/L) 
Approximate amount of protein loaded 
for 1-DE separation (mg) 
1 14 0.7 
2 16 0.8 
3 13 0.7 
4 18 1.0 
5 14 0.7 
6 9 0.5 
7 25 1.3 
8 34 1.8 
9 15 0.8 
10 
Median  
Range 
14 
14.5 
9-34 
0.7 
 
Table 2.4:  Total protein concentration of NS from 10 different individual samples and 
concentration of protein diluted at 1/20 for 1-DE.  
Median value and data range are displayed along the bottom of the table. 
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m 
Figure 2.21:  One-dimensional gel electrophoresis of bovine NS (n=10).  
11 distinct protein bands were identified; each respective band is labelled (a-k). 10 µl of NS 
sample at 1/20 dilution were loaded in well 1-10 with approximate concentration of protein 
loaded correspond to Table 2.4. M= MW marker (Precision Plus Protein Standards All Blue, Bio-
Rad Inc.).  
 
108 
Chapter 2 
Protein bands 
 
Approximate Mw (kDa) 
 
Presumed protein identity 
 
a 140 n/a 
b 120 - 130 n/a 
c 80 - 90 Lactoferrin 
d 68 - 70 n/a 
e 67 n/a 
f 65 Albumin 
g 57 Ab heavy chain 
h 50 n/a 
i 37 n/a 
j 
k 
l 
m 
35 
20 
15 
10 
Apolipoprotein A1 
Ab light chain 
n/a 
n/a 
Table 2.5:   Predicted of abundant NS proteins in 1-DE gel based on molecular weight (Mw).   
Proteins in italic would be described in Chapter 2 discussion. 
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2.4  Discussion 
Bovine respiratory disease in calves is a complex disease syndrome with many etiologic 
agents and is influenced by management and environment (Rice et al., 2007 and Taylor 
et al., 2010). The most frequent etiologic bacterial agents from fatal cases of BRD are 
Pasteurellae particularly, M. haemolytica (Confer, 1993; Rice et al., 2007; Katsuda et 
al., 2008) but, currently, there is no efficient and simple test to determine, ante 
mortem, the type of the disease-causing pathogen in the respiratory organs or to 
recognize the pathophysiological response of the animal towards this disease. 
Many studies on BRD have examined the natural flora of cattle to derive an association 
between the recovered bacteria and disease. Some researchers sampled the upper 
airways of live animals (Corstvet et al., 1973), bronchoalveolar lavages (Caldow, 2001 
and Senthilkumaran et al., 2013) while most studies have sampled lungs from animals 
that succumbed to BRD (Martin, 1983; Fulton et al., 2009; Burgess et al., 2011; and 
Klima et al., 2013). However, despite the likely importance of the nasal cavity as an 
immunologically active component of the route of infection, there has been little or no 
research conducted on the biochemical and immunological property of NS in cattle. 
The present study investigated and characterised the biochemical profiles of bovine NS 
as a potential a source of information regarding the mucosal and systemic immune 
status of cattle. Although the study by Caldow (2001), described the technique of 
bronchoalveolar lavage of cattle and discussed the benefits it offers over more 
conventional sampling methods in the diagnosis of respiratory disease, a later study 
conducted in Denmark still required the use of anaesthesia to collect trans-tracheally 
aspirated bronchoalveolar fluid (Angen et al., 2009).  Most studies have  used 
nasopharyngeal or bronchoalveolar lavage samples for cytology and parasitology but 
have not obtained this fluid in an undiluted form (Allen et al., 1992; Soethout et al., 
2004 and Hagberg et al., 2005). Studies on the proteomic and cellular compartments of 
lavage fluids required centrifugal filtration to concentrate the sample. Although nasal 
swabbing have been used in many investigations conducted on human and other animal 
species, the use of nasal swabs in cattle is mainly limited to the detection of the 
bacterial and viral pathogens within the lung or to determine antibiotic susceptibility 
(DeRosa et al., 2000; de Souza Figueiredo et al., 2010).  
Prior to this investigation, there have been no studies to characterise the biochemical 
and immunological properties of bovine NS. However to enable using a body fluid such 
as NS for novel methods of detection and monitoring of disease in the cattle, it was 
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necessary to have a reference range of analytes that are present in the NS of healthy 
animal. As there is no information on the composition of bovine NS, possibly due to the 
perceived difficulty of collecting sufficient volume of NS for analysis, this became the 
first objective of the project. Swabbing the nasal tract proved to be an inefficient 
method of collection of the fluid. Thus a system was therefore developed in this study 
which allowed bovine NS to be collected in sufficient volume for multiple analyses. 
Previous studies have collected NS on tampons with extraction of the NS by pressure 
produced by a syringe (Haig, et al., 2008) but here the sample was removed from the 
absorbent by centrifugation using modified centrifuge and universal tubes, which 
allowed over 10 ml samples of NS to be collected from each animal providing sufficient 
volume for biochemical, immunological and, described in Chapter 5, proteomic analysis.  
Biochemical analysis of the NS showed that most analytes such as urea, glucose and 
electrolytes were at similar concentrations to those in bovine serum, although as 
expected the total protein concentration was much lower. The sodium, calcium and 
phosphate concentration were found to be normally distributed among the NS samples. 
Whereas other analytes concentration such as total protein, albumin, potassium, 
chloride, urea, creatinine and total bilirubin were found to be not normally distributed.  
The variation observed may be due to individual differences present across the NS 
sample.  The AP, AST and GGT activity were observed to be normally distributed in the 
bovine NS. However unexpectedly, it was found that the activities of AP and GGT were 
greater by factors of 15.7-fold and 2.5-fold respectively in the NS than in serum from 
healthy animals. There are no previous reports of the activities of these enzymes in NS 
being greater than those found in serum or plasma in any species.   Indeed in the classic 
text on AP (McComb et al., 1979) there is no mention of AP in nasal mucosa or NS and 
only one reference to AP in olfactory cells related to the nasal cavity (Bourne, 1978).  
The lack of prior reports on the activity of AP in NS is likely to be due to the difficulty 
of collection of sufficient volumes of this fluid from animals such as laboratory rodents 
and reluctance of human volunteers to undertake NS collection. The two possible 
sources for AP in NS are due to leakage from serum, although this would require a 
tenfold increase in the activity by some form of concentration, or as a result of local 
synthesis and secretion of AP from the nasal epithelium.  Elucidation of this question is 
the objective of Chapter 3.  Alkaline phosphatase function is known in diverse biological 
processes, including reducing inflammatory responses in mice (van Veen et al., 2005), 
modulating host-bacterial interactions by dephosphorylating the Gram-negative 
bacterial cell wall component of LPS (Yang et al., 2013) and has been shown to detoxify 
this endotoxin in vitro and in vivo under physiological conditions (Poelstra et al., 1997a; 
Poelstra et al., 1997b and Koyama et al., 2002). 
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The immunoglobulins IgA and IgG, present in bovine secretions, are either produced 
locally by plasma cells or are derived from the blood plasma and transferred across the 
epithelium from the interstitial fluid compartment by selective or passive processes. It 
was evident from Sullivan et al. (1969) that the secretory immune system of cattle 
differed from that of other species where IgG was identified as the major 
immunoglobulin in milk, while IgA was the predominant isotype in this secretion in other 
species present at low concentration. However in the NS, IgA was at a higher 
concentration than IgG. 
It has been established that a prominent local IgA system in mammals can be found in 
the upper reaches of the respiratory tract, with a virtual absence around the alveolar 
region where antibody appears to be entirely of humoral origin. In cattle and sheep, the 
relative abundance of IgA in the NS (Mach and Pahud, 1971 and Morgan et al., 1981) 
compared to IgG which prominently present in the lower respiratory tract as shown by 
its abundance in bronchoalveolar lavage (Pringle et al., 1988). The ELISA result 
conducted on NS in this study has shown that IgA has a higher concentration in 
comparison to IgG. This finding was also reported by Morgan et al. (1981) where IgA was 
shown to be the major Ig in upper NS of ruminants. 
The mean result for IgG in the present study is comparable with the serum reference 
range provided by Duncan et al. (1972), although with several NS samples showing a 
higher concentration in comparison with the upper end of the reference range. There is 
evidence from other non-ruminant species that the proportion of IgG increases in 
secretions collected from lower regions of the respiratory tract (Waldman et al., 1973; 
Smith et al., 1975 and Morgan et al., 1980). A study conducted on ovine bronchoalveolar 
secretions suggested that ruminants also conform to this pattern (Gorin et al., 1979). 
Butler et al. (1972) have shown the concentration of IgA exceeds that of IgG in the NS, 
similar findings as in the present study. This would suggest that different lines of plasma 
cells differ in their relative proportions in tissue, in their rate of Ig production, or that 
mucosal IgG plasma cells contributed to the serum pool. 
Both mucosal immunoglobulins, IgA and IgG share a number of properties. 
Immunoglobulin A is relatively resistant to proteolysis (Newby and Bourne, 1976). Both 
of these immunoglobulins are capable of neutralizing viruses (Smith et al., 1976 and 
Mazanec et al., 1992) and prevent bacterial adhesion (Fubara and Freter, 1972).  
Although IgA may able to reduce antigen absorption (Stokes et al., 1975), it is not a 
function unique to this isotype and might also be affected by IgG (Walker et al., 1973).  
The difference between IgA and IgG lies in their ability to fix complement. 
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Immunoglobulin A does not bind and interact with complement (Knop and Rowley, 1974) 
and it has been proposed that the consequence of failure of IgA antibody-antigen 
complexes to initiate hypersensitivity reaction is important in the maintenance of 
mucosal homeostasis (Chatel et al., 2001). Many studies have shown that IgA and IgG 
plasma cells occur in relatively large numbers in the respiratory and digestive system. 
The increase in the number of these cells (Curtain and Anderson, 1971 and Allan et al., 
1979) in bovine respiratory and enteric diseases (Williams et al., 1975) suggests that 
these cells make a significant contribution to the humoral protection of the animal 
against invading pathogens. 
The GGT activity found in all of the NS analysed was observed to be up to 2.5 fold 
higher in comparison to normal GGT values in serum reference samples. This enzyme 
catalyses the transfer of the gamma-glutamyl moiety of glutathione (L-gamma-glutamyl-
L-cysteinyl-glycine, GSH) to an acceptor and plays a key role in the gamma-glutamyl 
cycle, a pathway for the synthesis and degradation of glutathione and drug and 
xenobiotic detoxification (Courtay et al., 1992). Consequently, GSH is a sulfhydryl-
containing tripeptide that is produced by most mammalian cells and is an efficient 
scavenger of toxic oxidants, including hydrogen peroxide, an oxidant that plays a major 
role in the oxidation present on the epithelial surface of the respiratory tract in human 
(Cantin et al., 1989). Cantin et al. (1989) found that GSH is present in the epithelial 
lining fluid of the normal lower respiratory tract, where it is believed to play a major 
role in providing antioxidant protection to the epithelial cells.  In this regard, it is 
possible that the main function of GGT seen in bovine NS is as a component in the 
pathway leading to the production of GSH, which serves to maintain integrity in the 
face of oxidising stressors in the respiratory tract.  
Bradford analysis demonstrated that protein concentration in bovine NS was between 10 
-20 g/L; almost half of the protein concentration found in bovine serum. Casado et al. 
(2005) reported that NS proteins present in humans are derived from local serous and 
mucus gland secretion and plasma exudation from the surrounding blood vessels. 
Therefore, the volume, concentration and types of NS protein in the cattle are 
dependent on the rate of glandular cell exocytosis and responses of local innate 
immunity towards any foreign irritation.  The result of protein separation with 1-DE has 
shown that 13 types of protein with differing molecular weights were identified. 
Although the proteins were further characterised with mass spectrometry and described 
in Chapter 5, preliminary prediction of the abundant proteins based on Mw was 
possible.  Mucosal proteins including albumin, having a Mw around 65-70 kDa 
(ALBU_BOVIN) and immunoglobulins were abundant in bovine NS. Antibody fragments of 
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heavy (O46780_BOVIN) and light chain (Q1RMN8_BOVIN) can be predicted to be present 
on 1-DE gel at around 55 kDa and 23 kDa respectively. In addition, lactoferrin, which 
has antimicrobial activity, had been previously reported to be present in NS (Raphael et 
al., 1989 and Cole et al., 1999) was and we predict that  this protein is represented by a 
band at around 80 kDa (TRFL_BOVIN). Recently, many studies have shown the present of 
apolipoproteins A1 (ApoA-1) to be present in human NS (Casado et al., 2005; Mörtstedt, 
2014 and Tomazic et al., 2014). Apolipoproteins are plasma proteins that are mainly 
involved in lipid metabolism, but also have antimicrobial and anti-inflammatory 
properties. Bovine ApoA-1 have a molecular weight of 27 – 35 kDa (Manjunanth et al., 
1989 and Ohnsorg et al., 2011) hence it was predicted that this protein would be 
represented on the 1-DE gel by a band at around this Mw region. 
The most striking finding of this chapter is that the enzymes AP and GGT are present in 
high concentrations in bovine NS and as AP has now been shown to may play a role in 
innate immunity, interacting in particular with LPS, there is the intriguing possibility 
that AP in the nasal passages has an effect on pathogens. Moreover, from this novel 
discovery AP may prove to be a new marker for response of the host mucosal immunity 
towards invading pathogen, and further characterization on this enzyme may provide 
better understanding on the pathophysiological response towards respiratory diseases. 
The next chapter will elucidate the source of AP in NS and examine the levels of AP 
activity in other tissues. 
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Chapter 3  
Characterization of alkaline phosphatase in bovine nasal mucosa 
and comparison with other bovine tissue 
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3.1  Introduction 
Alkaline phosphatase (AP, EC 3.1.3.1) is an enzyme that is widely distributed in nature. 
It has been found in blue‐green algae, bacteria, and in the tissues of all members of the 
animal kingdom (McComb et al., 1979).  Its exact function within cells is unknown 
however; in vitro it cleaves, with a high degree of specificity, the monophosphoric ester 
bond from a wide variety of substrates releasing phosphate radicals (Lad et al., 2003). 
In human, Harris (1989) and Fishman (1990) have reported at least four genes coding for 
AP and have been identified: non-specific AP liver/bone/kidney (ALPL), intestinal 
(ALPI), placental (ALPP) and germ cell AP (ALPP2) whereas in cattle, searches in NCBI 
database and literature have found only 2 genes coding for these enzymes which are the 
bovine ALPL (NM_176858) coding for a non-tissue specific AP and ALPI (NM_173987) 
coding for AP secreted in the intestine (Garattini et al., 1987; Hsu et al., 1987; Harris, 
1989; Hahnel et al., 1990; MacGregor et al., 1995; Hoshi et al. 1997 and McDougall et 
al. 1998). 
Alkaline phosphatase has been studied and characterized using several techniques in 
many species including cattle (Healy, 1971; Antonov et al., 1983; Van Hoof et al., 1988; 
Horney et al., 1992; Itoh et al., 2002 and Dziedziejko et al., 2009).  In 1933, Graham 
and Kay initially demonstrated that AP activity in bovine milk was heat labile and that 
AP measurements could be used to monitor the effectiveness of pasteurization where 
AP is inactivated at a temperature that is slightly higher than normal pasteurization 
conditions at 65°C (Chaudhuri et al., 2013). This first method described for AP used 
beta glycerophosphate as substrate followed by measurement of the liberated 
phosphorus. A more sensitive assay using phenyl phosphate as substrate was developed 
by Kay and Graham (1935). In this assay, AP cleaves off phosphorus from phenyl 
phosphate and leaves free phenol and phosphorus in solution. The liberated phenol was 
measured by means of Folin and Ciocalteu colour reagent (FCR).  
In 1938, Scharer improved the phenyl phosphate procedure by measuring the liberated 
phenol using Gibb’s reagent (BQC, 2, 6-dibromoquinone-4-chloroimimide) after protein 
precipitation of the reaction mixture with lead acetate. Improved sensitivity was 
obtained when Scharer reported on the use of n-butanol extraction to remove the BQC-
phenol complex from the reaction mixture (Scharer, 1938). The use of butanol 
extraction enabled the assay to be read visually. An AP assay using p-nitrophenyl 
phosphate (PNP) as a substrate has been described by Aschaffenburg and Mullen (1949). 
P-nitrophenyl phosphate has the advantage over phenyl phosphate since it is self-
indicating. Self-indicating substrates do not require secondary colour reactions in order 
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to measure the product formed.  Para-nitro-phenol phosphate is colourless to pale 
yellow in alkaline solution, but when the AP cleaves off the phosphate radical, it 
produces p-nitro-phenol which is deep yellow in colour with an absorbance maximum of 
405 nm.   
Cellular localization of target substances by histochemistry is a widely used technique in 
research and in histopathological diagnosis (Bitensky and Cohen, 1965 and McDougall et 
al., 2002). Histochemical methods have been use to localize AP in various tissue 
(Sugimura and Mizutani, 1979; Bell and Williams, 1979; Miao and Scutt, 2002 and 
Sabatakou et al., 2007). Qualitative evaluation of AP histochemistry has, for example, 
been used for the investigation of regulatory processes in bovine tissues (Sinowatz et 
al., 1982 and Van Noorden and Jonges, 1987).  However, there appears to be no 
evidence in the literature about attempts of revealing histochemically the distribution 
of AP in bovine nasal mucosa. 
 
For enzyme histochemistry, it is essential not to inactivate an appreciable proportion of 
the enzyme to be studied. Thus it is not enough to ensure that not more than a certain 
percentage of the enzyme has been lost, since it cannot be relied on that this loss 
occurs uniformly under all circumstances and does not represent the total enzymatic 
activity of a particular site within the cell (Shnitka and Seligman, 1961). This problem is 
most critical when studying the localization of 'soluble' enzymes, such as AP. Although 
Barka and Anderson (1963) contend that any histochemical demonstration of AP must 
involve the sacrifice of some of the enzyme by fixation in cold formalin followed by 
freeze-sectioning, this method has resulted in as much as 75% inactivation of this 
enzyme. Whereas sample fixation in acetone and embedding in paraffin wax have 
resulted in 80% loss of activity of AP (Barka and Anderson, 1963). Although tissue 
fixation is required for high quality tissue morphology, the process usually has an 
inhibitory effect on most of the enzymes’ activity such as in AP. Snap freezing with 
liquid nitrogen has yielded very valuable results for the localization of AP, while 
maintaining tissue integrity. This method of detection (Ermert et al., 2001 and Torres et 
al., 2007) can provide a sensitive, high-resolution localization of endogenous AP activity 
in the nasal tissue hence it was the method used in this study.  
  
Many different biochemical and immunological methods have been used to discriminate 
between the different AP at the enzyme and protein level. In this study, electrophoresis 
and immunological methods including western blot were used in attempts to 
characterize the AP present in bovine NS. The use of electrophoresis to separate AP 
isoenzymes has been reported in several species (Kaplan and Rogers, 1969; Cleeve and 
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Tua, 1984; Griffiths and Black, 1987 and Sharp et al., 2007).  Separation and 
quantitation of the AP isoenzymes has commonly involved electrophoretic methods that 
rely on differences in their physicochemical properties (Van Hoof and De Broe, 1994). Of 
these, the isoelectric focusing (IEF) method has proved to be very useful and capable of 
separating more than 12 clinically defined AP bands (Griffiths and Black, 1987 and 
Griffiths, 1989). 
 
The major function of bovine AP has been well documented in the literature 
summarized in section 1.3.  It is believed that the report in Chapter 2 of the discovery 
of a high level of AP activity in bovine NS (Ghazali et al., 2014) was the first such 
report. In this chapter, investigations into the source and characteristics of NS AP are 
described. 
 
 
3.1.1  Aims of study 
The discovery of high AP activity in bovine NS from Chapter 2 requires further 
investigation regarding the source and molecular characterisation of AP in this 
secretion. Hence, the specific aims of the work which is presented in this chapter were 
to determine: 
 
1. The source of AP in NS by localising the distribution of AP in the nasal mucosa by 
histochemistry.  
 
2. To compare the AP activity level in nasal mucosa with other tissues known to 
produce AP by extraction and analysis. 
 
3. To detect and quantify AP protein concentration in nasal mucosa and NS. 
 
4. To characterize the isoforms of nasal mucosa AP by electrophoresis, western blot 
and IEF. 
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3.2  Materials and methods 
3.2.1  Histochemistry 
3.2.1.1   Sample collection 
Bovine nasal mucosa was collected for cell morphological examination by gently 
separating the mucosal layer from the underlying nasal conchae, dissecting out a 1 cm 
square and fixing in 10% buffered neutral formaldehyde (Appendix 3.1) for at least 3 
days to ensure adequate fixation. Nasal mucosa collected for localisation of AP activity 
by histochemistry was snap frozen in liquid nitrogen and was transferred immediately to 
a -80°C freezer. 
3.2.1.2   Preparation of paraffin embedded tissues 
Following fixation in formalin, nasal mucosa was processed using the Shandon Excelsior™ 
(Thermo Scientific, UK) tissue processor on a pre-set programme for 17 hours. The 
processed tissues were embedded in paraffin wax (TCS Biosciences Ltd, Buckingham, 
UK). The paraffin-embedded tissues were cut at 7 µm with a microtome (Shandon™ 
Finesse, Thermo Scientific, UK) and mounted onto glass slides (Superfrost™, Thermo 
Scientific, UK). The slides were dried at 60°C for one hour and were heated at 37°C 
overnight. The slides were used for cell morphological examination. 
3.2.1.3   Cryosection preparation 
Nasal mucosa was frozen in optimal cutting temperature (OCT) compound in a suitable 
tissue mould. OCT containing the tissue was freeze at -20°C onto a specialized metal 
grid that fit onto the cryostat.  Nasal mucosa was sectioned at 8 µm thick in the 
cryostat at -20°C. Within 1 min of cutting a tissue section, the section was transferred 
to a room temperature microscope slide by touching the slide to the tissue. This step 
must be accomplished within 1 min of cutting the section to avoid freeze-drying of the 
tissue. The slide with the tissue section was immediately immersed into ethanol for 
fixation. The cryosection slides were stained with AP specific stain to localise the 
distribution of AP in nasal mucosa (section 3.2.1.5).  
3.2.1.4   Haematoxylin and eosin  
All sections were routinely stained with haematoxylin and eosin (H&E) for assessment of 
tissue morphology. Sections were deparaffinised by immersion in histo-clear (National 
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Diagnostics, New Jersey, USA) and then rehydrated with 70% absolute alcohol and 70% 
methylated spirit (Appendix 3.2) before rinsing in water. The sections were immersed in 
Gill’s haematoxylin for five min and rinsed in water for 30 sec. Sections were dipped in 
1% acid alcohol (Appendix 3.3) for 10 sec to eliminate excess haematoxylin and to 
enhance cellular differentiation, followed by washing in running tap water. Sections 
were blued in Scott’s tap water substitute (Appendix 3.4) and counterstained in eosin 
for five min. Sections were dehydrated with 70% methylated and 70% alcohol spirit 
before being cleared in histo-clear and mounted with DPX (Cellpath, UK). 
3.2.1.5   Alkaline phosphatase staining 
Cryosections were stained with Vector® Red Alkaline Phosphatase Substrate Kit (Vector 
Labs, Peterborough, UK) following the manufacturer’s recommended procedure 
(Appendix 3.5), in the presence or absence of levamisole inhibitor (Sigma-Chem Co, 
Poole, UK), counterstained with Gills Haematoxylin (Sigma-Chem Co, Poole, UK) and 
mounted with Histomount (National Diagnostics, New Jersey, USA). 
3.2.1.6   Image viewing and capture 
All H&E and AP stained sections were examined under a light microscope (Olympus 
BX51M, Southend-on-Sea, UK). Images were taken with Olympus BX51M and attached 
DP71 camera (Olympus, Japan), using Cell^D software (Olympus Soft Imaging Solutions, 
Germany). 
3.2.2  Alkaline phosphatase activity in tissue extraction  
3.2.2.1   Tissue samples and preparation 
Tissue samples of nasal mucosa, small intestine, heart, liver and kidney samples from 6 
adult cattle were collected at a slaughterhouse. Nasal mucosa was gently separated 
from the nasal conchae using a forceps and blade. Intestinal mucosa was obtained by 
gently scraping the mucosa of the small intestine with a metal spatula. Tissues were 
snap-frozen in liquid nitrogen and stored at -80°C prior to extraction. 
3.2.2.2   Butanol protein extraction 
Butanol AP extraction was conducted according to the method of Rudolph et al. (1997). 
Briefly, 2 g from each tissue were washed with isotonic saline solution and homogenized 
(Janke & Kunkel Ultra Turrax T25) in 5 ml saline.  Alkaline phosphatase was extracted 
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from 2 samples of crushed cancellous bone obtained from the metacarpal bones of 2 
different cattle.  
Tissue AP extracts were further processed by incubation with 100% n-butanol in ratio of 
1:4 of n-butanol:protein homogenates, with gentle agitation at 4°C for 30 min. 
Extraction with n-butanol facilitates the release of AP from membranes where it is 
anchored to phosphatidylinositol. The samples were centrifuged at 1,500 × g for 30 min 
at 4°C, the aqueous layer removed and centrifuged at 15,000 × g for 90 min with the 
supernatant being the AP extract. 
3.2.2.3   Measurement of alkaline phosphatase activity 
The AP activity and the protein concentration in the AP extracts were determined as 
described in section 2.2.5.1.  The AP activity of tissue extracts was recorded as enzyme 
activity per gram of tissue extracted (IU/g).   
3.2.2.4   Statistical Analysis 
Statistical analyses and graphs were performed using GraphPad Prism for Windows, 
version 5.0 (GraphPad Software Inc., California, USA). The normality of the data was 
examined using the D’Agostino and Pearson Omnibus normality test.  The relative AP 
activity in all different extracts was compared using Kruskal-Wallis test and individual 
pair comparison using Dunn's Multiple Comparison Test. Significance level (α) was set at 
0.05 for both tests. 
3.2.3  Western blot analysis 
3.2.3.1  Sample preparation 
Nasal mucosa and liver extraction from 6 different cattle carried out as in section 
3.2.2.1 were used for this experiment. Samples were diluted with ultrapure water to a 
concentration of 2-3 mg/ml.  Laemmli sample buffer (Bio-Rad Laboratories, Hemel 
Hempstead, UK)) and β-mercaptoethanol were added into the samples and were 
denatured by heating at 95ºC for 4 min. 
3.2.3.2  Antibody and conjugation 
Monoclonal antibody raised in mouse against human bone AP (Abcam, Cambridge #ab 
17272) was used to detect AP in the tissue extraction.  Conjugation of anti-bone AP 
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antibody with horse radish peroxidase (HRP) was performed using Lightning Link™ HRP 
conjugation Kit (Innova Biosciences, Cambridge  #701-0030) according to manufacturer’s 
instructions. Antibody used in this experiment were diluted with 5% skimmed milk at a 
dilution of 1/2000 (Anti-Bone AP conjugated with Lightning Link™ HRP). 
3.2.3.3  Western blot 
One-dimensional electrophoresis was carried out as in section 2.2.8. Proteins were 
transferred to a nitrocellulose membrane using the Mini Trans-Blot® Electrophoresis 
Transfer cell (BioRad, Hamel Hempstead) in 1x transfer buffer (Appendix 3.6). Fifteen µl 
(25 µg) of sample was loaded into each SDS-PAGE well and electrophoresis separation 
was conducted at 300 V for 20 min. The electrophoretic transfer was performed at 70 V 
for 60 min at 4ºC.  Once proteins were transferred onto the nitrocellulose membrane, 
the membrane was blocked in 5% skimmed milk (Appendix 3.7) for 60 min. Membrane 
blots were then incubated with anti-bone AP conjugated to HRP antibody (section 
3.2.3.2) at a dilution of 1/2000 for 2 hr.  Later, membrane blot was washed 3 × 5 min in 
TBST (Appendix 3.8).     
3.2.3.4  Image acquisition and assessment 
Visualization of immunoreactivity was completed using Pierce ECL to detect HRP 
activity (Thermo Scientific, Paisley #32209) according to the manufacturer’s 
instructions. Membranes were wrapped in Saran Wrap and were then exposed to 
radiographic film for between 30 sec and 5 min. Radiographic films were scanned using 
a UMAX PowerLook III Scanner (UMAX Technologies Inc, California, USA) under the 
following settings: transmissive mode, grey scale and a resolution of 600 dpi 
3.2.4  Agarose gel electrophoresis for alkaline phosphatase 
isoenzyme detection 
Samples of bovine NS and tissue extracts from NS, nasal mucosa, heart, small intestine, 
liver, kidney and bone were selected from the available samples for the separation of 
AP isozymes based on electrophoretic mobility on agarose gel. Samples were diluted to 
an AP activity of 280-350 IU/L with water and run on 2% agarose gel (Appendix 3.9).  A 
total of 15 µl of tissue extract was subjected to electrophoresis through a horizontal 
agarose gel in 1 × TAE buffer pH 8.6 for 45 min at 250 V. The agarose gel was then 
stained with Pierce 1-Step™ NBT-BCIP AP substrate solutions (Thermo Fisher Scientific 
Inc, Illinois, USA) for up to 1 hr at 37°C.  Gel Images were acquired using UMAX 
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PowerLook III Scanner (UMAX Technologies Inc., California, USA) under the following 
settings: transmissive mode, true colour RGB and a resolution of 600 dpi. 
3.2.5  Isoelectric focusing  
Samples of bovine NS and tissue extracts from NS, nasal mucosa, small intestine, liver, 
kidney and bone were selected from the available samples for the separation of AP 
isozymes based on pIs. Samples were diluted to an AP activity of 280-350 IU/L in IEF 
sample buffer pH 3-7 (Life Technologies, Paisley, UK) prepared according to 
manufacturer’s instructions.  The pI of the various AP isozymes was determined by 
separation using Invitrogen Novex® pH 3–7 IEF Gel (Life Technologies, Paisley, UK) and 
comparison to IEF standards. Ten µl of the prepared sample were loaded into each well 
such that IU of AP were loaded per well. Isoelectric focusing was conducted at 4°C using 
the following voltage gradient: 100 V, 1 hour; 200 V, 1 hour; 500 V, 30 min.  The gel was 
then stained with Pierce 1-Step™ NBT-BCIP ALP substrate solutions (Thermo Fisher 
Scientific Inc, Illinois, USA) for 5 hours at 37°C.  The pI of focussed bands was estimated 
in comparison to pH3-10 standards (Serva Electrophoresis, Heidelberg, Germany) which 
were run in a track of the IEF gels and stained with Coomassie blue following focusing 
and destained in 10% (w/v) acetic acid in 25% (w/v) methanol for 24 hours.  Gel Images 
were acquired as described in section 3.2.4. 
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3.3  Results  
3.3.1  The distribution and localisation of AP activity 
Histological assessment of bovine nasal mucosa stained with H&E show the respiratory 
portion of the nasal mucosa is lined by a ciliated, pseudostratified columnar epithelium 
with goblet cells. The lamina propria contains tubuloralveolar glands mainly serous and 
mucous glands (Figure 3.1 left columns). Histochemistry using an AP activity stain 
(Vector Red substrate) showed strong AP activity in the luminal and basal ends of nasal 
epithelium and serous glands (Figure 3.1 middle columns). Alkaline phosphatase activity 
staining was abolished in the presence of levamisole a known non-specific AP inhibitor 
(Figure 3.1 right columns). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 3.1:  Histology and AP activity histochemistry of bovine nasal mucosa.  
Routine staining of nasal mucosa with H&E (left column) and histochemical staining of AP activity using Vector Red substrate 
(central column) showed strong AP activity in the mucus at the luminal surface and in the basal cell layers of the epithelium (yellow 
arrow); as well as in serous glands (green arrow). Levamisole, a non-specific AP inhibitor, abolished the histochemical staining of 
these cells (right column). Image captures at x10, x20 and x40 magnifications are shown with appropriate scale bars. 
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3.3.2   AP activities in nasal mucosa and other tissues 
The extracts from nasal mucosal tissue (n=6) had mean AP activities which were not 
significantly different from the mean activity extracted from other bovine tissues known 
to produce this enzyme: liver, intestine and kidney, although the nasal mucosa extracts 
did have the highest median activity per gram of tissue extracted.  All of these extracts 
had significantly higher AP activities per gram of tissue extracted compared with the 
heart tissue (Table 3.1) that served as a negative control.  
Statistical analysis using Kruskal-Wallis test to compare the median AP activity between 
the bovine tissues revealed a significant difference (p<0.05).  However, Dunn's Multiple 
Comparison Test was used to compare AP activity between individual tissue pairs. The 
results have shown that apart from AP activity compared between heart vs. nasal 
mucosa and heart vs. liver, comparison of AP activity in other tissue pairs show non-
significance difference (p>0.05).   Data were presented in a box and whisker plot 
(Figure 3.2).   
 
Tissue Mean ± SD (IU/g) Median (Range) 
Nasal mucosa  14.2 ± 9.5 14.3 (1.0 - 27.6) 
Intestinal mucosa  10.2 ± 8.8 6.5 (2.2 - 24.0) 
Liver  11.5 ± 9.8 8.3 (1.0 – 27.2) 
Kidney  8.6 ± 4.4 7.4 (3.9 - 16.2) 
Heart 0.7 ± 0.3 0.6 (0.2 – 1.1) 
Table 3.1:  Alkaline phosphatase activity in bovine tissue extracts (n=6).  
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Figure 3.2:  Comparative of AP activity per gram of wet tissue in various bovine tissues 
(n=6).  
The AP activity in corresponding bovine tissue was quantified, expressed as enzyme unit per 
gram (IU/g) of tissue. Data presented in median with 25 to 75 percentile range. Horizontal bar 
indicating comparison of AP activity between tissue pairs with * and ** corresponds to significant 
difference of P ≤0.05 and P≤0.01 respectively. 
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3.3.3  Western blot analysis 
3.3.3.1   Optimisation of AP antibody on nasal mucosa and liver 
In order to characterise the AP isoforms present in NS and nasal mucosa, it would be 
valuable to investigate the enzyme using an antibody based approach. There is no 
antibody against bovine non-specific AP hence the monoclonal antibody against human 
bone AP (tissue non-specific AP) was used.  A number of antisera to AP were screened 
for cross reactivity [polyclonal rabbit anti-human bone AP and monoclonal rat anti-
human recombinant ALPL (Insight Bio., Middlesex)] with the mouse anti-human bone AP 
giving the greatest response in initial Western blots.  Thereafter, numerous attempts to 
use western blot were made using a second antibody system as well as direct 
conjugation of antibody to reporter enzyme.  The use of AP antibody as a two-step 
protocolwith a second antibody resulted in non-specific effect of AP antibody reacting 
with bovine Ig in the tissue samples. An attempt was made to use conjugation of 
antibody with as biotin (Thermo, Paisley #21217) however the biotinylated AP 
antibodies did not produce any signal.  Furthermore the biotinylation method used 
required high volume of AP antibody and involved long incubation time to conjugate.  
None of these approaches gave satisfactory results where AP isoform detection could be 
validated to an acceptable level.   
However, conjugations of antibody against human bone AP with HRP using Lightning 
Link™ HRP conjugation Kit (Innova Biosciences, Cambridge #701-0030) provided the 
clearest banding pattern on western blot.   Figure 3.3 summarises the cross-reactivity of 
antibody against human bone AP that were conjugated with HRP in bovine nasal mucosa 
and liver extracts. Antibody diluted to 1/1000 showed a stronger signal compared with 
sample incubated in 1/2000 of antibody. 
3.3.3.2   Western blot assessment  
For this experiment, 10 µl (15 µg) of sample was loaded into each SDS-PAGE well for 
electrophoresis separation and were transferred to radiographic film as described in 
section 3.3.3.1. Assessment of the HRP conjugated AP antibody reaction with nasal 
mucosa and liver samples from different animals (n=8) demonstrated comparable signal 
patterns between the group (Figure 3.4).  Alkaline phosphatase antibody should produce 
a positive signal at approximately 57 kDa. However, generally AP antibody has produced 
a robust signal in nasal mucosa (~70kDa) and a weaker signal at the same molecular 
weight was seen in the liver and other tissue extract. Additionally, for nasal mucosa 
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another 3 bands were detected at 35, 55 and 150 kDa in each of the individual samples. 
Another 5 weaker signals at approximately 25, 35, 40, 55 and 130 kDa were seen in all 
the liver samples. The detection of several signals in a tissue with the strongest around 
70 kDa and at different molecular weights indicates that the AP antibody has cross 
reactivity with other proteins. It was speculated that the antibody might cross react 
with albumin, which has a molecular weight of 66.5 kDa, consistent with the 
approximately 70 kDa band. 
3.3.3.3   Comparative analysis of alkaline phosphatase signals in nasal 
secretion and other bovine tissues.   
Another investigation on the cross reactivity of AP protein was performed in other 
bovine tissues. Commercially prepared bovine IAP was used as positive control and 
commercially prepared bovine serum albumin (BSA) at the concentration of 2 mg/ml 
was use as a negative control. The gross protein profile for each sample was visualised 
by Coomassie Briliant Blue stain and demonstrated a comparable pattern between 
samples (Figure 3.5A). Analysis of the membrane blot showed that a robust signal was 
detected at approximately 70 kDa in all the samples and controls with other weaker 
signals detected in NS and tissue samples at various molecular weights (Figure 3.5B).  A 
strong reaction was also obtained with commercial IAP at 65 kDa. 
3.3.3.4   Influence of albumin on AP stability 
This study was done to determine the effect of albumin on AP antibody reactivity and if 
pre-incubation with albumin would remove cross reactions. The effect of using AP 
antibody mixed with 4% albumin for incubation of membrane blot is shown in Figure 
3.6B. Although the presence of albumin slightly reduces the signal of other proteins in 
all the tissues, AP antibody retained its reactivity to other proteins for example with 
albumin which produced the strongest signal at ~70kDa (Figure 3.6A and B).   
3.3.3.5   Normalization effect 
This study was conducted to analyse the response of NS and other bovine tissue extracts 
to AP antibody after protein concentration and AP activity were normalized before 
electrophoresis. The protein profiles were assessed by Coomassie Brilliant Blue and are 
comparable across the different samples analysed with normalization of protein at 20 µg 
(Figure  3.7Ai and Bi) and with samples normalized at an AP activity of 300 -350 IU 
(Figure 3.7Aii and Bii). There is no gross variation seen on the protein profiles as a 
consequence of the normalization treatment. A robust signal of approximately 70 kDa 
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was detected in all samples except for bone tissue extract. Several weaker signals at 
various molecular weights were also detected in NS and all tissue extracts.   
3.3.3.6   Comparative analysis of alkaline phosphatase signals with 
unconjugated anti-alkaline phosphatase antibody 
This study was conducted to demonstrate the effect of HRP protein conjugation on AP 
antibody used throughout this study. Hence unconjugated AP was used to detect AP 
signal in nasal mucosa and liver tissue extracts. Anti-mouse IgG antibody conjugated 
with HRP was used as the secondary antibody and detected by calorimetric HRP (Opti-
4CN™). Results showed that AP antibody apart from showing a robust signal at 
approximately 70 kDa in all the samples it has also cross reactivity with several protein 
bands mainly seen at 30 and 160 kDa (Figure 3.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
130 
Chapter 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1/2000 1/1000 
Cattle 
1 
Cattle 
2 
Cattle 
1 
Cattle 
2 
NM L L L NM L NM NM M 
Figure 3.3:  The optimisation of HRP conjugated antibody against bone AP in nasal 
mucosa and liver extracts (n=2).  
Antibody was diluted with 5% skimmed milk at 2 different concentrations 1/1000 and 
1/2000. NM=nasal mucosa; L=liver and M=protein marker. 
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Figure 3.4:  :  Preliminary western blot analysis of AP in nasal mucosa and liver.  
The AP signals obtained from western blot analysis in nasal mucosa (n=8; lane 1-8) and liver 
(n=8; lane 9-16). 
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Figure 3.5:  Comparative analysis of AP in NS and other bovine tissues.   
A) SDS-PAGE of NS and tissue samples stained with Coomassie Brilliant Blue and 
subsequently compared with commercially prepared controls.  B) The AP signals obtained 
from western blot analysis show signals for all samples and prepared controls. M=protein 
marker; 1=commercially prepared BSA 2mg/ml; 2=commercially prepared bovine IAP; 
3=NS; 4=nasal mucosa; 5=liver; 6=intestine; 7=kidney; and 8=bovine serum 4 mg/ml. 
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Figure 3.6:  The influence of albumin on AP stability. 
The protein signals obtained from western blot analysis incubated in A) 1/2000 AP LL-HRP 
antibody and B) 1/2000 AP LL-HRP antibody with 4% albumin. Although the albumin reduces 
the protein signal, AP antibody still has reactivity with other proteins at different 
molecular weight for example given here is albumin (~70kDa).  1=commercially prepared 
bovine IAP; 2=NS; 3=nasal mucosa; 4=liver; 5=intestine; 6=kidney and 7=bovine serum 4 
mg/ml. 
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Figure 3.7:  Comparative analysis of AP Western blot signal between normalization effects 
of i) protein concentration and ii)  AP activity.   
A) The protein profiles were assessed by Coomassie Brilliant Blue and are comparable across 
the different samples analysed with normalization of protein at 20 µg and AP activity at 300 -
350 IU. There is no gross variation seen on the protein profiles as a consequence of the 
normalization treatment.  B) The AP signals obtained from western blot analysis show a non-
specific AP signals for all samples and negative for lane 8.  1&2=NS; 3&4=nasal mucosa; 5=liver; 
6=intestine; 7=kidney; 8=bone and M=protein marker. 
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Figure 3.8:  Comparative analysis of AP signals in nasal mucosa (n=7) and liver (n=7) 
with unconjugated AP antibody.  
 AP signals obtained from western blot analysis incubated in primary AP antibody at 
1/2000 and secondary anti-mouse HRP in nasal mucosa (lane 1-7) and liver (lane 8-14) and 
detected with calorimetric HRP (Opti-4CN™). 
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3.3.4  Agarose gel electrophoresis 
Electrophoresis of NS and various tissues extracts on an agarose gel followed by staining 
for AP activity produced bands for all the samples except for the bovine heart sample as 
expected due to its very low AP activity (Figure 3.9)  
Visual assessment showed that AP from NS and nasal mucosa extracts has the same 
mobility on agarose. Apart from the band produced from liver extract which shows the 
most anodal from the origin, the AP bands from all other tissue extracts (bone, kidney 
and intestine) have shown having lower electrophoretic mobility than the NS and nasal 
mucosa extracts though the variation in their mobility seen was not clearly distinct. 
3.3.5  Isoelectric focusing of alkaline phosphatase isoenzymes 
The AP from various bovine tissues separated by IEF and stained by zymography with an 
AP substrate, are shown in Figure 3.10. Although diluted to a similar AP activity, 
notable differences were observed in the band intensity of the AP isoforms. Close 
inspection of the loading well at the cathodal end of the gel, for the NS samples showed 
a deposit of AP activity, suggesting that a proportion of the AP in these samples was 
unable to enter the polyacrylamide gel, possibly due to the formation of large 
aggregates.  
Nevertheless, the IEF demonstrated that AP from the NS had isoforms with bands with 
AP activity at pH 4.8 (Figure 3.10-1) and 5.0-5.3 (Figure 3.10-2).  The nasal mucosa 
extract also had major bands at pH 4.8-5.2 (Figure 3.10-3) and several minor bands at 
pH 5.3 - 6.2 (Figure 3.10-4). Bovine bone AP had an isoform at pH 4.8 (Figure 3.10-5) 
and 5.0-5.3 (Figure 3.11-6), as in NS with several bands at pH 6.0 ‒ 6.7 (Figure 3.10-7). 
The liver AP resolved at lower pI with a major band at pI 4.6 (Figure 3.10-8). Intestinal 
and kidney AP had isoforms pI of 5.4-6.2 (Figure 3.10-9) with kidney AP also having 
major bands between at pI 5.2 and 5.3- (Figure 3.10-10).  The pI of the isoforms were 
estimated by comparison to standard protein of known pI value run on the same IEF gel 
with the track of the standard proteins separated and visualised with Coomassie blue 
protein stain rather than with AP zymography. 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.9:  Agarose gel electrophoresis of AP in NS and bovine tissue.  
Bovine tissue extracts and NS separated on 2%  horizontal agarose gel stained with 5-Bromo-4-chloro-3-indolyl phosphate with nitro blue 
tetrazolium chloride (BCIP/NBT) substrate. H = heart; NS = nasal secretion; NM = nasal mucosa; K = kidney; I = intestine; L = liver; B = 
bone; -ve = cathode; +ve = anode 
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Figure 3.10:  Isoelectric focusing of AP in bovine tissue and NS.  
Bovine tissue extracts and NS separated on IEF gels over a pH 3–7 range and stained with 5-Bromo-4-chloro-3-indolyl phosphate with nitro blue 
tetrazolium chloride (BCIP/NBT) substrate. M = IEF standard protein marker (stained with Coomassie blue); −ve = cathode; +ve = anode. Two 
different samples of NS were run in duplicate. Samples of extracts from nasal mucosa, bone and intestine were run in duplicate with liver and 
kidney extract being run in single tracks. Annotated boxes around isoforms bands as discussed in section 3.3.4. 
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3.4 Discussion 
In this chapter, experiments were carried out to investigate the source of AP that was 
found in bovine NS and further characterize this enzyme to provide information 
regarding the possible role it plays in host defence or in maintaining homeostasis.  
 
Within lung tissue, non-specific AP activity has been previously demonstrated within the 
cell and on the surface of respiratory epithelium in humans, where it is able to 
dephosphorylate ATP to AMP and to adenosine, important for mucociliary clearance 
(Picher et al., 2003). The enzyme was also reported several decades ago in human nasal 
mucosa (Bourne, 1948) and more recently described in this tissue and in micro litre 
volumes of NS of guinea pigs (Gawin et al., 1991) and in the related olfactory 
epithelium of mice and rats (Gladysheva, 2002).  Apart from these reports, the activity 
and production of AP in NS and nasal mucosa has not, to our knowledge, been 
documented.  However the prior identification of AP in the nasal mucosa did indicate 
that the AP in the NS may be due to secretion of the enzyme from the mucosal cells. 
 
This histochemical technique for AP localization conducted in this study was found to be 
highly reproducible and easy to perform. Fixation was found to be a critical step in the 
successful demonstration of AP activity in nasal mucous tissues. Pilot histochemistry 
examination results show that the use of periodate-lysine-paraformaldehyde (PLP) 
although does not inhibit/destroy AP activity it reduced the tissue and cell constituents 
for morphological analysis. Snap freezing with liquid nitrogen preserves AP activity very 
well and assists in tissue sectioning while maintaining the tissue cell integrity. 
Additionally, inhibition of AP activity by levamisole provided a clear distinction of 
bovine isozymes in this histochemical analysis. By employing the histochemical 
technique for AP established in this study, the localization of AP on nasal mucosa has 
been confirmed.  The distribution of AP activity as assessed in the present study is 
mainly present in the mucus at the luminal surface and in the basal cell layers of the 
epithelium as well as in the serous glands of the nasal mucosa as shown in Figure 3.1. 
The findings confirmed that NSAP was produced locally by the nasal mucosa cells and 
were secreted into the luminal surface by serous glands exocytosis.  
 
The second aim was to measure and compare the AP activity level in nasal mucosa with 
other relevant tissue known to produce AP: liver, intestine and kidney. The AP 
extraction method used was similar to a method described by Rudolph et al. (1997) and 
results expressed in enzyme activity/g of wet tissue used.  The AP derived from the 
nasal mucosa extracts (n=6) were similar in activity to those of liver, kidney and 
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intestinal mucosa. However, nasal tissue and liver had significantly higher activities 
than heart. This level of AP activity in nasal mucosa justifies further investigation on its 
function in bovine NS. The finding of AP activity being higher in nasal mucosa compared 
with serum AP reference values also points to the source of AP in NS as being of nasal 
mucosal origin and secreted locally rather than due to plasma leakages. Comparison of 
AP activity with bone extracts was not included in this study due to the lack of fresh 
bone samples. It would be important to include bone tissue in future study of AP 
activity due to its vital role in calcium homeostasis and in skeletal mineralization. 
 
However, the variation of AP activity observed in nasal mucosa and other bovine tissues 
do not represent the actual concentration of the AP enzyme present in these tissues.  
Hence, the next aim was to detect and possibly quantify the AP concentration in nasal 
mucosa and other relevant tissue by Western blotting. This method could also be used 
to validate AP antibody for future work on NSAP such as immunocytochemistry. Western 
blot analysis to determine the specificity of AP antibody used was carried out in NS and 
in various tissue extracts and included BSA and commercially prepared bovine IAP as 
negative and positive control respectively.  It was found that apart from the possible 
detection of AP as a band of approximately 57 kDa, a stronger band at a molecular 
weight of approximately 70 kDa was also detected in all the samples (Figure 3.4). A 
band at approximately 70 kDa was also present in BSA and IAP with the former 
indicating that the antibody used in this study was not specific for AP protein. It was 
inferred that the antibody cross reacts with albumin based on the finding that antibody 
detects the commercially prepared BSA and detected bands in all samples at the 
molecular weight similar to bovine albumin (~70 kDa).  
 
The apparent cross-reactivity with numerous proteins could be due to possible intrinsic 
characteristics of the BSA with AP or the non-specific effect of the AP antibody reacting 
with bovine immunoglobulins. However, the reaction with commercial IAP and the 
presence of some bands on western blot not visible in Coomassie blue stained gels may 
indicate that the antibody has some reaction with bovine APs. However based on the 
poor results demonstrated by Western blotting and the cross reactivity of the AP 
antibody (Abcam, Cambridge #ab17272) against albumin and other high abundance 
proteins present in NS, tissue extracts and controls used in this study, it was concluded 
that this approach with this antiserum would be unlikely to yield reliable and 
repeatable information of the AP in immuno detection systems.  It is possible that other 
commercial antiserum to human (or mouse) AP could be used to assess bovine AP by 
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Western blot, however each antiserum would need to be assessed for cross reaction and 
specificity for bovine AP confirmed before use. 
The discovery of high AP activities in the bovine nasal mucosa suggests an important 
physiological role for this enzyme. Although to date there has been several biochemical 
evidences on AP function scientifically reported, the most well-researched AP function 
has been in its major involvement in bone mineralization (Yoon et al. 1989; Beertsen 
and van den Bos 1992 and Fedde et al. 1999) and dephosphorylation of adenosine 
nucleotides (Gallo et al., 1997).   
 
Fractionation of AP into its isoenzymes is useful in distinguishing its molecular 
characteristic and differentiating nasal AP from AP in other tissue.  Preliminary study 
was first performed by separating AP from NS and other tissue extract with SDS-PAGE 
and stained with 5-Bromo-4-chloro-3-indolyl phosphate with nitro blue tetrazolium 
chloride (BCIP/NBT) substrate and the gel was observed every hour for up to 5 h at 37 
°C.  However, no bands were observed to be present in NS or any of the tissue extracts 
following SDS-PAGE.  This may be due to the presence of SDS in the polyacrylamide gel, 
denaturing and running buffers where SDS exhibited a strong inhibitory effect on AP 
activity (Bortolato et al., 1999 and Zappa et al., 2001). Furthermore, it was suggested 
that the heating process at 95 ºC for 4 min involved during sample preparation could 
inactivates the AP activity (Ikehara et al., 1978 and Yasuura et al., 1985).  However 
there were still no visible bands present on the polyacrylamide gels run in the absence 
of SDS and without a reduction step.  
 
Attempting to devise an alternative electrophoretic method, agarose electrophoresis 
was performed. With agarose, the migration of non-reduced large protein or complexes 
occurs as is likely to be the reason for detecting AP after the electrophoresis. Agarose 
gel has been able to show the electrophoretic mobility for all the samples except from 
heart sample. Apart from the band produced from liver extract which shows the most 
anodal from the origin, the intestine and kidney extract produced bands having lower 
electrophoretic mobility than the NS and nasal mucosa extracts though the variation 
seen could not be distinctly visualized. The separation produced was not distinct and 
samples from the NS, nasal mucosa and bone had smeared appearances. These smearing 
seen may be avoided by increasing the dilution of samples loaded in the agarose gels,  
 
Isoelectric focusing was most effective of the electrophoretic methods in relation to 
characterization of the enzyme and the separation of high-specific activity 
preparations.  In this study, IEF demonstrated differences between the AP of NS and 
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extracts of AP from other tissues.  The AP in NS and in the mucosa had pIs of 5.2 and as 
such had a different pattern of AP isoforms compared to AP from other tissues. These 
differences are either resulting from the expression of a different gene in the mucosa or 
from the same gene product being changed by PTMs. An investigation of the gene 
responsible in the nasal mucosa for production of AP in NS is necessary before this 
question can be settled. Furthermore the discovery of AP in nasal epithelium and NS in 
cattle presents opportunities for further investigation of the role of the enzyme in the 
susceptibility of mammals to infection through the nasal route. 
 
The AP have been postulated to be involved in a range of other processes, including cell 
adhesion (Hui et al. 1993), vitamin B transport (Rindi et al. 1995), metastasis (Manara et 
al. 2000), and cell signaling (Swarup et al. 1981; Muller et al. 1991). Recent studies of 
the biological function of AP have revealed that the enzyme has the ability to 
dephosphorylate LPS endotoxin from Gram-negative bacteria (Poelstra et al., 1997; 
Koyoma et al., 2002 and Beumer et al., 2003) reducing the toxic effects of LPS (Bates et 
al., 2007) and, in the intestine, can be induced by Resolvin E1, an anti-inflammatory 
derivative of omega-3 fatty acids (Campbell et al., 2010).  Thus intestinal AP has a 
major function in reducing the effects of LPS from intestinal bacterial flora (Lalles, 
2014) and may have a similar function in livestock (Mani et al., 2012).  
 
If AP in NS has the same activity on LPS then its presence in this secretion could 
contribute to the host defences by acting against invading pathogens in the respiratory 
tract responsible for BRD. It is of interest that AP in bronchial and alveolar fluid is 
believed to function in the extracellular dephosphorylation of ATP to fuel the activity of 
cilia in the airways (Picher, 2003) while there may also be an interaction between ATP 
and nasal AP in minimizing inflammation as has been suggested for IAP (Lalles, 2014). 
Furthermore in this species, NS can be transferred to the mouth as cattle have the 
tendency to lick their muzzle and nostrils so that the nasal AP could be effective in the 
rumen as an anti-endotoxin with a dephosphorylation activity (Lalles, 2014). 
 
In conclusion, this chapter has demonstrated that NSAP was produced locally and 
secreted by the nasal epithelial cells.  This study also illustrates characteristic 
molecular differences between the isoenzymes of NSAP as demonstrated by IEF 
methodology.  The bovine NS and nasal mucosa isoenzymes have been characterized 
with respect to their pIs and compared them with other bovine tissues known to 
produce AP.  Whether nasal AP isoenzymes represent specific biomarkers for the 
response of local innate response, in particular in the ability to dephosphorylate LPS, or 
merely reflect intermediate products of nasal AP biosynthesis remains to be 
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determined. In order to fully understand the molecular differences that define the 
bovine nasal AP isoenzymes and their clinical significance, subsequent work will be 
described in the next chapter which includes a detailed genomic characterization of the 
AP gene expression. 
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4.1  Introduction 
As detailed in Chapters 2 and 3 AP activity in NS has been shown to be high and it was 
demonstrated by histochemistry and tissue extraction that the NSAP is present in the 
nasal mucosa. Results from the IEF   have also shown that NSAP and AP from nasal 
mucosa are the same isoform, having the same pI value but different from other AP 
related tissues suggesting that the NSAP is a different isoenzyme from the AP from other 
tissues, but it could still be that it is the same gene product but with different post 
translational modifications.  In order to determine if the AP is produced locally and to 
characterize the nature of the isoenzyme, it was necessary to confirm the expression 
and determine the sequence of an AP gene in the nasal mucosa and to determine if the 
difference from other APs is at the gene level.  
In bovine, previously characterised APs are encoded by multiple genes that can be 
classified by their expression patterns into two general groups, the tissue-non-specific 
APs also known as ALPL for their liver expression and the tissue-specific AP known as 
ALPI due to being expressed primarily in the intestine. The physiological role of tissue 
non-specific AP as a phospho-monoesterase with a high optimum pH, which is not found 
in mammalian tissue, has yet to be defined in most tissues although there are numerous 
suggestions (McComb et al., 1979). This is especially true for the nasal AP which has 
been identified by this research. One of the better studied biological functions of APs is 
the role of bovine ALPL in osteogenesis by promoting bone mineralization, as 
demonstrated by the presence of collagenous and non-collagenous proteins due to 
mutation that results to ALPL deficiency in cattle (Fisher et al., 1987).  However a 
relatively recently and physiologically relevant AP action that has been identified, is the 
detoxification of the LPS by bovine IAP (Goldberg et al., 2008 and Lalles, 2010). The 
ALPI has been implicated in mediating host-bacterial interactions through its ability to 
dephosphorylate lipid A of the Gram-negative bacterial cell wall component LPS (Lalles, 
2010).  
As the name suggests non-specific AP gene is expressed in various tissues mainly liver, 
kidney and bone.  Histochemical distribution of AP within the bovine liver is mainly 
present in the bile canaliculi as compared to human where the strongest reaction is 
seen in the sinusoids and the endothelium of the central and periportal veins (Ordy et 
al., 1966). In kidney, AP is mainly distributed at the brush border membrane of the 
renal proximal convoluted tubule (Yamamoto and Yasuda, 1973 and Prasad et al., 2005). 
The presence of AP in bone has long been described originally by Bourne (1943) and 
Pritchard (1952), showing the source of bone AP is found mainly in osteoblast and 
146 
Chapter 4  
 
predominantly located in the plasma membrane (Gothlin and Ericsson, 1971). In 
mammals, ALPI is expressed by intestinal epithelial cells and is enriched in vesicles that 
are actively released from the cell microvillar tips into the intestinal lumen (McConnell 
et al., 2009; Shifrin et al., 2012).  
Yang et al. (2012) reported that all mammals including cattle had a single AP gene at 
the ALPL-like locus, which was surrounded by genes that were orthologs in all species 
with locally well-assembled genomes, showing that this region of the genome has been 
well-conserved among mammals. However, the genomic situation at the ALPI-like locus 
differed greatly among taxa, with several species having multiple ALPI-related genes. 
Since the discovery of the ability of bovine IAP to dephosphorylate LPS, various genomic 
investigations have identified 6 ALPI-related genes named ALPI-like1-6 (Yang et al., 
2012) but only four of which (ALPIl2; E1BJE3, ALPIl4; ENSBTAT000002229, ALPIl5; 
F1N2M5, and ALPIl6; F1N6T5) are annotated in Ensemble. 
Alkaline phosphatase represents a family of conserved isoenzyme identified in many 
animal species.  In bovine, AP exists as several isoenzymes in different tissues. Within 
the respiratory tissues, non-specific AP activity has been previously demonstrated 
within the cell and on the surface of the lower respiratory epithelium in humans, where 
it is able to dephosphorylate ATP to AMP and adenosine, important for mucociliary 
clearance (Picher et al., 2003). The enzyme was also reported several decades ago in 
human nasal mucosa (Bourne, 1948) and more recently described in this tissue though 
only in  micro litre volumes of NS of guinea pigs (Gawin et al., 1991) and in the related 
olfactory epithelium of mice and rats (Gladysheva, 2002). Heat stability analysis on 
human serum AP has been used as a means of identifying the organ origin of the enzyme 
contributing to the total enzyme activity in the serum (Tan et al., 1972).  Bone AP was 
found to be more heat-labile than liver AP and the two can be differentiated by pre-
incubating the serum at 56° for 10 min before enzyme assay (Tan et al., 1972 and 
Anderson et al., 1990).  The expression level of heat stable AP using histochemistry for 
the detection of pneumocyte type-1cell was reported to be 10 fold lower in human in 
compare to monkeys (Nouwen et al., 1990). Up to the present time there have been no 
studies to determine whether AP gene expression is active in the nasal mucosa of human 
or other animal. 
4.1.1 Coding for gene expression 
Reverse transcription polymerase chain reaction (RT-PCR) represents a powerful 
indirect method to analyse RNA levels (Freeman et al., 1999 and Erlich, 1999) and gene 
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characterisation by standard sequencing of the PCR product.  Sequence analysis of PCR 
product would then compare with the AP gene to confirm any genetic divergence. In 
eukaryotes most of the gene protein coding region is not a continuous DNA sequence 
reading out co-linearly into messenger RNA (mRNA) but is composed of an alternating 
array of coding sequence, called exons separated by intervening pieces of non-protein 
coding DNA referred to as introns. The removal of these intronic sequences from the 
initial RNA transcript and the joining of all exons in a head to tail arrangement occur, 
through a precise mechanism mediated by the splicing machinery in the nucleus 
(Weiner, 1993), to form a mRNA molecule. Genomic DNA containing introns can be used 
to express the gene of interest but these sequences can span up to hundreds of kilo 
bases and are therefore impossible to clone into the currently available mammalian 
expression vectors. Alternatively cDNA, which is a direct copy of the mRNA transcript, 
can be made in vitro, and used to directly transcribe and translate genes to a functional 
protein. Thus, the cDNAs encoding the bovine genes ALPL and ALPI have been used in 
this chapter. 
4.1.2 Aims of Study 
The aims of the work presented in this chapter were to: 
 
1. Investigate the expression  of the AP gene in bovine nasal mucosa  
 
2. Exploit the difference in coding sequences of AP isoform to design primers to 
differentiate between the bovine ALPL and ALPI genes 
 
3. Determine the sequence conservation/similarity between bovine tissue non-
specific AP and IAP with nasal derived AP  
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4.2  Materials and methods 
4.2.1 Sample material 
Nasal mucosa, liver and small intestine tissue were collected from the same cattle (n=6) 
used for the preparation of tissue extracts (as described in section 3.2.1.1) within 1 hr 
of euthanasia.  Tissue sections (1 by 1cm square and 1cm thick) were collected and 
preserved in RNAlater (Ambion, Darmstadt, Germany).  The samples were stored at -
80°C until RNA extraction.  
4.2.2 Total cellular RNA extraction 
Approximately 100mg of tissue samples were disrupted using a blade and was placed 
into a RNase-free microcentrifuge tube for RNA preparation using PureZOL™ (Bio-Rad 
Laboratories, Hemel Hempstead, UK) according the manufacturer's protocol. The lysate 
was homogenised by repeated passage through a clean syringe and 23-gauge needle (10 
times). The homogenised lysate was centrifuge at 10,000 x g for three min at 20°C. 
RNA was precipitated from the tissue lysate supernatant with 70% (v/v) ethanol and 
applied to RNeasy® mini column (Qiagen, Crawley, UK) and centrifuged at 8000 x g for 
15 sec. The flow through was discarded and the column was placed into a new tube. 
The RNeasy® mini column was washed by adding 350 µl RW1 buffer (washing buffer 
consists of guanidine salt and ethanol) and centrifuged at 8000 x g for 15 sec. Possible 
genomic DNA contamination was eliminated by including DNase treatments. DNase 
incubation mixture was added onto the RNeasy® mini column and incubated for 15 min 
and spun at 8000 x g for 15 sec and washed with 350 µl RW1 buffer and centrifuged at 
8000 x g for 15 sec. The column was washed twice by adding 500 µl of RPE buffer and 
centrifuged at 10,000 x g for two min. To elute the RNA, the column was transferred to 
a new RNase-free microcentrifuge tube. Thirty µl of RNase-free water was added 
directly onto the centre of the silica gel membrane and centrifuged at 10,000 x g for 
one min. All steps were carried out at 20 to 25°C. The RNA samples were stored at -
80°C until further analysis. 
4.2.3 Estimation of the quantity and integrity of total RNA 
The isolated RNA was spectophotometrically quantified by using the NanoDrop ND-1000 
Spectrophotometer (Thermo Scientific, Epsom, UK) at absorption of 260 nm. The RNA 
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purity was assessed by measuring the ratio of the absorbance at 260 and 280 nm. A 
typical ratio of 1.8 to 2.0 was obtained for most of the samples which is acceptable.  
4.2.4 cDNA synthesis  
Reverse transcription (RT) reactions were performed with RNA samples from nasal 
mucosa, liver or small intestines. Two µg RNA samples were denatured at 65°C for 5 
min. Fifty µl of the reaction mix consisting of 2µg of total RNA sample, 1x First strand 
buffer, 0.5mM each of dNTPs, 10mM dithiothreitol, 3µg random primers, 20U of 
RNAseOut and 400U M-MVL reverse transcriptase (Life Technologies Ltd, Paisley, UK) 
were incubated for 30 min at 37°C, 60 min at 42°C, 15 min at 70°C and then held at 
4°C.   
4.2.5 Analysis of total RNA  
The mRNA of nasal mucosa and other tissue AP were analysed on 2% (w/v) agarose gels 
containing ethidium bromide in 1 X TAE buffer and ran at 80 V for 20 min to assess the 
integrity of the total mRNA. 
4.2.6 Primer design 
Coding sequences (CDS) of the bovine IAP gene APLI (NM_173987) and non-specific AP 
gene ALPL (NM_176858) were derived from the National Centre for Biotechnology 
Information (NCBI) website. Primers were designed using an interactive web-based 
primer program algorithm, GeneFisher software version 1.2.2 (BiBiServe, Bielefeld, 
Germany), the primers were synthesised commercially (Eurofins, Germany). The primer 
details are shown in Table 4.1. 
4.2.7 Polymerase chain reaction  
A total of volume of 25µl PCR reaction mix comprising 12.5µl RedTaq® DNA polymerase 
buffer (Sigma Chem. Co, Poole, UK), 0.5µl of each primer (5pmol per reaction tube), 
and 200ng gDNA. Amplification conditions were 30 cycles (94°C for five min, 94°C for 
one min, 58°C for one min, 72°C for one min, 72°C for 10 min). The PCR products (2µl) 
were visualised using 0.5ug/ml ethidium bromide stained agarose gel and quantified 
against a 100bp DNA mass ladder (Life Technologies, Paisley, UK). 
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4.2.8 Purification and sequence analysis  
Polymerase chain reaction products were purified using QIAquick PCR purification kit 
(Qiagen, Crawley, UK) according to manufacturer’s instructions. The PCR products were 
sequenced using Big Dye v3.1 Terminator (Life Technologies, Paisley, UK) in 10µl 
reaction volume containing 200-500ng template, 1X sequencing buffer, 32mM primer 
and 1x Big Dye mix.  
The sequencing reactions were carried out in two randomly chosen nasal mucosa 
samples with forward and reverse primers in separate reactions. The sequencing 
products were ethanol precipitated, resuspended in formamide and read using capillary 
electrophoresis on Applied Biosystems 3130XL Genetic Analyzer (Hitachi, Tokyo, Japan). 
The ‘BLAST’ search engine within the NCBI database was used to analyse sequence data 
(Figure 4.1). 
4.2.9 Genomic analyses 
AP related sequences were obtained from sequenced genomes present in NCBI and 
Ensembl by BLAST searches using the bovine ALPL (NM_176858) and ALPI (NM_173987) 
sequences as query. Primer sequences were retrieved and subjected to alignment and 
phylogenetic analysis using UniProt software from EMBL-EBI. 
The BLAST search engine within the NCBI database (www.ncbi.nih.gov/BLAST/) was 
used to analyse sequence data. 
 
 
 
 
 
 
 
  
 
 
Accession number 
 
Primer notation 
 
Sequence 5/-3/ 
 
Sequence 
coordinates 
 
Product length 
 
ALPL 
 
NM_176858 
 
ALPL-F 
ALPL-R 
 
GACAGCTGCCCGCATCCTCA 
CCTTCTCCATCCAGCTCATACTCCA 
 
489-989 
 
500 
 
ALPI 
 
NM_173987 
 
ALPI-F 
ALPI-R 
 
GGGAGTGGTGACCACCTCCA 
GTCAATGCGGCCTCCCTCCA 
 
206-706 
 
500 
 
Table 4.1:  Primer sequences generated and used in RT-PCR for the amplification of bovine AP present in nasal, liver and intestinal tissues.  
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Figure 4.1:  The nucleotide sequence of the ALPL gene fragment (NM_176858) amplified by 
RT-PCR.  
Yellow=AP coding sequence; Blue=ALPL gene sequence and Red=forward and reverse primers. 
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4.3  Results 
4.3.1  Analysis of RNA quantity and quality 
Full-length total RNA was isolated from the bovine nasal mucosa tissue of 6 dairy cows. 
Good quality RNA samples were obtained as determined by ultraviolet 
spectrophotometry (A260/A280 value > 1.8) and agarose gel electrophoresis assessment 
(Figure 4.2); revealing intact 18s and 28s ribosomal RNA species. 
4.3.2  PCR amplification and analysis of nasal mucosa AP mRNA 
Bovine nasal mucosa AP cDNA amplified by RT-PCR produced a single PCR product at the 
predicted size of 500bp with primers against specific regions for bovine ALPL gene 
(Figure 4.3a). Alkaline phosphatase primers derived from ALPL also recognises cDNA for 
liver therefore suggesting that the nasal mucosa AP having the same gene with liver AP. 
However, there was no amplification of nasal mucosa cDNA with primers for the bovine 
ALPI gene (Figure 4.3 b). Alkaline phosphatase primers derived from ALPI only 
recognises cDNA for intestinal tissue. The used of liver and intestine cDNAs also served 
as positive and negative controls for each primer pair used in this experiment.  
4.3.3  Sequencing of PCR product 
The nucleotide sequences of purified PCR products were determined using genetic 
analyser and assessed with CLC Genomic Workbench Version 5.5.2 (CLC bio, Cambridge, 
UK). The nucleotide sequence was compared to the NCBI database to identify those 
genes which shared the greatest sequence identity with bovine nasal tissue sample.  
Sequences of the PCR products from two biological samples of nasal tissue amplified 
with ALPL primers, showed complete homology with this region of the ALPL splice 
variant (Figure 4.4). 
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Figure 4.2:  Ethidium bromide stained agarose gel showing the integrity of the 18s and 28s 
ribosomal RNA components. 
 N1=nasal mucosa 1; N2=nasal mucosa 2 and M=Marker (100 bp DNA ladder). 
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Figure 4.3:  Alkaline phosphatase mRNA analysis from various bovine tissues by RT-PCR.  
The presence of a single 500 bp DNA fragment corresponding to the predicted product size was 
visualised when using (a) tissue non-specific AP primers (ALPL gene) and (b) intestinal AP primers 
ALPI gene. PCR products were present in nasal mucosa only when non-specific AP primers were 
used. M=Marker (100 bp DNA ladder); MQ=high purity water; B=blank; N=nasal mucosa; L=liver; 
I=intestine. 
 
 
 
 
 
 
 
  
Figure 4.4:   The nucleotide sequence of bovine nasal mucosa mRNA shows 100% homology to the bovine ALPL gene (NM_176858).  
Box in red are the forward and reverse primers used for amplification by RT-PCR. 
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Figure 4.5:  Gene sequence of PCR product from 2 different samples of AP from bovine nasal mucosa shows 100% homology with bovine ALPL gene.
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4.4 Discussion 
The findings from the histochemistry study (Chapter 3) demonstrated the presence of 
AP in the nasal mucosa and the evidence of strong AP activity presence along the 
epithelium and mucosal glands suggesting that the AP was produced locally.  In order to 
substantiate this finding, RT-PCR analysis was performed on RNA extracted from the 
bovine nasal mucosa from four healthy cows. The data obtained showed that a clear 
PCR product at 500 bp was observed when primers derived from the ALPL gene were 
amplified. However, there is no product detectable when the primers corresponding to 
the bovine ALPI gene were used in the RT-PCR reaction, thus indicating that only the 
tissue non-specific AP is produced and expressed locally in the bovine nasal mucosa. 
While the liver has long believe to be the major site for tissue non-specific AP 
production, this enzyme has been considered to be present and expressed also in the 
mammalian kidney, bone and placenta (Goldstein et al., 1980; Hahnel et al., 1990; Ali 
et al., 1996; Prasad et al., 2005 and Zimin et al., 2009). The tissue non-specific AP has 
also been reported to be present in brain tissue (Brun-Heath et al., 2011) and 
circulating B cells in human (Hossain and Jung, 2008).  The assay of AP in serum has 
been used as a marker of liver function for several decades (McComb et al., 1979) 
though bone AP can contribute to the serum activity.  The tissue non-specific AP and 
IAP genes are different, reflected in their different patterns of tissue expression. The 
ubiquitously expressed ALPL plays an important function in bone mineralization in 
bovine (Fisher et al., 1987).  In humans, over 261 different mutations in ALPL have been 
linked to hypophosphatasia and skeletal abnormalities, of which 75% are missense 
mutations.  Several of these mutations result in dominant inheritance of the disease 
(Mornet et al., 2011), suggesting that modest changes in AP function at sites of bone 
mineralization can lead to deleterious phenotypes, by restricting the evolution of copy 
number variation of this gene once it became dedicated to this function. 
Although the principal function of NSAP remains in doubt, the histochemistry results in 
Chapter 2 have demonstrated that strong AP activity was present at the epithelia of the 
nasal mucosa and further investigation could be done to determine whether nasal AP 
bio-synthesis occurs in the cytoplasm which is localized exclusively in the cytoplasmic 
membrane (periplasm) or the outer membrane as seen in most prokaryotic cells 
(Hoffman and Wright, 1985; Klionsky and Emr, 1989; Matsumoto et al., 1990 and Qureshi 
et al., 2010). Alkaline phosphatase expression in the goblet cells, entero-endocrine 
cells, and absorptive epithelial cells (brush borders) of the intestines expressing AP 
(Mutoh et al., 2002), as well as in the uterine body in human (Franco et al., 2012) may 
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reflect a role in surface epithelial protection for this enzyme.  Recent studies of the 
biological function of IAP have revealed that the enzyme has the ability to 
dephosphorylate LPS endotoxin from Gram-negative bacteria (Poelstra et al., 1997b; 
Koyama et al., 2002 and  Beumer et al., 2003) to reduce the toxic effects of LPS (Bates 
et al., 2007). Bovine IAP has a major function in reducing the effects of LPS from 
intestinal bacterial flora (Lalles, 2010 and Campbell et al., 2011).  Possibly a similar 
function occurs for NSAP but will need further investigation to verify. 
The specific reason as to why nasal tissues expressing mRNA encoding the tissue non-
specific AP genes is unclear, but the induced expression probably results from the 
reaction of certain cytokines or hormones with their cellular receptors in response to 
invading pathogens and inflammatory signals. We have known that AP in NS is produced 
in the nasal mucosa and if AP in NS has the same activity on LPS then its presence in 
this secretion would contribute to the host defences by acting against invading 
pathogens. It is of interest that AP in bronchial and alveolar fluid is believed to function 
in the dephosphorylation of ATP to fuel the activity of cilia in the airways (Picher et al., 
2003). 
Additional studies will be necessary to understand the role of AP present in the bovine 
nasal mucosa and NS. However, based on the sequence similarity/conservation of nasal 
AP with tissue non-specific AP it is possible that it may play a role in dephosphorylation 
of LPS, modulating immunological responses that are essential to protect the host 
against infection and restore homeostasis. The expression of nasal AP on surface 
epithelia of the nasal mucosa as demonstrated in Chapter 3 could indicate a protective 
role for the enzyme, situated in a position to communicate with the external 
environment and protect local tissues from invading pathogens such as LPS producing 
bacteria. 
Since both of the AP genes encode enzymes with well conserved catalytic activities, it 
strongly suggests that NSAP may has the same capability to dephosphorylate LPS. The 
assumption is based on the same physiological requirement and environmental condition 
where IAP is produced. Similar to the intestine, the nasal mucosa is also a major site of 
infection, being where the onset of respiratory diseases usually happens. Gram-negative 
bacteria like M. haemolytica and P. multocida are commonly present in the nasal 
mucosa and capable of causing pneumonia in cattle (Whiteley et al., 1992 and 
Senthilkumaran et al., 2013). Therefore, the presence of high AP activity and tissue AP 
expression in the nasal mucosa could mirror the capacity of IAP to detoxify LPS and may 
be important for modulating innate immune responses to LPS producing bacteria. It 
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could be hypothesized that the infection with Gram-negative bacteria causing BRD in 
cattle may have been the driving force that lead to the presence of nasal AP being 
secreted by the nasal tissues and shaped the rapid evolution of the ALPL gene 
expression.  
The results of this chapter confirm that the presence of AP in NS is due to local 
production in the bovine nasal mucosa with the expression of a local ALPL gene. 
Furthermore there is the possibility that AP activity is up-regulated during infection or 
inflammation of the upper respiratory system. Hence, further work is needed to 
investigate this finding. Microarray technology could be used to monitoring the changes 
of AP gene expression during healthy and diseased phase in parallel.  In-situ 
hybridisation could be performed to give a more detailed analysis and specific 
localization of AP mRNA within the respiratory cells of nasal mucosa.  
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Proteomic investigation of bovine nasal secretion 
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5.1  Introduction 
Determination of potential biomarkers in bovine NS of healthy and diseased animals 
might contribute to the early diagnosis of respiratory diseases in cattle. Nasal secretion 
contains a variety of proteins derived from plasma, cellular and glandular sources from 
both mucous cell and serous cell secretions such as lysozymes, lactoferrin and 
immunoglobulins (Baraniuk, 2000; Baraniuk and Staevska, 2004).  As in humans, bovine 
NS contains similar proteins that are capable of forming a barrier against microbial 
infections transmitted through aerosols. Determination of the normal profile of bovine 
NS is essential to determine the physiological function of the proteins present in NS and 
identify disease-specific changes. Therefore, the understanding of the proteome map 
and identification of proteins in bovine NS could provide an important insight into the 
innate and acquired immune defence mechanism involve in the development of 
respiratory diseases.  Passalacqua et al. (2001) demonstrated that there is a similarity 
in mucosal response patterns between the upper and lower respiratory airways hence 
any potential biomarkers identified at the nasal mucosa could provide a similar view on 
the immunological responses happening in the lungs.  
The nasal mucosa is designed to regulate airflow and permit exudation of interstitial 
fluid to provide water for humidification and ciliary activity. The nasal mucosa glands 
contain serous and mucus cells. Generally, the major protein classes detected in human 
NS reported by Casado et al. (2005) and Baraniuk et al. (2000) are cytoskeletal proteins 
(33%), innate (27%) and acquired immunity (21%) system proteins and other cellular 
proteins (20%). Host defence is a prominent function of NS. Among the components of 
the secretions, the mediators of adaptive immunity include IgA and IgG, which are 
produced by plasma cells juxtaposed to submucosal glands. The immunoglobulins were 
also believed to act in the lumen of the airway and on the mucosa to prevent the 
attachment and invasion of pathogenic organisms. The cytoskeletal proteins may have 
been derived from the turnover of epithelial lining manipulation. Mediators of innate 
mucosal host defence are also found in NS and include substances that selectively 
disrupt bacterial cell walls and membranes, requisition microbial nutrients, or act as 
traps for microbial attachment. 
Proteomics is the study of the entire proteins and peptides in an organism or a part of 
it, such as a cell (Peddinti et al., 2010), tissue (D'Ambrosio et al.,2005 and Beddek et 
al., 2008), or fluids like NS (Casado et al., 2005), bronchoalveolar lavage fluid (BALF) 
(Racine et al., 2011), plasma (Henning et al., 2014), serum (Alonso-Fauste et al., 2012), 
uterine fluid (Faulkner et al., 2012), urine (Pyo et al., 2003), or saliva (Ang et al., 2011 
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and Lamy et al., 2012). It is widely believed that changes in the composition of the 
proteome could mirror disease states and provide evidence to its origin, eventually 
leading to targets for early diagnosis or new treatments. Proteome analysis presents a 
major task due to its complexity, however MS has proven to be a central analytical 
technique for tackling this kind of studies (Tanaka et al., 1988 and Link et al., 1999). An 
important advantage of using proteomic is the ability of this method to provide an 
impartial approach which allows the investigation of numerous potential biomarkers 
that may carry specific information of a disease. Lindahl et al. (1998, 1999, 2001 and 
2004) has demonstrated a comprehensive investigation of proteins of human 
broncheoalveolar lavage and NS which found many potential biomarkers in asthmatic 
and allergic rhinitis patients such as the involvements of an altered form of lipocortin-1 
and Clara cell protein-16 in BALF and NS of smokers. Those investigations were 
performed using 2-DE as the separation method and identification using MALDI-TOF-MS. 
The key advantage of applying proteomic methods in the study of NS is its ability to 
provide an unbiased approach that allows the investigation of numerous putative 
biomarkers that could represent the health status or respiratory disease information of 
the animal.  Laemmli (1970) reported on the application of SDS-PAGE and later in 1975, 
O’Farrell demonstrated the usage of 2-DE by including isoelectric focusing as the first 
stage. These two techniques basically separate proteins according to two intrinsic 
characteristics: pI and molecular weight.  
Separation is accomplished in two steps; proteins are first fractionated by isoelectric 
focusing (proteins migrate to their pI in a pH gradient) and then in a perpendicular 
dimension by SDS-PAGE. A characteristic protein spots is obtained from any sample 
analysed. After the 2-DE separation, the difficulty to identify these protein spots 
remains. These gel separation techniques have been successfully used for more than 30 
years and are still widely used (Zürbig and Jahn, 2012). A major advance in the 
identification of proteins was achieved with the implementation of MS. The first step in 
this process of identifying proteins in the spots (2-DE) or bands (1-DE) by MS is to 
subject them to a proteolytic, usually trypsin in-gel digestion (Henzel et al., 1993 and 
Henzel et al., 2003).  
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5.1.1 Aims of study 
The aims of the work presented in this chapter were to: 
1. Identify the proteins present in healthy NS from individual animal using 1-DE 
2. Investigate variation of protein spot intensity in NS across healthy animals 
3. Identify the proteins present in 2-DE from pooled healthy NS samples  
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5.2  Materials and methods 
5.2.1  Bovine nasal secretion samples 
Eight bovine NS samples for 1-DE and 6 bovine NS samples for 2-DE from the same group 
of animals described in section 2.2.1 were randomly selected and used in this study. 
The NS was collected as described in section 2.2.2. 
5.2.2  Protein quantification 
The protein concentration of the pooled samples was determined by Bradford assayas 
described in section 2.2.3.  
5.2.3  One-dimensional gel electrophoresis  
Ten-μg of protein from each NS was utilised for this experiment and 1-DE was carried 
out on the Criterion electrophoresis system from Bio-Rad according to steps described in 
section 2.2.8. Nasal secretion sample at 1/20 dilution were loaded in well 1-10 with 
approximate concentration of protein loaded correspond to Table 2.4.   
5.2.4  Sample preparation for two-dimensional gel electrophoresis  
Five µl of NS sample from 6 different healthy animals were used for 2-DE separation. 
These were carried out individually on 2-DE gels to observe any variation of protein 
separation between the samples.  Protein concentrations were determined to allow 
dilution of samples to an equal protein loading of 200 µg for 2-DE protein separation 
first by its pI (IEF) and later by its Mw (SDS-PAGE).  
Subsequently, 5 µl of NS sample from each of the 6 healthy animals, used in the 
previous investigation were pooled for 2-DE separation. Pooled samples were run on 
duplicate gels and major protein spots selected and analysed by MS for protein 
identification.  
5.2.5  Two-dimensional gel electrophoresis  
Separation by pI was carried out using 11cm immobilized pH Gradient (IPG) strip with a 
pH range of 3 to 10 (Bio-Rad, Hemel Hempstead, UK). After 200 g of protein loading on 
the IPG strips, with NS diluted in a rehydration buffer (8M Urea, 2% CHAPS, 50 mM DTT, 
0.2% Bio-Lyte®) (Bio-Rad, Hemel Hempstead, UK) and covered in 500µl of mineral oil, a 
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combination of rehydration and focusing step was carried out over 17 hr with a total of 
35000 V-hr. The IPG strips were then removed, oil drained with filter paper and then 
treated with two equilibration buffers both made from a stock solution comprised of 6M 
urea, 0.375 M Tris-HCl, pH 8.8, 2% (w/v) SDS, 20% (v/v) glycerol, the first of these 
containing 2% (w/v) dithiothreitol (Sigma-Aldrich, Poole, UK) to reduce the proteins and 
subsequently the alkylating agent iodoacetamide at 2.5% (w/v) (Sigma-Aldrich, Poole, 
UK) both were incubated for a duration of 15 min each. IPG strips were then placed 
onto Criterion™ XT Bis-Tris Gel and submerged in Tris-glycine running buffer on a 
Criterion™ electrophoresis system at 200 volts for 1 hr (Bio-Rad, Hemel Hempstead UK).   
5.2.6  Gel staining and image acquisition 
Polyacrylamide gels were stained and the gel images were acquired accordance to the 
steps described in section 2.2.8.4.  
5.2.7  Statistical analysis of variation on protein spots expression 
Two-DE gel images were uploaded onto Nonlinear Progenesis SameSpots 2D gel image 
analysis software (Nonlinear Dynamics, Newcastle, UK) which was used to identify 
protein spots which were differentially expressed between 6 individual NS samples 
(inferred by the programme by normalised spot intensities). Initial results were filtered 
using the programme’s statistical analysis function, with only those with a power value 
of >80% and ANOVA significance score of <0.05 between groups of individual gels, being 
chosen for protein identification.   
5.2.8  Tryptic in-gel digestion of proteins 
Protein spots were excised using a scalpel blade from the 2D gels of the pooled NS 
samples, diced if necessary and placed into eppendorf tubes and washed in 500µl of 
100mM ammonium bicarbonate for 30 min. This wash was poured away and the gel 
pieces washed twice in 500µl of 50% acetonitrile/100mM ammonium bicarbonate for 30 
min to de-stain the gel pieces. The gel pieces were finally washed in 50µl of acetonitrile 
to shrink the gel pieces for 10 min, after which the solvent was removed and the gel 
pieces air dried completely in a vacuum centrifuge for 2 hr. In gel digestion was 
performed with sequencing grade trypsin (Promega, Southampton UK, V511A) which was 
re-suspended in 20µl of 25mM ammonium bicarbonate and added to the dried gel 
pieces. Once the trypsin has absorbed and the gel pieces fully rehydrated a further 20µl 
of 25mM ammonium bicarbonate was added over the gel pieces.  
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The protein was allowed to digest overnight at 37°C. The following day the Eppendorf 
tubes were pulse centrifuged to pellet the gel pieces and the liquid transferred to a 96 
well plate. To the remaining gel pieces, 20µl of 5% formic acid was added and allowed 
to incubate for 20 min on the shaker after which 40µl of acetonitrile was added and the 
incubation continued for a further 20 min. The gel pieces were pelleted and the liquid 
added to the 96 well. The combined extracts on the plate were dried down in a vacuum 
centrifuge. 
5.2.9  Mass spectrometry analysis 
Peptides were solubilized in 0.5 % formic acid and fractionated on a nanoflow uHPLC 
system (Thermo RSLCnano) before online analysis by electrospray ionisation (ESI) mass 
spectrometry (MS) on an Amazon ion trap MS/MS (Bruker Daltonics). Peptide separation 
was performed on a Pepmap C18 reversed phase column (LC Packings), using a 5 - 85% 
v/v acetonitrile gradient (in 0.5% v/v formic acid) run over 45 min at a flow rate of 0.2 
µl/min. Mass spectrometric analysis was performed using a continuous duty cycle of 
survey MS scan followed by up to ten MS/MS analyses of the most abundant peptides, 
choosing the most intense multiply charged ions with dynamic exclusion for 120s 
(Burchmore, pers. comm. 2013).  
5.2.10 Protein identification 
Mass spectrometry data was processed using Data Analysis software (Bruker) and the 
automated Matrix Science Mascot Daemon server (v2.1.06). Protein identifications were 
assigned using the Mascot search engine to interrogate mammalian protein sequences in 
the NCBI Genbank database for Bos taurus, allowing a mass tolerance of 0.4 Da for both 
MS and MS/MS analyses (Burchmore, pers. comm. 2013). Analysis of the MS and MS/MS 
spectral data was performed using SwissProt database version 57.15. Protein scores with 
CI.95% were considered indicative of a positive identification with individual ion scores 
at P value 0.05 or better, indicative of identity or extensive homology. 
Tryptic digestion, ESI-MS/MS and protein identification were performed in Glasgow 
Polyomics with the MS analysis and initial Mascot search being undertaken by Ms. S. 
Eadie. 
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5.3   Results 
5.3.1  One-DE on individual nasal secretion samples 
Preliminary observation of 1-DE on bovine NS shows no distinctive difference in term of 
protein band variation between 10 individual NS samples. A total of 13 distinctive bands 
within a track (Figure 5.1) were excised and processed for protein identification. Upon 
tryptic digestion and MS, the 11 proteins with highest MOWSE scores in each band are 
identified in Table 5.1.  
 
As predicted in Chapter 2, band f and g were identified as albumin and Ig heavy chain 
respectively. Immunoglobulin light chain was found near to the predicted band size at 
band j below apolipoprotein A1 which have a molecular weight of around 30 kDa. 
Protein having anti-microbial properties such as lactoferrin, serotransferrin and 
cathelicidin were also identified. Odorant binding protein, low-Mw soluble proteins 
highly concentrated in the nasal mucus of vertebrates which is involved mainly in scent 
recognition and associated with pheromone-sensitive neurons was identified at band k. 
Other protein bands that were identified were alpha-2-macroglobulin and bovine 
cytoskeletal keratin derived from the nasal epithelium during sampling of NS. 
 
In addition, Table 5.2 tabulated by name and NCBI accession number all the protein hits 
identified in respective of the protein bands from 1-DE separation that have MOWSE 
score of >100 and peptide matches of >3 (UniProt Reference). 
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Figure 5.1:  One-DE of NS from healthy animals (n=10).  
Thirteen distinct protein bands labelled (a-m) were identified in Table 5.1 by MS 
based on the Mascot database. M= Mw marker (Precision Plus Protein Standards All 
Blue, Bio-Rad Inc.). Ten µl of NS sample at 1/20 dilution were loaded in well 1-10 
with approximate concentration of protein loaded correspond to Table 2.4. 
 
 
 
a 
b 
c 
d 
e 
f 
g 
h 
i 
j 
k 
l 
m 
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Band ID Identification  
(UniProt Reference) 
Estimated 
Mw (kD) 
MOWSE 
score 
Peptide 
matches 
Coverage 
% 
 
a 
 
Alpha-2-macroglobulin 168953 3363 149 41 
b 
 
Albumin 71244 1632 66 52 
c 
 
Albumin 71244 1638 65 53 
d 
 
Lactoferrin 80113 2189 86 47 
e 
 
Serotransferrin  79856 2398 97 55 
f 
 
Albumin 71244 2880 237 71 
g 
 
Immunoglobulin heavy 
chain 
51391 995 37 53 
h 
 
Fibrinogen beta chain 50407 831 35 44 
i 
 
Apolipoprotein A1 30258 837 50 43 
j 
 
Immunoglobulin light 
chain  
24863 1368 51 34 
k 
 
Odorant binding protein 18447 727 85 67 
l 
 
Cytoskelatal keratin 54986 607 22 17 
m 
 
Cathelicidin 17931 490 25 44 
Table 5.1:  Protein with highest hits from 1-DE seperation identified by MS. 
Mascot peptide database was used to identify the proteins. Data tabulated were from Mascot 
database result. 
 
 
 
 
 
 
  
 
Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
a 
  
Alpha-2-macroglobulin* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.2:  List of protein hits identified that have MOWSE score of >100 and peptide matches of >3 in relative to its respective protein band. 
Protein bands analysed were from 1-DE gel separation in Figure 5.1 and were arranged in descending order of MOWSE score.  * Protein identified with the 
highest MOWSE score.  
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
b 
 
Albumin* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.2:  Continued.  
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
c 
 
Albumin* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.2:  Continued 
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
d 
 
Lactoferrin* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.2:  Continued.  
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
e 
 
Serotransferrin* 
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
f 
 
Albumin* 
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
g 
 
Immunoglobulin heavy chain* 
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
h 
 
 
 
Fibrinogen beta chain* 
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
i 
 
 
Apolipoprotein A1* 
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
j 
 
Immunoglobulin light chain* 
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
k 
 
 
Odorant binding protein* 
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
l 
 
Cytoskeletal 
keratin* 
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Band ID 
 
List of protein hits identified having MOWSE score of >100 and peptide matches of >3 (UniProt Reference) 
 
m 
 
Cathelicidin* 
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5.3.2  Two-DE separation from six individual samples and analysis 
of protein spots expressions 
All 6 individual gel images from healthy animal are shown in Figure 5.2.  Variation of 
protein spots intensities across 6 individual 2-DE gels were compared using SameSpots 
2D gel image analysis software. Two-DE image analysis showed 60 differentially 
expressed spots with ANOVA P ≤0.05 and 60 spots with fold change ≥2, with power >0.8 
(Figure 5.3).  The variation between the 6 individuals for selected peaks is described in 
section 5.3.5 after the identity of protein was determined by MS of spots from the 2-DE 
gel of the pooled sample. 
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a b 
c d 
e f 
Figure 5.2:  Sample images of healthy NS proteome on 2-DE gels from 6 different 
animals (a-f). 
Protein separation was identical to pooled sample however the protein spots intensity for Ig 
heavy and light chains were lighter in individual samples. No obvious variation of protein 
spots distribution or expression were observed within the individual samples 
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3 10 
pI 
Figure 5.3:  Reference image of 2-DE map of differentially expressed spots across the 6 
different NS collected from healthy cattle. 
Representative of the composite for 2-DE map of NS obtained by performing the first dimension 
(IEF) on IPG strips pH 3–10 and the second dimension on 4–12% gradient SDS-PAGE gels. The 
protein spots were visualized by Coomassie blue staining. Mr standard values are indicated on 
the left. 
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5.3.3  Two-DE on pooled nasal secretion samples 
Two-dimensional electrophoresis separation was carried out on pooled NS samples in 
triplicate. Initial 2-DE image visual analysis showed NS protein were well separated 
across the gel having major protein spots at 75 kDa, 60 kDa and 25 kDa marked as x, y 
and z respectively (Figure 5.4) . Preliminary presumption of protein identification by 
comparison to 2DE gels of bovine serum (Skrzypczak et al., 2001) were made with these 
3 major protein spots which are x = albumin; y = Ig heavy chain and z = Ig light chain.  
Replicates of the 2-DE gel of pooled NS samples show no significant difference in protein 
spots distribution. 
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Figure 5.4:  Protein spots of pooled bovine NS from healthy animal identified on 2-DE.  
Preliminary presumption were made at that time indicating major NS protein such as 
x=albumin; y=Ig heavy chain and z=Ig light chain. 
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5.3.4  Identification of major proteins in bovine nasal secretion 
after 2-DE 
All major high abundance protein spots were selected for protein identification. A total 
of 40 protein spots were selected and analysed for protein identification by MS. All 
protein spots that were identified by MS were later grouped into ten major proteins 
(Figure 5.5). Following that, the 10 major proteins were further grouped according to 
the source of production mainly glandular, vascular and cellular proteins. The total 
protein spots identified by MS were listed in Table 5.3 and data were also presented in 
percentage as shown in Figure 5.6. Selection criteria in the list were Mascot score 
higher than 100 and sequence coverage over 10%. 
 
Distinct functional categories to which these proteins can be ascribed are indicated in 
Figure 5.7.  However, the results show the percentages of the total types of nasal 
protein present in the secretion and do not represent their respective concentration in 
the NS. Polypeptides involved in innate (34%) and acquired immunity (20%) system were 
major components. The proteins identified were also categorized according to their 
source of origin mainly vascular, cellular, glandular and cytoskel etal derives proteins 
based on protein ontology search in NCBI.  Vascular proteins (74% of all proteins 
identified) may be derived from plasma exudation from the local blood vessels that are 
present in the nasal cavity, turnover of epithelial goblet and ciliated cells (cytoskeletal 
proteins, 11%), cellular proteins (6%) and exocytosis from glands (glandular proteins, 9%) 
as represented in Figure 5.8.  
 
Glandular proteins constitute 9% out of the 40 total protein spots that were selected for 
having significant expression changes and identification. Proteins categorized in this 
group were the odorant binding protein and lactoferrin.  Vascular proteins are the most 
abundant protein present in bovine NS, comprising 85% of all the protein detected. 
These proteins commonly derived through plasma extravasation from the superficial 
fenestrated capillaries and post capillary venous flow which exudes across the nasal 
epithelium provides the constituent of NS.  Consequently this process contributes the 
albumin, immunoglobulins mainly monomeric IgA, IgG, Ig heavy chains and light chains, 
serotransferrin and apolipoprotein-A1 were detected frequently having the same 
concentrations as their plasma.  
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Figure 5.5:  Two-DE with major spots of high abundance proteins selected and 
identified with MS.  
Protein spots were individually identified as shown in Table 5.3 and colour grouped (circled) 
according to their origin. Yellow=glandular proteins; blue=vascular proteins and red=cellular 
proteins. 
 
 
  
Protein 
spot no.* 
 
Protein identification (UniProt reference) 
Theoretical  
pI 
Theoretical 
Mw (Da) 
MOWSE 
Score 
Peptide 
Matches 
% coverage 
       
123 Serotransferrin (TRFE_BOVIN) 6.75 135925 300 45 13 
128 Serotransferrin variant 1 (Q2HJF0_BOVIN) 7.46 79870 1394 102 11 
133 Serotransferrin precursor (G3X6N3_BOVIN) 8.01 119410 129 36 14 
152 Serum albumin precursor (AMBP_BOVIN) 5.26 68772 101 31 10 
219 Serum albumin precursor (VTDB_BOVIN) 5.60 66432 240 68 14 
278 Ig heavy chain precursor (B/MT.4A.17.H5.A5) – bovine 
(O46780_BOVIN) 
6.07 49981 166 77 19 
298 Apolipoprotein A-I precursor (V6F9A2_BOVIN) 4.21 128432 107 21 18 
300 Ig heavy chain (Q45UT4_BOVIN) 6.35 51309 621 38 23 
301 Fibrinogen beta chain (FIBB_BOVIN) 6.66 50993 117 23 31 
302 Serum albumin precursor variant 4 (ALBU_BOVIN) 5.75 70951 101 27 10 
303 Complement C3 precursor (G3X7A5_BOVIN) 4.54 185047 108 36 10 
306 Lactoferrin (B9VPZ5_BOVIN) 8.69 78056 103 20 14 
308 Complement C3 (CO3_BOVIN) 4.97 175007 115 27 16 
312 Lactoferrin (TRFL_BOVIN) 8.50 80002 129 32 18 
314 Odorant binding protein precursor (Q0IIA2_BOVIN) 3.98 55030 107 26 21 
331 Ig heavy chain (Q2TBV8_BOVIN) 5.74 57902 121 45 30 
396 Fibrinogen beta chain (F1MAV0_BOVIN) 8.45 45650 114 29 16 
415 Albumin precursor (ALBU_BOVIN) 4.23 31820 140 33 10 
468 Serum albumin precursor variant 7 (VTDB_BOVIN) 3.82 30071 139 42 12 
472 Complement C3 precursor (CO3_BOVIN) 4.68 63048 118 18 10 
540 Apolipoprotein A1 (APOA1_BOVIN) 5.71 30276 1296 77 36 
543 Immunoglobulin light chain ( H2EQP9_BOVIN) 7.54 24536 118 28 14 
567 Apolipoprotein A1(APOA1_BOVIN) 5.36 27549 130 60 16 
571 Glutathione S-transferase (GSTA2_BOVIN) 8.33 9048 118 21 14 
572 Immunoglobulin light chain, lambda gene cluster (Q1RMN8_BOVIN) 7.54 24536 189 23 16 
577 Serum albumin precursor (AMBP_BOVIN) 4.53 2122 126 17 12 
C
h
a
p
te
r 5
 
1
9
1
 
 578 Gluthathione S-transferase (GSTP1_BOVIN) 7.30 23481 525 26 11 
580 Apolipoprotein A1 (APOA1_BOVIN) 5.57 28432 179 32 18 
583 Odorant binding protein (OBP_BOVIN) 3.57 2765 457 144 21 
585 Keratin, type 1 cytoskelatal 10- Bos taurus (K1C10_BOVIN) 3.79 18503 187 33 16 
605 Keratin, type II cytoskeletal 8 – Bos taurus (K2C8_BOVIN) 3.79 18509 233 48 12 
662 Surrogate light chain (O77624_BOVIN) 8.02 21114 170 22 12 
660 Serum albumin precursor (ALBU_BOVIN) 5.69 79901 1391 121 28 
663 Serum albumin (ALBU_BOVIN) 5.60 79870 2568 163 30 
664 immunoglobulin lambda light chain constant region 3 allotypic 
variant IGLC3d, partial - Bos taurus  (H2EQP6_BOVIN) 
4.63 19711 230 22 16 
666 Lactoferrin (Q6LBN7_BOVIN) 7.67 76143 301 40 14 
668 Serum albumin precursor (Q5DM41_BOVIN) 5.00 76020 124 27 10 
670 Serum albumin precursor (AMBP_BOVIN) 4.81 69526 179 86 13 
671 Serum albumin precursor (ALBU_BOVIN) 5.53 22233 137 20 11 
674 Odorant binding protein (OBP_BOVIN) 4.91 18503 600 135 19 
Table 5.3:  Protein spot identifications (n=40) from 2-DE conducted in section 5.3.2. 
List of proteins identified by MS, together with theoretical isoelectric point (pI), molecular weights (Mw), MOWSE score, peptide matches and percentage 
of coverage. * Protein spots selected from 2-DE separation in Figure 5.3.    
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Figure 5.6:  Major high abundance protein spots selected and identified using MS (n=40). 
Data presented in percentage. 
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Figure 5.7:  Pie chart showing the classification of the proteins identified in bovine NS (n=40) 
according to their biological function based on protein ontology search in NCBI. 
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Figure 5.8:  Percentage of proteins (n=40) identified by MS further categorized according to 
their source based on protein ontology search in NCBI. 
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5.3.5  Variation of protein spot intensity across six healthy nasal 
secretion samples 
Figure 5.9 to 5.18 show the image analysis of protein spots that was carried out using 
SameSpots 2-DE gel image analysis software to quantify variation of protein spot 
intensities of NS across 6 healthy individual cattle (section 5.3.2) with mean and range 
of the protein spot intensity given for the 10 major proteins identified in section 5.3.4. 
Protein spot intensities were given in normalized log volume but were transformed into 
actual value of data (intensity unit) and compared in Figure 5.19. The median and range 
for protein spot intensity for all major protein were presented in Figure 5.20.  
The mean (±SD) for the actual value of protein intensity for all the major proteins were 
spot 663:albumin (8.02 ± 1.4), spot 540:apolipoprotein A1 (5.84 ± 3.9), spot 
308:complement C3 (4.38 ± 1.8), spot 301:fibrinogen beta chain (2.86 ± 0.4), spot 
571:glutathione S-transferase (1.10 ± 0.2), spot 583:odorant binding protein (6.13 ± 
2.5), spot 300:Ig heavy chain (4.37 ± 1.0), spot 543:Ig light chain (6.71 ± 2.8), spot 
128:serotransferrin (2.85 ± 0.6) and spot 666:lactoferrin (1.94 ± 0.8). 
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Albumin 
Figure 5.9:  Variation in albumin spot intensity between individual NS samples. The median 
of albumin protein spot intensity between 6.95 different NS is 6.9 ranging from 6.77 – 6.95. 
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Figure 5.10:  Variation in apolipoprotein A1 spot intensity between individual NS samples. 
The median of apolipoprotein A1 spot intensity between 6 different NS is 5.96 ranging from 
5.81 – 6.01. 
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Complement C3 
Figure 5.11:  Variation in complement C3 spot intensity between individual NS samples. The 
median of complement C3 protein spot intensity between 6 different NS is 5.66 ranging from 
5.29 – 5.81. 
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Figure 5.12:  Variation in fibrinogen beta chain spot intensity between individual NS 
samples. The median of fibrinogen beta chain protein spot intensity between 6 different NS 
is 5.47 ranging from 5.45 – 5.54. 
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Figure 5.13:  Variation in glutathione S-transferase spot intensity between individual NS 
samples. The median of glutathione S-transferase spot intensity between 6 different NS is 
6.01 ranging from 5.99 – 6.16. 
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Figure 5.14:  Variation in odorant binding protein spot intensity between individual NS 
samples. The median of odorant binding protein spot intensity between 6 different NS 
is 5.86 ranging from 5.78 – 6.08. 
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Immunoglobulin heavy chain 
Figure 5.15:  Variation in Ig heavy chain spot intensity between individual NS samples. 
The median of Ig heavy chain protein spot intensity between 6 different NS is 5.63 
ranging from 5.51 – 5.77.  
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Figure 5.16:  Variation in Ig light chain spot intensity between individual NS samples. 
The median of Ig light chain protein spot intensity between 6 different NS is 5.91 
ranging from 5.8 – 6.1. 
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Figure 5.17:  Variation in serotransferrin spot intensity between individual NS samples. 
The median of serotransferrin protein spot intensity between 6 different NS is 5.45 
ranging from 5.3 – 5.57.  
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Figure 5.18:  Variation in lactoferrin spot intensity between individual NS samples. The mean 
of lactoferrin protein spot intensity between 6 different NS is 6.26 ranging from 6.08 – 6.54. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Figure 5.19:  Measurement of the 10 major protein spot intensities in 2-DE gels from NS across 6 different healthy cattle. 
Spot intensity results were converted from log normalise value to actual value of data. 
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Figure 5.20:  All major protein spot intensities from 6 2-DE gels were quantified and result 
presented in of median (range). 
Spot intensity results were converted from log normalise value to actual value of data. 
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5.4  Discussion 
The largest body surface in human and animal is the lining of the respiratory tract, 
gastrointestinal tract, and reproductive system each of which is covered by mucous 
membranes, named for their capacity to secrete mucus (Kaliner et al., 1984; Kaliner et 
al., 1986 and Wallace, 2008). This mucus forms a physical and chemical barrier as the 
first line of host defence against inhaled microbial invaders. Many studies of NS and 
mucus secretions in human have defined some of the physiologic and pharmacologic 
controls of human to maintain homeostasis and healthy (Kaliner et al., 1984; Allen et 
al., 1993; Casado et al., 2005 and Miyake et al., 2006). However, the constituents that 
are found in NS and their roles in animal health and disease are still in the initial phases 
of exploration. Bovine NS provides one potential and convenient source of mucous 
membrane secretions for biochemical and proteomic analysis, although certain NS 
mucoproteins have shown not to be able to penetrate 2-DE gel due to its relatively large 
size (Ghazali et al., 2014).  Nasal secretion includes a variety of proteins, which appear 
to serve important functions in host defence. Most of the antiphlogistic proteins are 
synthesized and secreted by serous cells in the sub mucosal glands, and it appears that 
the serous cell is the resident antimicrobial cell in mucous membranes (Cole et al., 2002 
and Joo et al., 2004). 
 
Proteomics has become a valuable and essential tool for researchers to study the 
changes in protein expression level in the animal host at the time of stress and disease 
conditions (Eckersall and Whitfield 2011; Eckersall et al., 2012 and Almeida et al., 
2014). The identification of NS proteins established in this study will promote the 
understanding of respiratory diseases and their fundamental pathological processes. 
Nasal secretion may also serve as a useful model for the analysis of lower pulmonary 
secretions in preventing airway colonization and pulmonary infections.  Over the years, 
many groups have applied proteomic approaches to analyse differences in the human NS 
proteome mostly involving allergic rhinitis (Tomazic et al., 2013 and Tomazic et al., 
2014) and chronic rhinosinusitis (Upton et al., 2011) with healthy controls. Most of the 
proteins identified in human NS (Casado et al., 2005) were similar with the nasal 
proteins detected in cattle with many proteins involved in innate and acquired 
immunity (Figure 5.7).   
 
In this study, it has been demonstrated that the use of gel based proteomics either with 
1-DE and 2-DE and MS protein allowed identification to catalogue the protein profile in 
bovine NS.  One-DE gels on NS samples were able to separate proteins according to their 
molecular weight and 13 distinct protein bands were found. Upon MS analysis, 10 
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different proteins with the highest MOWSE score in each band but with 3 bands having a 
common protein, namely bovine serum albumin. However, apart from the proteins 
having the highest hits, MS results were also able to identify numerous other proteins 
within each band having MOWSE score of >100 and peptide matches of >3 (Figure 5.2). 
Therefore it was justified to apply 2-DE separation method to increase the separation of 
the proteins by pI as well as by Mw. 
 
Two-DE was carried on NS from six healthy animals. The gel image revealed protein 
spots that were well distributed within the gel having protein spots at different pI and 
Mw.  The initial 2-DE study demonstrated that there was a reasonable consistency 
between samples (see below) and following a 2-DE run with pooled samples the major 
protein spots visualized were sent for MS analysis.  Most protein identified were similar 
to those found by 1-DE though glutathione S-transferase (GST) was also identified at 
around 25 kDa and at a basic form with pI values between 8.5 and 10.0. 
 
The bovine NS contained high-abundant plasma proteins, such as albumin and 
immunoglobulins, glandular serous cell proteins (lactoferrin, OBP and polymeric 
immunoglobulin receptor) and epithelial keratins. Odorant binding protein  has been 
demonstrated to have sequence similarity with a superfamily of soluble carrier proteins 
called lipocalins which include some proteins thought to be involved in the mechanism 
of releasing and modulating chemical messages with pheromonal activity (Pelosi, 1994) 
and also having actively involves in antimicrobial processes (Flower, 1996).  Serous cells 
are also involved in forming adaptive immunity protection by transporting locally 
synthesized IgA. Mucosal plasma cells secrete IgA as a dimer link by the joining chain 
(IgJ). This secretory IgA is endocytosed and transported through the serous cells to be 
exocytosed into the gland duct mucus with other serous granule proteins.  
 
Complement C3 has been widely believed to be important for bacterial inactivation and 
immune complex formation by activation of the classic complement cascade. 
Lactoferrin is presumed to be a part of the innate immune system and due to its 
strategic position on the mucosal surface lactoferrin represents one of the first defence 
systems against microbial agents invading the organism mostly via mucosal tissues. This 
protein has been reported to disrupt the growth and proliferation of a variety of 
infectious agents including both Gram-positive and negative bacteria, viruses, protozoa, 
or fungi (Kirkpatrick et al., 1971). Its ability to bind free iron, which is one of the 
elements essential for the growth of bacteria, is the key for the bacteriostatic effect of 
lactoferrin (Arnold et al., 1980). Brock (1980) has demonstrated that a lack of iron 
inhibits the growth of iron-dependent bacteria such as E. coli.  Furthermore the 
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presence of fibrinogen highly suggests that these proteins participate with innate 
immune processes by forming coagulated mass of mucins, albumin and other 
components (Cassado et al., 2005).   
 
Nasal secretion contains antimicrobial proteins and peptides as a first-line host defence 
against microbial invaders. Lactoferrin, stored in and secreted from serous cells in nasal 
submucosal glands, is the most abundant antimicrobial protein of NS but is also secreted 
from neutrophils in inflamed secretions (Niehaus et al., 2000). It is bactericidal for 
gram-positive bacteria and in combination for some gram-negative bacteria (Elisson and 
Giehl, 1991 and Raphael et al., 1989). Given lactoferrin’s strong antibacterial properties 
it was suggested that together with AP both proteins constitutes the two major 
antibacterial proteins that were present and locally produced in NS. Other factors, or 
cofactors acting with lysozyme and lactoferrin, were also recorded to contribute to the 
antimicrobial properties of nasal fluid (Cole et al., 1999). It may be possible in the 
future to add AP to the list of endogenous NS anti-bacterial mediators as discussed in 
Chapter 3. 
 
Bovine GSTs are soluble proteins with typical molecular masses of around 25-30 kDa, 
each composed of two polypeptide subunits. The GST proteins have evolved by gene 
duplication to perform a range of functional roles. Glutathione S-transferases also have 
non-catalytic roles, binding flavonoid natural products in the cytosol prior to their 
deposition in the vacuole (Alfenito et al., 1998 and Boušová et al., 2011). Recent 
studies have also implicated GST as components of ultraviolet-inducible cell signalling 
pathways and as potential regulators of apoptosis (Ishii et al., 2003). Glutathione S-
transferases constitute the family of enzymes best known in their role in enzymatic 
detoxification of endo- and xenobiotics.  In this capacity, the present of GST in NS may 
be to catalyse the conjugation of a number of electrophilic xenobiotic compounds to 
the tripeptide glutathione and in so doing make them less harmful. Glutathione S-
transferases also provide protection against oxidative stress, catalyse various metabolic 
reactions and function as non-enzymatic carrier proteins for several ligands (Marrs, 1996 
and Sheehan et al., 2001) 
 
Apolipoprotein A1 is the major protein of plasma high density lipoprotein and plays an 
important role in lipid transport and metabolism. Apolipoproteins function in lipid 
transport as structural components of lipoprotein particles, cofactors for enzymes and 
ligands for cell-surface receptors. In particular, apolipoprotein AI is the major protein 
component of high-density lipoproteins. Additionally, apolipoprotein AI is known to have 
anti-inflammatory effects in rabbit by inhibits vascular inflammation in NZW rabbits 
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(Patel et al., 2010), negatively regulates ovalbumin-induced neutrophilic airway 
inflammation in mice (Dai et al., 2012) reducing the inflammatory response of sinusitis 
in human (Do Carmo et al., 2008).   
 
The variability of the proteins between samples presented on graphs in Figure 5.19 and 
5.20.  Most of the nasal proteins are not normally distributed as shown by median and 
range but this may be due to some protein that is present in low abundance such as 
OBP, complement C3 and albumin seen in NS sample no. 2 and 6.  The variations 
observed may be indicative of either individual differences or due to physiology or 
pathophysiology. Hence more work is needed to further investigate each of the 
individual protein present and determine their specific biological function in the NS. 
In this chapter, it has successfully been demonstrated that proteomic separation 
technique such as 1-DE and 2-DE accompanied with ESI-MS/MS approaches can be used 
for the investigation and identification of NS proteins in animals. The main advantage of 
this method is the easier comparison across two or more sets of samples using imaging 
analysis.  Although the 2-DE separation of the bovine NS have been successfully 
presented in this chapter particularly in protein expression and identification, a series 
of limitation have to be dealt with when using this approach. Determination of 
unambiguous protein identification in NS is difficult for the differential of protein 
expression between individual animals.  The preparation of 2-DE needs intensive work 
and sample losses are frequent during electrophoretic separation because very basic 
and acidic proteins cannot often be detected. The considerable length of time for 
analysis and the issue of low reproducibility remain the major setback for using this 
method of separation. Not all proteins can be resolved, for example membrane proteins 
may not be well represented due to their poor solubility (Gygi et al., 2000 and Santoni 
et al., 2000). Similarly low abundant proteins, for example AP (Chapter 3) are not likely 
to be potential mucosal biomarkers using 1-DE or 2-DE because they are often lost 
during the electrophoretic procedure.  
 
Recently, the concept of differential gel electrophoresis (DiGE) has been introduced to 
reduce gel-to-gel variability. Briefly, each of two samples is differentially labelled with 
fluorescence dyes (Cy3 and Cy5), and the two samples are then resolved simultaneously 
within the same 2D gel. Another important advantage of DiGE is that an internal 
standard labelled with the third dye commonly Cy 2 can be incorporated into the same 
gel, hence making the quantitative intensity analysis more accurate. The comparison of 
two samples has been reported to be satisfactory with DiGE (Wu, 2006). This new 
method will be discussed in the next chapter where the use of proteomics to compare 
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and differentiate the proteins present in NS of healthy, diseased and vaccinated cattle 
is discussed. Until recently, 2-DE and DiGE have remained the laboratory methods of 
choice to investigate the proteome, understanding the molecular changes or to perform 
comparative analysis of proteins. 
 
Nevertheless, the use of gel based proteomics in this chapter as discussed earlier is not 
without disadvantages. However as describe in section 1.4, most of the drawbacks in gel 
electrophoresis could be possibly overcome by the alternative application of gel free 
proteomic method. The use of gel free proteomic method such as Multidimensional 
Protein Identification Technology (MudPIT) coupled with tandem MS/MS for protein 
identification has several important advantages. For example, MudPIT separates 
peptides in 2D liquid chromatography. This allows greater separation of peptides that 
can be directly interfaced with the ion source of a mass spectrometer, which maximizes 
sensitivity (Weerapana et al., 2007). This modern proteomic technology avoids the band 
broadening associated with many chromatographic steps, which can decrease resolution 
(Kislinger et al., 2005). The application of this procedure, however, also requires the 
manipulation of specimens with high purity to avoid contamination problems (Kislinger 
et al., 2005 and Abdallah et al., 2012). 
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Chapter 6  
Comparative proteome analysis of nasal secretion from naive, 
malignant catarrhal fever challenged and vaccinated cattle  
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6.1  Introduction 
6.1.1  Malignant catarrhal fever  
Malignant catarrhal fever (MCF) is a generalized often fatal disease particularly in 
cattle, but also other ruminants including captive and farmed species of deer, antelope, 
water buffalo (Dettwiller et al., 2011), bison (Schultheiss et al. 1998 and Berezowski et 
al. 2005), and occasionally of domesticated pigs (Alcaraz et al., 2009 and Gauger et al., 
2010). Malignant catarrhal fever is caused by gamma-herpesviruses of the genus 
macavirus, including alcelaphine herpesvirus 1 (AlHV-1) and ovine herpesvirus 2 (OvHV-
2) (Russell et al., 2009 and Davison et al., 2009). These viruses infect their reservoir 
hosts (wildebeest for AlHV-1 and sheep for OvHV-2) efficiently without showing 
apparent clinical sign of disease but cause lymphoproliferative disease that is generally 
fatal when they infect susceptible hosts such as cattle, bison and deer. Malignant 
catarrhal fever is found worldwide wherever these susceptible hosts mix with reservoir 
animals (Russell et al, 2009). 
The blue wildebeest (Connochaetes taurinus) is the major reservoir host, but black 
wildebeest (Connochaetes gnou) are also carriers. All or most wildebeest appear to be 
infected by this virus (Hamblin and Hedger, 1984). Domesticated sheep (Ovis aries) are 
the reservoir hosts for OvHV-2, and most individuals are infected. Zarnke et al. (2002) 
and Cooley et al. (2008) have reported some species of wild sheep, such as Dall's sheep 
(Ovis dalli) and mouflon (Ovis musimon) were also carriers. Goats are the carriers for 
CpHV-2 (Li et al., 2003). Most goats are thought to be infected with this virus, based on 
high seroprevalence to MCF viruses (Yeşlbağ, 2007); however goats can also be infected 
asymptomatically with OvHV2, and serological tests cannot distinguish these two 
organisms (Powers et al., 2005). Alcelaphine herpesvirus-2 (AlHV-2) is carried 
subclinically in hartebeest (Alcelaphus buselaphus) and topi (Damaliscus korrigum).  
Up to the present, MCF still causes major economic losses to the cattle production 
worldwide especially for the African small-holders and local cattle industry (Russell et 
al., 2009). The AlHV-1 and OvHV-2 genomes have been completely sequenced, revealing 
that they are highly-related viruses (Ensser et al., 1997 and Hart et al., 2007). Malignant 
catarrhal fever virus is transmitted by contact or aerosol, mainly from wildebeest calves 
(AlHV-1) and lambs (OvHV-2) under 1-year old (Mushi et al., 1981 and Li et al., 1998). 
Incubation periods after experimental inoculation of cattle are 2–12 weeks (Buxton et 
al., 1984 and Taus et al., 2006). The causal viruses are passed between individuals of 
the reservoir hosts and from reservoir to MCF-susceptible species by the horizontal 
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route, although Plowright (1965) and Rossiter (1981) have reported that vertical 
transmission has been inferred from recovery of AlHV-1 from a wildebeest fetus and 
from the detection of anti-MCF virus antibodies in the serum of some gnotobiotic lambs 
respectively. In addition, Mushi et al. (1981) works on the isolation of AlHV-1 have 
shown that the principal source of free virus in wildebeest is in the tears and nasal 
secretions. 
Several distinct patterns of clinical disease have been described for MCF in cattle: 
peracute, head and eye, alimentary, neurological and cutaneous (OIE, 2004). The head 
and eye form is the most common expression of disease in cattle. Common signs include 
pyrexia, inappetence, ocular and nasal discharge, lesions of the buccal cavity and 
muzzle, diarrhoea and depression. The clinical signs depend to some extent on the 
species infected, the virus and how long the animal survives after the onset of clinical 
signs. Many deer die within 48 hr of the first clinical signs and affected bison generally 
die within 3 days (O’Toole et al., 2002). In contrast, mortality seen in cattle can occur 
within a few days or weeks after the first clinical signs (Russell et al., 2012).  
While a diagnosis on clinical and gross post mortem examination may be possible in 
acute and more prolonged cases with a typical signs of the disease, wide spectrum of 
clinical manifestations that can develop requires laboratory examination to arrive a 
definitive diagnosis.  Characteristic lesions of this disease include histological changes 
of non-purulent vasculitis and interstitial infiltration of lymphoid cells in most of the 
tissues particularly the brain, kidneys and liver, which associated with the presence of 
necrotic ulcers at epithelial surfaces often provide the basis for reaching a diagnosis 
(Liggitt and DeMartini, 1980).  
Laboratory diagnosis in MCF-susceptible species has benefited from recent 
developments in molecular virology. Sequencing of the genome of AlHV-1 has allowed 
the development of both generic and specific reagents for amplification of diagnostic 
fragments of both AlHV-1 and OvHV-2 genomes by PCR (Bridgen and Reid, 1991; Baxter 
et al., 1993 and Flach et al., 2002).  A direct ELISA has also been developed recently 
that offers a simple and inexpensive alternative to other serological tests (Fraser et al., 
2006). The use of PCR allows sensitive confirmation of the presence of MCF viruses in 
infected animals and may also be useful for phylogenetic and epidemiological studies in 
both natural and MCF-susceptible hosts (Russel et al., 2009).  Conventional and real-
time (quantitative) PCR assays have been developed for the detection of OvHV-2 and 
AlHV-1 viral DNA (Baxter et al., 1993; Flach et al., 2002 and Traul et al., 2005).  
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Additionally, the detection of MCF virus-specific antibodies or DNA in an animal with 
clinical signs will also support a diagnosis of MCF cases. 
The current control that is successfully reducing the occurrence of clinical cases is only 
by minimizing the contact between carrier animals and susceptible livestock. Recently, 
an immunisation strategy developed by Haig et al. (2008) using prime vaccination and 
boost immunisations of attenuated AlHV-1 in adjuvant intramuscularly in the upper neck 
to stimulate a mucosal barrier of virus–neutralising antibody in the nasal and oro-
pharyngeal region. This approach has successfully protected cattle challenged 
intranasally with a fatal dose of virulent AlHV-1. In addition, the same group also have 
conducted a proteomic study analysing the changes of peptides composition in AlHV-1 
during the transition from virulent to attenuated virus in tissue culture (Dry et al., 
2008).  They have suggested that the different protein expression present between the 
virulent and attenuation of AlHV-1 were due to altered viral gene expression in the 
infected cell.  
Duncan et al. (1972) and Morgan et al. (1981) have reported the normal values of IgA 
and IgG concentration in bovine nasal secretion were ranged between 1.8 - 3.9 and 0.1 - 
0.7 g/L respectively.  Both of the mucosal antibodies have been reported to increase in 
nasal secretion in vaccinated and experimentally challenged cattle against P. 
haemolytica, IBR and PI-3 viruses (Mukur et al., 1975; Komar et al., 1975 and Nelson 
and Frank, 1989).  As reported in Chapter 2, bovine NSAP activity from apparently 
healthy cattle (n=38) have been shown to be 15.7-fold higher at 80:1259 IU/L than the 
serum reference range for AP. Subsequently, the bio and genomic characteristic and 
possible physiological function of bovine NSAP have been discussed in detail in Chapter 
3 and 4. The NSAP activity during MCF and vaccination has not been measured or 
reported. Hence this could provide a novel approach to study and better understand the 
progression of host response towards diseases and vaccinations. 
Likewise, currently there is no known proteomic study that has analysed the changes in 
protein composition of NS from animal infected by AlHV-1, or indeed any bovine 
respiratory disease. As mentioned above the most common route of MCF virus 
transmission reported is by aerosol and NS being the primary innate defence mechanism 
against the causative agent, it is possible that changes in the NS protein composition 
occur in animals infected with MCF.  Therefore, this chapter describes a novel use of 
difference gel electrophoresis (DiGE), a modern comparative proteomic technology, to 
analyse the NS proteins in animal infected and vaccinated against AlHV-1.  
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6.1.2  Difference gel electrophoresis  
In 1997, Unlu and co-workers first described the 2-D Difference gel electrophoresis 
(DiGE) technique to profile proteins (Unlu et al., 1997).  The method of DiGE overcomes 
the reproducibility problems of conventional 2-DE by labelling proteins with spectrally 
distinct fluorescent dyes prior to electrophoretic separation with different samples run 
on a single gel. The dyes used are cyanine dyes (GE Healthcare DiGE CyDye Fluorescent 
CyTM, Hatfield) and there are three spectrally distinct CyDyes available: Cy2, Cy3, and 
Cy5. These are used to label different samples allowing up to three samples bound to 
the three different CyDyes to be electrophoresed on the same gel. The gel is then 
scanned with a fluorescent imager at different wavelengths and each of the samples on 
the single gel is visible separately.  All three CyDye DiGE fluorescent minimal dyes have 
different absorption and emission spectra. Because of the different absorption and 
emission spectra, the CyDyes can be used for multiplexing of up to three different 
protein samples on the same 2-DE gel. Due to the high degree of sensitivity the labelling 
method used, a single protein as low as 125pg can be detected following electrophoresis 
(Chakravarti et al., 2005).  
There are two types of DiGE labelling chemistries available, one labels lysine residues 
within sample while the other labels cysteine, these are termed minimal and saturation 
labelling respectively.  Lysine is the most widely employed labelling method due to the 
reactive N-hydroxysuccinimide ester group that forms a covalent bond with the ε-amino 
group of lysine side chains.  The content of lysine is generally very high in most proteins 
such that an excessive amount of dye is required to direct the reaction to completion 
(Westermeier et al., 2008).  Labelling of the lysine with the CyDyes is extremely 
sensitive, with picogram sensitivities (Chakravarti et al., 2005). Minimal labelling 
CyDyes are supplied as N-hydroxy Succinimidyl esters, which react with primary amino 
groups, typically the terminal amino group of lysine side chains; with labelling reactions 
optimised so only 2.5% of the total number of lysine residues is labelled (Lilley & 
Friedman, 2004). If all of the lysines were labelled the proteins would become too 
hydrophobic and not stay in the solution (Westermeier et al., 2008).  
Whereas in a minimally labelled DiGE experiment samples that are to be compared are 
labelled with either Cy3 or Cy5 CyDye fluorescents (Lilley & Friedman, 2004). For 
samples to be compared quantitatively and the comparison to confer any statistical 
power then a pooled internal standard must be utilised and ran on all gels (Unlu et al., 
1997 and Chakravarti et al., 2005). The pooled internal standard comprises equal 
aliquots of every sample within the experiment and is labelled with the Cy2 CyDye. This 
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will result in three differentially labelled samples: two samples labelled separately to 
Cy3 and Cy5 and the pooled internal standard labelled with Cy2. These are then mixed 
and co-resolved in the same 2-D gel (Kondo and Hirohashi, 2006).  The use of the pooled 
internal standard could ensures that all proteins in the sample are represented assisting 
both inter and intra gel matching.   
The DiGE technology is able to prevent the issue of variation in spot volumes due to gel-
specific variation such as sample entry and electrophoresis in either the first dimension: 
immobilised pH gradient (IPG) strip or second dimension: SDS-PAGE. Having been ran 
together under identical condition with proteins migrating under the exact conditions 
the problems of reproducibility are overcome (Unlu et al., 1997; Lilley and Friedman, 
2004 and Westermeier et al. 2008). Furthermore the relative amount of a protein in a 
gel in one sample compared with another will be unaffected (Lilley & Friedman, 2004). 
Additionally, labelling with CyDyes have shown to allow greater level of detection of 
protein spots than Coomassie Blue and a comparable level of detection of protein spots 
as with silver stain or SYPRO Ruby (Gharbi et al., 2002 and Gade et al., 2003). 
For quantification, measurements are made relative to the Cy2 signal for each resolved 
protein (Chakravarti et al., 2005). The Cy2 signal should be the same for a given protein 
across all the different gels because it came from the same bulk mixture, therefore any 
differences represent gel-to-gel variation, which can be effectively neutralised by 
normalising all the Cy2 values for a given protein across all the gels (Friedman and 
Lilley, 2008). Therefore, by using the Cy2 signal to normalise the ratios between the 
DiGE gels could provide direct comparisons of spot volumes to be made between the 
Cy3 and Cy5 labelled samples and the Cy2 labelled internal standard for that gel (Tonge 
et al., 2001 and Lilley and Friedman, 2004).  
The use of sufficient replicates and the presence of the same pooled standard present 
in each gel allows for the application of the students t-test and analysis of variance 
(ANOVA) statistical analysis despite the samples having been separated on different 
DiGE gels (Lilley and Friedman, 2004). The imaging software developed for the DiGE 
system: DeCyderTM (GE Healthcare, Hatfield) is typically used for analysis. DeCyder is 
able to process all the scanned gel images, detect the spots, match spots across the gels 
and perform statistical analysis. The DeCyder software package has a triple codetection 
algorithm that allows simultaneous detection of labelled protein spots from images that 
arise from the same gel and increases the accuracy in the quantification of standardised 
abundance. The standardised abundances can then be compared across groups to detect 
changes in the protein expression (Alban et al., 2003). 
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The minimal labelling method in DiGE technology is compatible with the downstream 
processing of selected protein spots. Spots, usually selected based on their differential 
expression between experimental groups are excised from the gels and trypsin digested 
to yielding tryptic peptides of an appropriate size efficient for mass spectrometry 
analysis. Mass spectrometry is an analytical technique that measures the mass-to-charge 
ratio (m/z) on ions based on their motion or magnetic field (Westermeier et al., 2008). 
For protein identification selected protein spots are firstly trypsin digested, which 
cleaves peptides bonds at the carboxylterminal of lysine and arginine amino acid 
residues (Lilley and Friedman, 2004 and Chakravarti et al., 2005). The peptide masses 
are determined using the mass spectrometer to create a unique peptide mass 
fingerprint that makes it possible to infer the amino acid composition of those peptides. 
Subsequent identification of the protein is achieved by using software such as Mascot 
(Matrix Science) that assimilates mass spectrometry data and identifies proteins, 
matched from other genomic and proteomic database, such as NCBI and SWISS-PROT. 
 
6.1.3  Aims of study  
The aims of the work presented in this chapter were to: 
 
4. Measure and compare the NSAP activity in pre and post-challenge animal with 
AlHV-1. 
 
5. Measure and compare the nasal mucosal antibody, IgA and IgG concentration in 
pre and post-challenge animal with AlHV-1. 
 
 
 
6. Determine the changes of protein expression in NS of healthy, MCF challenge and 
vaccinated cattle by DiGE technology. 
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6.2  Materials and methods 
6.2.1  Animals 
Samples of bovine NS were obtained from cattle involved in MCF immunisation studies 
carried out at the Moredun Research Institute (MRI), Scotland and were provided by Dr 
G. Russell (Haig et al., 2008). Twenty three disease-free and OvHV-2 seronegative male 
Friesian-Holstein cross-calves between 3 and 5 months of age were used in the 
experiments. The animal experiments were carried out with the approval of the MRI’s 
experiments and ethics committee and complied fully with the Home Office of Great 
Britain and Northern Ireland “Animals (Scientific Procedures) Act 1986”.  Animals 
exhibiting a rise in rectal temperature >40 °C for 2–4 days along with inappetance and 
ocular or nasal discharge were euthanized with an overdose of intravenous sodium 
pentobarbitone. 
 
6.2.2  Immunisation study design 
The calves were randomly assigned to 6 different groups (Table 6.1). On week 0, naive 
and disease calves were treated with sterile phosphate buffered saline (PBS).  
Vaccinated calves were treated by intramuscular (IM) at the upper neck region with 
either complete Freund’s adjuvant (CFA) or attenuated C500 AlHV-1 in CFA [107.3 to 107.5 
tcid50/ml virus, where tcid50/ml is the tissue culture infective dose of virus giving a 
cytopathic effect (CPE) in 50% of wells containing cultured fibroblasts] as primary 
immunisation. Immunisation boosts were given 4 weeks later by IM or intranasal (IN) 
with either incomplete Freund’s adjuvant (IFA) or attenuated AlHV-1 in IFA or adsorbed 
in chitosan [0.2% (w/v) in sodium acetate buffer pH 7.5].  
On week 10, all of the calves were administered virulent C500 strain AlHV-1 as 
challenge either by intravascular (IV) at the dosage of 104.5 tcid50/ml virus or IN (10
4 
tcid50/ml virus) route (Table 6.1). Calves that succumbed to MCF or showing clinical sign 
of MCF were euthanized and post mortem for examination of the mesenteric lymph 
nodes. Survived animals were euthanized 12 weeks after challenged to look for any 
signs of infection or disease. 
  
Group 
 
(no. of animals) 
 
Vaccine type 
 
Primary 
Immunisation 
Route 
 
Booster 
Type 
 
Booster 
Route 
 
 
Pre- 
challenge 
sampling 
 
Challenged 
Route 
 
Post-
challenged 
sampling 
 
Week 0 
 
Week 4 
 
Week 8 
 
Week 10 
 
Week 12 
1 
(n=4) 
Complete Freund’s 
Adjuvant 
IM 
Incomplete 
Freund’s Adjuvant 
IM 
Collection of 
NS 
IV 
Collection of 
NS 
2 
(n=5) 
Att.  AlHV-1 
Virus 
Att.  AlHV-1 
Virus 
IN 
3 
(n=3) 
Att.  AlHV-1 
Virus 
Att.  AlHV-1 
Virus 
IM 
4 
(n=4) 
Att.  AlHV-1 
Virus 
Att.  AlHV-1 
Virus 
IN 
IN 
 
5 
(n=3) 
Att.  AlHV-1 
Virus 
Att.  AlHV-1 
Virus 
IM 
6 
(n=4) 
PBS PBS IM 
Table 6.1:  The experimental design details of the immunisation and control groups used in this study. 
AlHV-1= Alcelaphine Herpesvirus-1; Att.=attenuated; PBS=phosphate buffer solution; IM=intramuscular; IN=intranasal; IV=intravenous. 
 
C
h
a
p
te
r 6
 
2
2
2
 
223 
Chapter 6 
6.2.3  Bovine nasal secretion 
Nasal secretion samples were collected from the experimental animal at d-56 and at d-
84 post AlHV-1 immunisation by Dr. G. Russell of MRI. The NS were processed as 
described in section 2.2.2. and were stored in -80°C until further analysis. 
6.2.4  Alkaline phosphatase activity 
Alkaline phosphatase activity in NS pre and post challenge was measured using pNPP 
enzymatic reaction as described in section 2.2.5.1. 
6.2.5  Analysis of mucosal antibody response  
Analysis of nasal mucosal antibody mainly IgA and IgG was performed by measuring their 
concentrations in NS during pre and post challenge using species-specific ELISAs (Bethyl 
Labs, USA) as described in section 2.2.6. 
6.2.6  Difference gel electrophoresis  
6.2.6.1   Experiment design 
Three different CyDye DiGE Fluorescent minimal dyes are available for protein labelling: 
Cy3, Cy5 and Cy2, each of which can be visualised separately when scanned with a 
fluorescent imager at different wavelengths. The selections of NS for DiGE experiment 
were based on the post-challenge outcome result (section 6.3.1). Three groups of NS 
samples were used to represent the healthy, disease and vaccinated group (Table 6.2).  
 
 
 
 
 
 
Table 6.2:  The different types of NS used for DiGE experiment and their designated group  
*Nasal secretion samples from Table 6.1 
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Figure 6.1 summarized the experimental design for the DiGE experiment. Fifty μg of NS 
protein was pooled according to their respective group: healthy (n=4), disease (n=4) and 
vaccinated (n=3). Subsequently, the NS proteins were bound separately to both Cy3 and 
Cy5 fluorescent dyes according to their respective DiGE gel shown in Figure 6.1. Each 
gel contained a CyDye DiGE Fluorescent Cy2 dye labelled pooled internal standard, 
which containing equal volumes from control and challenged groups at each time point. 
Bound to Cy2 this acted as an internal standard throughout the DiGE experiment. For 
each group of animal two gels were ran, with the respective samples bound to opposite 
Cy dyes, together with the Cy2 internal standard. DiGE images were analysed using 
DeCyder v7.0 and protein spots that were found to be differentially expressed in the 
disease and vaccinated group identified. Spots were picked from preparatory gels, ran 
alongside the DiGE gels. A preparatory gel was ran for the pooled healthy, disease and 
vaccinated group and was loaded with a greater concentration of protein at 500 µg, 
making spot picking and identification of the protein possible. Both DiGE and 
preparatory gels were prepared and run by Mr. A. Scott of Glasgow Polyomics. 
 
 
 
 
 
 
 
6.2.6.2  Preparatory gels 
For each of the 3 different groups: pooled healthy (Group 6 pre-challenge), pooled 
diseased (Group 6 post-challenge) and pooled vaccinated (Group 5 post challenge) 
group, 500 μg of protein was mixed with 350 μl of rehydration buffer (6M urea, 2M 
thiourea, 4% CHAPS, 0.002% (w/v) bromophenol blue) into which 3.5 mg of dithiothreitol 
(DTT) and 1.75 μl IPG pH 4 - 7 buffer (GE healthcare biosciences 17-6000-86, Hatfield) 
had been added. These were mixed for 30 min and added into individual strip holders 
Figure 6.1:  Experimental design for DiGE experiment (n=3) and Coomassie stained 
Preparatory gels (n=3) and layout of samples in gels. 
Healthy=group 6 pre-challenge (n=4); Disease=group 6 post-challenge (n=4) and   
Vaccinated=group 5 post-challenge (n=3). 
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(“coffins”) which hold the sample for focusing.  A 24 cm pH 4-7 IPG strip (GE Healthcare 
Life Sciences 17-6002-32, Hatfield) was placed gel side down into the coffins. One ml of 
mineral oil was added over the IPG strip. Each IPG strip was focused to 8000 V over 27 
hr.  
Following focusing the IPG strips was washed in two IEF equilibrium buffer washes for 15 
min each. The first with 10mg/ml DTT added and the second with 25mg/ml of 2-
iodoacetamide added. Each IPG strip was placed between the two halves of the gel 
cassette directly onto the top of a 24cm 12.5% SDS-PAGE gel. One ml of 0.5% agarose 
with bromophenol blue was added on top of the gel to seal the strip to the gel and to 
serve as a dye front for monitoring the progress of the gel. The gel cassettes were 
placed into the ETTAN DALT system with 2% SDS running buffer. The gels were run at 1V 
per gel for 18 hr. The gels were fixed for 1 hr in 40% ethanol / 10% acetic acid, washed 
twice for 10 min in dH2O and stained in colloidal Coomassie for 48 hr.  
6.2.6.3   DiGE gels 
Equal masses of total protein (0.5 mg) from healthy, diseased and vaccinated group 
were pooled separately. The pooled samples were then labelled with 400 pmol of 
different CyDye Fluorophors.  Each DiGE gel had two samples of 50μg of protein bound 
to either Cy3 or Cy5 dyes together with 50μg of the Cy2 bound pooled internal standard. 
To bind the Cy dyes to the protein, the prepared samples were mixed with 1μl of Cy3 
and Cy5 fluorescent dyes separately and placed in the dark on ice for 30 min. One μl of 
10mM lysine was then added to stop the Cy’s reaction with the protein. For each gel the 
Cy3 bound sample, the Cy5 bound sample and the Cy2 bound protein were mixed 
together for each gel as detailed in Figure 6.1, with rehydration buffer containing DTT 
and IPG buffer and added to a coffin with a 24cm 4-7 IPG strip (GE Healthcare Life 
Science 17-6002-32, Hatfield, UK). The strips were focused as described for the 
preparatory gels. Similarly, for the second dimension the strips were washed as 
described for the preparatory gels and ran at 1 V per gel for 18 hr. 
6.2.6.4   Protein separation 
The separation was carried out on IPGphor (GE Healthcare, Hatfield) in the first 
dimension (IEF electrophoresis, pI 4-7), followed by equilibration and reduction of IEF-
strips according to standard protocols (Hannigan et al., 2007 and McNamara et al., 
2011). Focused IPG strips were then loaded on top of SDS-polyacrylamide gels (13% total 
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acrylamide, 3% bis-acrylamide), and the 2-DE was carried out using a DALT 12 vertical 
gel electrophoresis system (GE Healthcare, Hatfield UK). 
6.2.6.5   Image analysis of DiGE gels 
After 2-DE, gels were scanned using Typhoon™ 9400 Imager (GE Healthcare, Hatfield), 
the protein spots were analysed with DeCyder 2-D Differential in-gel analysis (DIA) 
software v7.2 (GE Healthcare, Hatfield) and biological variation analysis (BVA) software.  
The BVA processes multiple gel images and also performs gel-gel matching of spots 
allowing quantitative comparisons of protein expression across multiple gels (GE 
Healthcare DeCyder User manual, Hatfield). A direct comparison between of spot 
volumes was made between the Cy3 and Cy5 labelled samples and the Cy2 labelled 
sample for that gel. The ratios were normalised and compare with those generated for 
that particular spot from other gels. The presence of the same pooled internal standard 
in each gel allowed for the application of the two-way analysis of variance (ANOVA) 
statistical analysis (Lilley and Friedman, 2004).  
The statistical analysis in DeCyder is based on the standardized protein log abundances, 
which are defined as the log10 of the standardized abundances (Fodor, et al. 2005). The 
standardized abundance is derived from the normalized spot volume standardized 
against the intra-gel standard. The logs of the standardized abundance values are used 
in order that the data points approach a normal distribution around zero, thereby 
fulfilling the requirements of the subsequent statistical tests (GE Healthcare DeCyder 
User manual, Hatfield). In this study, one-way ANOVA was used to evaluate the protein 
expression of NS from the healthy, disease and vaccinated group of animals.  
As this experiment assessed the variation of protein expression in NS in 3 different 
conditions of animal, a one-way ANOVA was used to identify protein spots that were 
differentially expressed as a result of the intranasal challenge of AlHV-1. The 
preparatory gel images were loaded into the BVA module, designated as pick spot maps, 
and matched to the DiGE gels. Differentially expressed protein spots whose log 
standardised abundance was statistically significant for 3 different conditions were 
selected for identification, matched to the pick spot maps and subsequently excised 
from the preparatory gel for tryptic in-gel digestion and protein identification.  
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6.2.7  Protein digestion and mass spectrometry analysis  
Protein tryptic in-gel digestion was performed as described in section 5.2.8, while MS 
analysis and protein identification were carried out as described in section 5.2.9 and 
5.2.10 respectively. 
6.2.8  Statistical Analysis 
Data for post-challenge survival percentage between groups were analysed by sample 
paired t-test between percent (www.statpac.com/statistics-calculator/percents.htm) 
to compare experimental groups. Nasal secretion AP, IgA and IgG response data of pre 
and post challenge were compared using paired t-test. DeCyder, after spot matching, 
one-way ANOVA statistical test was used to select protein spots which were 
differentially expressed between the healthy, disease and vaccinated group base on the 
BVA module. P value < 0.05 is considered significant for both tests. 
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6.3   Results 
6.3.1  Post-challenge outcome 
Table 6.3 shows that all the animals in group 5 (IM prime with attenuated virus in CFA 
and IM boost with attenuated virus in IFA) and 2 of 4 animals in group 4 (IM prime with 
attenuated virus in CFA and IN boost with attenuated virus adsorbed to chitosan 
adjuvant) survived a lethal challenge with AlHV-1 given by the intranasal route. Only 
the immunisation regime for group 5 produced significant protective effects (P = 0.04, 
group 5 vs. groups 6) whereas the immunisation regime for group 4 did not produce 
significant protective effects (P = 0.21, group 4 vs. groups 6). 
Two of the group 5 animals were euthanized 12 weeks after challenge to look for signs 
of infection or disease. The remaining group 5 animals survived for a year after 
challenge, when it was euthanized to terminate the experiment.  All of the control 
animals given PBS without immunising virus and challenged intranasally with virulent 
virus succumbed with MCF between 3 and 7 weeks after challenge.  
Group 3 animals, given the same immunisation regime that vaccinated group 5 cattle 
against intranasal virus challenge, all succumbed with MCF when the virus was given 
systemically.  These animals developed MCF over a similar time period as unimmunised 
control group animals given virus systemically and compared with group 1, no difference 
between the 2 groups as no animal survive the challenge. 
Adjuvant alone had no MCF-protective effect as all the animals in group 1 died within 
the second week post-challenge.  Finally, of the unvaccinated animals, those challenged 
intravenously with virus were seen to develop clinical signs of MCF earlier than those 
that were intranasally challenged.  The animals exhibiting a rise in rectal temperature 
>40 °C for 2–4 days along with inappetance and ocular or nasal discharge (Figure 6.2) 
were euthanized with an overdose of intravenous sodium pentobarbitone. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Group 
 
(no. of animals) 
Treatment 
Type 
Treatment route 
 
(primary/booster) 
Challenge 
route 
Death 
 
0-12 w 
post-challenge 
Survivor 
 
> 12 w 
post-challenge 
1  
(n=4) 
Adjuvant IM/IM 
IV 
4 0 
2  
(n=5) 
Att. virus IM/IN 5 0 
3 
(n=3) 
Att. virus IM/IM 3 0 
4 
(n=4) 
Att. virus IM/IN 
IN 
2 2 
5 
(n=3) 
Att. virus IM/IM 0 3 
6 
(n=4) 
PBS IM/IM 4 0 
Table 6.3:  Post-challenge outcome of the immunisation procedures.  
The  number of animal showing onset of MCF clinical signs either died or euthanized within 12 weeks post challenge are indicated in the 
‘death’ column while animals that survived for autopsy at the end of the experiment are indicated on the ‘survivors’ column (*). 
Att=attenuated; PBS=phosphate buffer solution; IM=intramuscular; IN=intranasal; IV=intravenous. 
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A 
B 
C 
Figure 6.2:  Clinical signs of MCF seen in cattle after challenge with AlHV-1 were euthanized. 
(A) Cattle showing clinical signs of increase in nasal and ocular discharges. Close up images of 
nostril (B) and eye (C) shows increased in nasal and ocular secretion respectively. (Images 
courtesy of Dr. G. Russell) 
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6.3.2  Response of nasal secretion alkaline phosphatase activity 
on AlHV-1 challenge 
Following intranasal challenge with AlHV-1, the NSAP activity was measured pre and 
post-challenge in the animals that have been vaccinated (group 4 and 5) and those that 
not receive any kind of vaccination (group 6) to observe whether the immunisation 
regime and MCF disease have an effect on the high AP activity seen in NS of healthy 
animals (Chapter 2). The result data showing the changes of NSAP activity on day 14 
after receiving AlHV-1 challenge are shown in detail in Figure 6.3. 
There was no significant change in NSAP on day 14 post challenge but the NSAP activity 
in both vaccinated groups tended to be higher than the pre-challenge NSAP activity 
however in the disease group, NSAP activity tended to decreased. Nevertheless, all the 
NSAP activity finding pre and post-challenge in all the 3 animal groups were similar with 
the AP activity finding in Chapter 2 where it showed a higher AP activity in the NS in 
compare to the serum reference. 
Paired t-test comparison using GraphPad Prism v5, reveal that animal challenge with 
AlHV-1 have no effect on the NSAP activity in both vaccinated group 4 and 5 having no 
significant difference and mean±(SD) of (p=0.26, 3220±1290 IU/L) and (p=0.06, 
1900±170 IU/L) respectively. Similar finding was also seen in the disease group 6 where 
the decreased NSAP activity observed was not significantly difference (p=0.13) having a 
mean±(SD) of 1608 ±1666 IU/L. 
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Figure 6.3:  Nasal secretion AP activity (IU/L) response from cattle challenge intranasally 
with AlHV-1. 
Data comparison of median NSAP activity pre and post-challenge by paired t-test. 
Att=attenuated; PBS=phosphate buffer solution; IM=intramuscular; IN=intranasal 
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6.3.3  Response of mucosal antibody in nasal secretion 
Following intranasal challenge with AlHV-1, the IgA and IgG mean concentration in NS of 
group 4, 5 and 6 has shown to be significantly increased. The result data showing the 
changes of IgA and IgG concentration after AlHV-1 challenge were shown in detail in 
Figure 6.4 and 6.5 respectively.  
Paired t-test comparison using GraphPad Prism v5, revealed that animals challenged 
with AlHV-1 had a significant effect on the IgA concentration in the vaccinated group 4 
and 5 having significant differences with p < 0.05 with mean±(SD) of 3.18±0.7 g/L and 
6.60±0.6 g/L respectively. However for IgG concentration, only group 5 shows a 
significant difference in post challenge having mean±(SD) of 3.30±0.5 g/L but not for 
group 4 (p=0.09) with mean±(SD) of 1.70 ±0.9 g/L.  
In contrast, the mucosal antibody concentration in the disease animals (group 6) post-
challenge show no significant difference in IgA concentration [p=0.05; 
mean±(SD)=3.13±0.4 g/L] but increased significantly for IgG concentration in NS post 
challenge [p<0.05; mean±(SD)=2.18 ±0.9 g/L]. 
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Figure 6.4:  Concentration of NS IgA (g/L) response from cattle challenge intranasally with 
AlHV-1.  
Data comparison of median NS IgA concentration pre and post-challenge by paired t-test. 
Att=attenuated; PBS=phosphate buffer solution; IM=intramuscular; IN=intranasal 
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Figure 6.5:  Concentration of NS IgG (g/L) response from cattle challenge intranasally with 
AlHV-1.  
Data comparison of median NS IgG concentration pre and post-challenge by paired t-test. 
Att=attenuated; PBS=phosphate buffer solution; IM=intramuscular; IN=intranasal 
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6.3.4  DiGE analysis 
All three CyDyes satisfactory bound to the nasal protein as evidenced by the 9 Cy 
images, of which 3 were the Cy2 bound internal standard. Figure 6.6 shows all 9 of the 
spot maps images created from the 3 DiGE gels as well as the 3 preparatory gel images 
representing the pooled healthy, disease and vaccinated group (Figure 6.7).  Figures 6.8 
details an example of DiGE gel image from healthy and disease group, with molecular 
weight and isoelectric point markers indicated together with labelled protein spots. 
 
In DeCyder v.7.0, all DiGE images and Coomassie stained preparative gel images were 
analysed in the differential in-gel analysis (DIA) module. Total of 432 spots were 
detected in DIA module after the area of interest and the exclusion parameters were 
defined. Of the 432 spots that were identified, 71 were matched across the gels. One-
way ANOVA was used in the BVA module to identify spots which were expressed 
significantly different between the 3 DiGE gels. A significance threshold of P≤0.05 was 
used and the false discovery rate was applied (Burchmore, pers. comm. 2014).  
A total of 20 spots were differentially expressed in bovine NS in comparing the disease 
and vaccinated group as a result of AlHV-1 challenge.  Eight spots showed increased and 
12 spots decreased in expression in the disease group compared to the healthy group. 
Whereas for the vaccinated group, 11 spots showed increased and 9 spots decreased in 
expression in compared to the healthy group. 
Table 6.4 lists the proteins that were detected in the spots that were differentially 
expressed in the disease and vaccinated group as a result of the AlHV-1 challenge. Using 
the log standardised abundance it was possible to plot the changes in spot volume in the 
disease and vaccinated group and compare their changes to results from the healthy 
group. Figure 6.6 – 6.8 depict the graphs of the major protein spots that were 
differentially expressed (change in abundance) in the disease and vaccinated group as a 
result of the AlHV-1 challenge in comparison with the healthy group. 
From the spots that varied in expression within the disease and vaccinated group, 4 
major spots were increased (spot 267: IgA; spot 380: IgG; spot 68: α 2-macroglobulin 
and spot 313: odorant binding protein) and another 4 major spots decreased ( spot 271: 
apolipoprotein-A1; spot 240: fibrinogen beta chain; spot 347: hemopexin and spot 57: 
ceruloplasmin) in expression in both of the group and were selected to further illustrate 
the changes in expression post challenge with AlHV-1 are shown in Figure 6.12 and 6.13 
respectively. In addition, Figure 6.14 shows the other 4 major spots expression that 
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were decreased in the disease group but increased in the vaccinated group (spot 320: 
haptoglobin; spot 244: complement C3; spot 352: serotransferrin and spot 451: 
cathelicidin). 
The protein accession numbers were converted to gene ontology (GO) terms using NCBI 
and UniProt to identify each protein and subsequently their respective molecular and 
biological functions of the proteins that were affected as a result of AlHV-1 challenge. 
The GO terms for all the proteins were grouped and displayed in percentage values on a 
pie chart. Figure 6.15 and 6.16 represent all the proteins that were either increased in 
expression or decreased in expression for the disease and vaccinated group 
respectively. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  6.6:  Nine spot map images from 3 DiGE gels consisting of pooled NS assigned according to Figure 6.1 
Approximate peak wavelengths of excitation and emission values used to view Cyanine fluorophores (Excitation wavelength/ Emission 
wavelength) given in nanometres (nm). Fluorophore Cy3= (550/570); Fluorophore Cy5= (650/670); Fluorophore Cy2= (492/510). 
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Figure 6.7:  Three preparatory gel images stained with Coomassie blue 
representing the pooled healthy, disease and vaccinated group and were 
used to pick the spot that were differentially expressed for MS analysis 
and protein identification.  
 
  pH 4 pH 7 
15 kDa 
100 kDa 
Figure  6.8:  Spot map DiGE image of NS samples from the healthy and disease group. 
2
4
0
 
C
h
a
p
te
r 6
 
  
Spot Protein name 
p 
value 
MS 
Accessiona 
Theoretical 
Mw (kDa) 
MOWSE 
score 
Peptide 
matches 
Protein functionb 
Biological 
processb 
 
240 
 
 
 
Fibrinogen beta chain 
 
 
 
0.0045 
 
 
 
CAA23444 
 
 
 
57 
 
 
 
722 
 
 
 
112 
 
 
 
 
APP, fibrin non-active form; involved in blood coagulation, 
cellular and matrix interactions, endothelial cell proliferation, 
the inflammatory 
response 
 
Defence 
 
 
 
372 
 
 
 
Albumin 
 
 
 
0.0049 
 
 
 
AAA51411 
 
 
 
71 
 
 
 
1661 
 
 
 
228 
 
 
 
APP; main serum protein, transport of different molecules, 
responsible for the oncotic pressure, antioxidant properties 
 
 
Transport 
 
 
 
271 
 
 
 
Apolipoprotein A1 
 
 
 
0.0044 
 
 
 
AAB21444 
 
 
 
30 
 
 
 
368 
 
 
 
74 
 
 
 
APP, main protein component of HDL; phospholipid, reverse 
cholesterol transport,  LCAT cofactor, anti-inflammatory 
 
 
Lipid 
metabolism 
 
 
57 
 
 
 
Ceruloplasmin 
 
 
 
0.035 
 
 
 
XP_592003 
 
 
 
121 
 
 
 
434 
 
 
 
40 
 
 
 
APP, major copper-binding protein; no clear role in copper 
transport, proposed functions: iron(II) oxidation, cellular iron 
levels 
 
Transport 
 
 
 
391 
 
 
 
Kininogen 
 
 
 
0.00055 
 
 
 
AAI05500 
 
 
 
70 
 
 
 
449 
 
 
 
85 
 
 
 
Anticoagulant/anti-inflammatory properties, inhibition of 
vascular cell adhesion/ migration/ proliferation/ differentiation 
 
 
Defence 
 
 
 
347 
 
 
 
Hemopexin 
 
 
 
0.018 
 
 
 
NP_001029784 
 
 
 
52 
 
 
 
342 
 
 
 
63 
 
 
 
APP, major heme-binding protein; toxic heme scavenger and 
transporter to the liver,  heme  iron recycler, antioxidant effect 
 
 
Transport 
 
 
 
126 
 
 
 
Lactoferrin 
 
 
 
0.0088 
 
 
 
AAI16052 
 
 
 
80 
 
 
 
1107 
 
 
 
149 
 
 
 
APP, iron-binding glycoprotein; iron transport, 
antimicrobial/anti-inflammatory/immune system modulation 
 
 
Transport 
 
 
 
244 
 
 
 
 
Complement C3 
fragments 
 
 
 
0.031 
 
 
 
 
CAJ31249 
 
 
 
 
68 
 
 
 
 
554 
 
 
 
 
110 
 
 
 
 
Involved in complement cascade 
 
 
 
 
Defence 
 
 
 
 
320 
 
 
 
 
Haptoglobin 
 
 
 
 
0.0069 
 
 
 
NP_001035560 
 
 
 
46 
 
 
 
383 
 
 
 
60 
 
 
 
APP; hemoglobin-binding protein, iron elimination control, 
antioxidant/anti-inflammatory role, immunomodulation 
 
 
Transport 
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 451 
 
Cathelicidin 
 
0.029 
 
CAA70616 
 
18 
 
412 
 
59 
 
Antimicrobial properties 
 
Defence 
 
352 
 
 
 
Serotransferrin 
 
 
 
0.016 
 
 
 
NP_803450 
 
 
 
80 
 
 
 
1404 
 
 
 
147 
 
 
 
APP, iron-binding protein; iron transport and distribution, 
antimicrobial activity, involved  in growth, differentiation and 
cytoprotection 
 
Transport 
 
 
 
380 
 
IgG2 heavy chain 
 
0.036 
 
AAB37380 
 
51 
 
749 
 
58 
 
Immunoglobulin fragment; antigen recognition 
 
Defence 
 
 
68 
 
 
Alpha 2-macroglobulin 
 
 
0.0058 
 
 
NP_001103265 
 
 
167 
 
 
621 
 
 
85 
 
 
APP; proteases inhibition and clearance, inflammatory regulation 
 
 
Defence 
 
 
313 
 
 
Odorant binding protein 
 
 
0.0022 
 
 
P07435 
 
 
18 
 
 
579 
 
 
97 
 
 
Binds a wide variety of chemical odorants, sensory transduction, 
olfaction 
 
Transport 
 
 
267 
 
IgA light chain 
 
0.016 
 
XM_005219676 
 
25 
 
343 
 
45 
 
Immunoglobulin fragment; antigen recognition 
 
Defence 
 
478 
 
 
 
Serpin 
 
 
 
0.0046 
 
 
 
Q1JPB0 
 
 
 
46 
 
 
 
578 
 
 
 
78 
 
 
 
Cysteine or serine protease inhibitor family; neutrophil proteases 
Regulation 
 
 
Defence 
 
 
 
465 
 
 
 
Plasminogen 
 
 
 
0.033 
 
 
 
NP_776376 
 
 
 
91 
 
 
 
317 
 
 
 
104 
 
 
 
APP, plasmin non-active form; serine protease, anticoagulant 
properties by fibrinolysis, cell migration enhancer, inflammatory 
response regulation 
 
Defence 
 
 
 
264 
 
Igλ light chain 
 
0.0085 
 
AAK84156 
 
25 
 
716 
 
45 
 
Immunoglobulin fragment; antigen recognition 
 
Defence 
 
80 
 
Complement C3 
 
0.0004 
 
AAI12453 
 
189 
 
530 
 
83 
 
APP; involved in complement cascade 
 
Defence 
 
422 IgG1 heavy chain 0.016 AAB37381 36 697 60 Immunoglobulin fragment; antigen recognition Defence 
Table 6.4:  Proteins differentially expressed in NS between healthy, disease and vaccinated group.  
p values <0.05 was considered significant different in protein expression, and a list of proteins identified by MS, together with theoretical molecular 
weights, peptide matches, accession number, MOWSE score, protein function and biological processes. APP = Acute phase protein. 
a
 Database accession 
numbers: SWISS-PROT (http://us.expasy.org/), ncbi (http://www.ncbi.nlm.nih.gov/). 
b
 Protein Function and Biological Process, if not stated otherwise, 
according to SWISS-PROT (http://us.expasy.org/uniprot/). 
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Spot 267: IgA 
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Spot 68: α-2-macroglobulin 
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Spot 313: Odorant binding protein 
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* Spot 478: Serpin 
Figure 6.9:  Spots that increased in abundance in disease and vaccinated (protected) 
group. 
*Spot 478: Serpin was decreased in abundance in vaccinated cattle 
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Spot 271: Apolipoprotein A1 
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Spot 240: Fibrinogen beta chain 
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Spot 57: Ceruloplasmin 
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Spot 347: Hemopexin 
Spot 372: Albumin 
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Spot 391: Kininogen 
Figure 6.10:  Spots that decreased in abundance in disease and vaccinated (protected) 
group. 
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Spot 352: Serotransferrin 
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Spot 320: Haptoglobin 
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Spot 451: Cathelicidin Spot 126: Lactoferrin 
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Spot 244: Complement C3  
H
e
a
lth
y
P
ro
te
c
te
d
H
e
a
lth
y
D
is
e
a
s
e
P
ro
te
c
te
d
L
o
g
 S
ta
n
d
a
rd
iz
e
d
 A
b
u
n
d
a
n
c
e
0.2
0.1
0
-0.1
-0.2
Figure 6.11:  Spots that varied responses but had significant change in 
comparison to healthy animals.  
Apart from spot 451: Cathelicidin that decreased in abundance in disease and 
vaccinated (protected) group, other spots show decrease in abundance in disease 
group but increased in abundance in vaccinated (protected) group. 
 
 
  
(d) 
(b) (a) 
(c) 
Figure 6.12:  Selected spots are highlighted alongside graphical presentation showing increased in log standardised abundance in the disease and 
vaccinated (protected) in compare to the healthy group. 
(a) IgA, (b) IgG, (c) Alpha 2-macroglobulin and (d) Odorant binding protein. 
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(b) (a) 
(c) (d) 
Figure 6.13:  Selected spots are highlighted alongside graphical presentation showing decreased in log standardised abundance in the disease and 
vaccinated (protected) in compare to the healthy group. 
(a) Apolipoprotein A1, (b) Fibrinogen beta chain, (c) Hemopexin and (d) Ceruloplasmin 
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(d) (c) 
(a) 
Figure 6.14:  Selected spots are highlighted alongside graphical presentation showing decreased and increased in log standardised abundance in the disease 
and vaccinated (protected) respectively in compare to the healthy group. 
(a) Haptoglobin, (b) Complement C3, (c) Serotransferrin and (d) Cathelicidin 
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(a) (b) 
(n=1) 
(n=6) 
(n=5) 
(n=7) 
(n=1) 
Figure 6.15:  Using gene ontology annotations, the biological functions of all of the proteins (n=20) from the spots that increased (a) 
and decreased (b) in disease group were compared. 
Proteins biological function according to SWISS-PROT (http://us.expasy.org/uniprot/). 
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(a) (b) 
(n=4) 
(n=7) 
(n=1) 
(n=5) 
(n=3) 
Figure 6.16:  Using gene ontology annotations, the biological functions of all of the proteins (n=20) from the spots that increased (a) and decreased 
(b) in vaccinated group were compared. 
Proteins biological function according to SWISS-PROT (http://us.expasy.org/uniprot/). 
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6.4 Discussion 
Effect of NSAP activity, IgA and IgG concentration in response to AlHV-1 intranasal 
challenge 
 
The NS sample used in this chapter derived from a previous immunization study showing 
that a vaccine based on attenuated AlHV-1 protected cattle challenged intranasally with 
pathogenic AlHV-1 C500 from developing clinical MCF (Haig et al., 2008). The intranasal 
challenge of AlHV-1 given to the animals that were or were not given protection had no 
effect on the AP activity present in the NS. No significant difference between the pre-
challenge and post-challenge NSAP activity was observed within the 3 tested groups 
(group 4, 5 and 6) and there was no significant association between immunised cattle 
and NSAP activity. However the post challenge sample was taken 14 days after 
challenge to fit with the objectives of the original experiment and it is possible that 
changes in AP occurred in the time immediately post challenge.  There may also have 
been degradation of AP during storage (around 5 years) even though kept at -80oC.  It 
would be valuable to repeat the investigation with fresh samples taken more frequently 
post-challaenge. 
 
There was a significant increase of nasal mucosal antibodies in the NS of animals from 
group 5 indicating that cattle given both prime vaccination and booster by IM increase 
the IgA and IgG concentration in NS when challenged with AlHV-1 intranasally.  In 
contrast, only the IgA concentrations were significantly increased in the NS from group 4 
animals whereas no significant change in the IgA and IgG concentration were observed 
in the NS collected from the animals in group 6. 
 
The increase in IgA and IgG antibodies expression in NS resulting from intranasal 
challenge of AlHV-1 could play a role in protection against MCF by contributing 
additional antibodies present in the nasal mucosa thereby neutralizing virus at the 
portal of entry. Furthermore, Peri et al. (1982) and Waldman et al. (1973) have 
reported that respiratory viruses given challenge by oral route in rabbits, mice or man 
have also led to the increase of IgA response in NS. Studies in sheep have shown that 
the numbers of IgA antibody containing cells in the upper respiratory tract could be 
enhanced following intratracheal boosting of intraperitoneally primed animals 
(Scicchitano et al., 1984). Immunization studies by Burrough et al. in 1982 showed that 
intranasal IBR-PI3 virus vaccines were unable to stimulate any significant cell-mediated 
or humoral antibodies in the serum. However a later work by Saoud et al. (2004) 
reported that trivalent vaccine for IBR, PI3 and P. multocida type B given intranasal had 
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stimulated the development of satisfactory level of circulating and mucosal antibodies 
in the NS. 
 
Although the intranasal route may provide the alternative route of MCF immunization, 
this study has shown that the group of animal that received primary vaccination and 
booster of attenuated AlHV-1 vaccine both given via IM route has led to a better 
outcome with 100% survival rate in comparison to the group that receive booster given 
by the intranasal route (Table 6.3). The result also showed that immunization given by 
the former regime produced a higher IgA and IgG concentration in the NS in compare to 
the latter regime (Figure 6.4 and 6.5). 
 
In an earlier report by Howard et al. (1986), replication of M. bovis in the bovine 
respiratory tract elicited IgG and IgA responses in tracheobronchial washings, similar to 
the responses present in NS seen in the present study. These similarities may relate to 
the invasiveness of M. bovis which causes extensive lung lesions which was also typically 
seen in MCF infections (Reynolds et al., 1985; Howard et al., 1986; Haig et al., 2008 and 
Russell et al., 2009). Invasive AlHV-1 given at a fatal dose as demonstrated in the 
immunization study in this chapter might evoke IgG responses since IgG plasma cells 
predominate in the lower respiratory tract (compared with IgA cells in the upper tract, 
Morgan et al., 1981). Alternatively IgG antibodies may be partially serum-derived in 
response to the inflammation and damage produced by invasive infections of AlHV-1 
given challenge intranasally. 
 
 
Protein identification and changes in protein expression 
 
Even though the healthy, disease and vaccinated NS show a very similar protein 
composition, as seen from their gel images and their ontology analysis (Figure 6.6 and 
Table 6.4), some marked differences in expression levels and patterns were observed 
(Figure 6.9 - 6.14) by DiGE analysis. Of the proteins that were found to decrease in the 
unvaccinated group of animals when challenge with AlHV-1, it was clear from the gene 
ontologies obtained from UniProt that most of the proteins associated with host defence 
mechanism were increased in expression. Mucosal antibodies like IgA, IgG, alpha 2-
macroglobulin and other proteins involved in the host innate defence mechanism 
constitute 87% of the total proteins that were up regulated in the NS from the disease 
group compared to 56% of up regulated proteins seen in the vaccinated group. The rest 
of the NS proteins were mainly involved in transporting biomolecules such as odorant 
binding protein involved in nasal sensory transduction and binding to a wide variety of 
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chemical odorants. Other proteins found to decrease in expression were mainly serum 
APPs such as apolipoprotein A1, albumin, ceruloplasmin, hemopexin, fibrinogen as well 
as proteins having antimicrobial and anti-inflammatory properties like cathelicidin, 
serotransferrin and lactoferrin. 
 
Most of the proteins that involve in local defence mechanism such as immunoglobulins 
and antimicrobial proteins like serotransferrin and lactoferrin were up regulated in the 
vaccinated group hence suggesting that immunizations given via IM were able to 
stimulate the increase of local innate protection in the nasal mucosa. However the 
majority of APPs such as apolipoprotein A1 were decreased in expression in comparison 
to both healthy and disease group. Although cathelicidin is an antimicrobial protein in 
NS showing a higher protein expression in the vaccinated group than in disease, its 
expression was below that seen in the healthy group.   
 
Alpha 2-macroglobulin functions as a broad-spectrum inhibitor of serum proteases and 
those produced by pathogens. Although it is a strongly positive APP in rats (Jinbo et al., 
2002 and Strnad et al., 2000), in mice both increased (Isaac et al., 1999) and decreased 
(Kristiansson et al., 2007) levels of the protein have been found associated with 
different inflammatory processes, as well as in humans (Makis et al., 2000 and 
Chowdroska et al., 2004). In this study, alpha 2-macroglobuline (spot 68, Figure 6.7) 
was slightly increased in NS from the disease group and almost 4-fold increase in 
abundance in the vaccinated group. Antibodies constitute essential components of the 
mucosal immune system of vertebrates and also the main humoral immunity commonly 
present in the serum. In case of infection immunoglobulin levels in the organism are 
increased in order to fight the pathological agent. This is clearly shownin the DiGE 
investigation by the increased of IgA and IgG abundance in the NS post-challenge where 
the vaccinated group having a higher increased compare to the disease group. This 
findings correlate with the IgA and IgG results obtained by ELISA as shown in section 
6.3.3. 
 
The most abundant protein in NS which is albumin has multiple functions. It transports 
different molecules, such as metals, fatty acids or drugs, and is the major protein 
responsible for the biomolecule transportation. Also, in general it represents the 
predominant antioxidant in serum (Kouoh et al., 1999 and Roche et al., 2008). 
Furthermore, albumin is a negative acute phase reactant (Schreiber et al., 1982 and 
Gruys et al., 2005). This corresponds to the change observed at spot 372 (Figure 6.10) 
which represents the main albumin spot, the albumin level is decreased in NS from the 
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disease group and even lower in abundance seen in the NS from the vaccinated group. 
Visual comparison of the major protein spot (albumin) on the DiGE gels between the 
healthy, disease and vaccinated group also confirmed this finding (Figure 6.6). 
 
Another serum transporter that can multi-task is transferrin. Although its primary role is 
to transport iron, in addition it has been reported that it possesses antimicrobial 
properties and is implicated in growth and differentiation activities. Like albumin, 
serotransferrin (spot 352 in Figure 6.8) is considered as a negative APP in cattle. DiGE 
results showed decreased in abundance in NS from the disease group however 
serotransferrin was significantly increased in the vaccinated group. This probably due to 
the effect of immunization receive prior to AlHV-1 challenge which resulted to increase 
of serotransferrin in NS although further study need to be done to conform this theory. 
  
Hemopexin (spot 347 in figure 6.8) binds and scavenges heme released by the turnover 
of heme proteins, thus preventing heme mediated oxidative stress and heme-bound iron 
loss. Although its synthesis is induced under inflammatory conditions, the protein was 
decreased in the disease and vaccinated group probably due to the increased binding 
activity due to significant degradation of heme containing compounds in NS. The main 
protein component of HDL, apolipoprotein AI (spot 240 in Figure 6.8), is involved in 
phospholipids and reverse cholesterol transport. It also functions as a cofactor for 
lecithin-cholesterol acyltransferase (LCAT) and possesses anti-inflammatory and anti-
coagulant properties (Chen and Albers, 1985 and Andersson, 1997).  Additionally, this 
protein has been suggested to inhibit toxicity (Ma et al., 2004). Apolipoprotein A1 
usually categorized as a negative APP and the NS expression in this study was also 
significantly reduced both from the disease and vaccinated group post-challenge with 
AlHV-1. 
 
Apart from studies of lactoferrin showing its major function in milk, this protein is also a 
characteristic mucosal protein with antimicrobial and anti-inflammatory properties. 
Lactoferrin present in the bovine NS is believed to be produced and secreted locally by 
the nasal exocrine glands whose biological function has been discussed in detail in 
Chapter 5.  It has been often reported to rise in disease cases such as in mastitis 
(Hagiwara et al., 2003 and Eckersall et al., 2006) and respiratory toxicity (Ghio et al., 
1999). However in this study, lactoferrin expression was decreased in the disease group 
but increased almost 5-fold in protein abundance within the vaccinated group. As in 
serotransferrin, the increase in expression seen in vaccinated group might be related to 
the successful immunization effect against AlHV-1 given by the IM route.  This however 
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needs to be further investigated to confirm exactly the specific pathway whereby the 
vaccine could stimulate the increase of lactoferrin expression in the NS. 
 
In conclusion, this study reveals that as a result of intranasal challenge of AlHV-1, the 
bovine NS proteome from both disease and vaccinated group showed differential 
expression of a number of proteins. The comparable results also indicate that many of 
the responses to infection and inflammation in the NS are conserved within the nasal 
mucosa.  The changes of NS protein expression as a result of MCF challenge and 
vaccination have not been reflected in other studies and together with the result from 
the previous chapter, this study shows that the majority of the NS protein present 
consist mainly of protein that are involved in innate immunity protection and 
transportation, whereby these NS proteins were differentially expressed in the disease 
and vaccinated cattle in response to AlHV-1 challenge.   
 
Up to the present time, there are only a few proteomic studies of human NS and no 
published work was found to use proteomic technology as a tool to study the NS from 
animals. The used of DiGE has shown in this chapter to be able to successfully identify 
and measure the changes of NS protein expression in MCF challenged and vaccinated 
cattle. This would allow a more comprehensive understanding on disease progression 
and host response towards infection as well as the detection of potential biomarkers.  
However, the use of proteomic methods to investigate a novel biological fluid like NS 
requires much more work to be done.  Proteomic methods such as DiGE could be used to 
analyse and examine the NS collected daily post infection to study progression on 
disease recovery. Furthermore, more work should be done to find a way to normalise 
the results data collected and also to observe if volume of NS production could affects 
the concentration or abundance of nasal proteins. In addition, most of the NS proteins 
detected and analysed in this chapter consist of soluble proteins with Mw <200 kDa 
hence preventing the detection of larger proteins such as mucins that do not get into 
the electrophoresis gels. The use of larger pore acrylamide gels to separate bigger and 
multimeric protein complexes may allow for the detection of these proteins. 
 
The DiGE system is a variant of 2-DE which offer the possibility of including an internal 
standard making comparison of gels easier and quantification of proteins more accurate 
(Marouga et al., 2005). The DiGE technique, first described by John Minden’s lab (Unlu 
et al. 1997), circumvents many of the issues associated with traditional 2-DE such as 
reproducibility and analytical problems associated with gel to gel variation and a 
limited dynamic range; all of which severely hamper a quantitative differential display 
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study (Lilley and Friedman, 2004; Friedman and Lilley, 2008). Utilising DiGE technology 
allows for a more accurate and sensitive quantitative proteomic study because DiGE as 
shown in this study has proven to be a powerful technology for differential display 
proteomics where the individual abundance changes for thousands of intact proteins can 
be simultaneously monitored in replicate samples over multiple variables with statistical 
confidence (Lilley and Friedman, 2004; Friedman and Lilley, 2008). 
However, some common drawbacks of 2-DE would still occur including limited sample 
capacity, insufficient detection of low-abundant and hydrophobic membrane proteins as 
well as low visualization sensitivity (Monteoliva and Albar, 2004). Alternatively the non-
gel based technique liquid chromatography–mass spectrometry (LC/MS) has the 
potential to identify highly complex samples for large scale proteome analysis such as 
the human plasma proteome (Fujii et al., 2004). The work of Martin and Synge (1941) 
had suggested that small sorbent particles and pressure could produce fast LC 
techniques. Since then, LC/MS has seen enormous growth in clinical laboratories 
especially during the last 15–20 years. It offers analytical specificity superior to that of 
immunoassays or conventional high performance/pressure liquid chromatography (HPLC) 
for low molecular weight analytes and has higher throughput than gas chromatography-
mass spectrometry (GC-MS; Grebe and Singh, 2011). 
Therefore, LC/MS could offer a great alternative to overcome many 2-DE limitations. 
However, LC/MS and similar “shotgun” methodologies are non-quantitative based 
proteomic hence for quantification of potential biomarkers in bovine NS using this 
technology, quantitative methods based on protein labelling (such as iTRAQ or SILAC) or 
on unlabelled approaches should be considered for future studies. 
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The aims of this thesis were outlined in Chapter 1 and the relevant conclusions have 
been detailed in the appropriate chapters. This chapter serves to summarise the most 
significant findings from preceding chapters and to highlight the areas which have been 
recognised as worthy of future research. 
Bovine respiratory disease (BRD) has the greatest economic impact towards the cattle 
farming industry and up to the present, pneumonia is a leading cause of loss to the 
cattle industry in the United States and Europe (Griffin, 1997 and Ackermann et al., 
2010). An estimated 1.9 million animals (Nicholas and Ayling, 2003 and Nicholas, 2011) 
are affected by BRD each year in the UK with costs estimated at around £60 million 
annually (NADIS, 2007). Many efforts have been made to identify the primary respiratory 
pathogen responsible based upon gross necropsy and histopathological lesions 
(Tegtmeier et al., 1999 and Gagea et al., 2006).  However, given a typical interval of 
several days to weeks between disease onset and death (Belknap, 1993) it is uncertain 
how post mortem findings and isolation of etiologic agents solely could be beneficial for 
early detection and prevention of BRD. Therefore, there is a need to understand exactly 
how the host innate immunity responds towards the onset of infection and is involved in 
protecting the animal. 
Aerial transmission through contaminated NS is an important route of infection for BRD 
(Taylor et al., 2010 and Fulton and Confer, 2012) and the most common clinical sign 
observed in respiratory cases is excessive nasal discharges (Briggs and Frank, 1992 and 
Love et al., 2014). Although the etiopathogenesis of BRD is multifactorial and complex, 
all of the pathogens have the common route of infection which is intranasal. The nasal 
mucosa is the primary portal of entry for not only inspired air but also respiratory 
pathogens thus NS produced by the nasal mucosa can play a major role to protect the 
lower respiratory tract from inhaled microbes. The increase in production of NS during 
disease is known to be one of the protective innate responses against aerial borne 
infections. 
Therefore, NS serves as a valuable source of biological sample to investigate how it acts 
as a protective barrier against respiratory disease. However, the application of using a 
NS sample for diagnosing or monitoring respiratory diseases in veterinary species is not 
common. Unlike human (Rubin, 2002; Ganz, 2003 and Laube et al., 2006), the clinical 
biochemistry of NS from animal has not been well characterised but could provide 
useful indicators of immune function and status. Therefore to use a biological fluid such 
as NS for diagnosing and monitoring disease or for the detection of biomarkers, it was 
necessary first to establish a reference range of analytes that are present in the NS of 
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healthy cattle. Prior to the investigation, there is no information on the composition of 
the bovine NS, possibly due to the perceived difficulty of collecting a sufficient volume 
of NS from healthy animals for analysis. 
It was with this in mind that a practical and non-invasive method for the collection of 
bovine NS in substantial volume was developed which was described in detail in Chapter 
2. Previous studies by Haig et al. (2008) described the collection of bovine NS on 
tampons and the secretion was removed by mechanical extraction with 60 ml syringe. 
However this method although allowed the collection of undiluted NS samples, the 
actual volume of NS removed from the tampon was low being between 1-3 ml, when 
compared to the actual NS absorbed by the tampon which could be assessed by means 
of weighing the tampon weight post collection.  
 
This study has established a method of extracting NS from the absorbent of the tampon 
by centrifugation using modified collecting tubes (Figure 2.2), which have allowed up to 
12 ml of NS to be collected at a time from each animal. This method allowed NS to be 
collected in substantial volume hence provide sufficient amount of biological samples 
for multiple analysis. Moreover, the requirement to apply non-invasive techniques to 
collect samples for experiments have been one of the primary aims in any study 
involving animal especially in veterinary research. The method described in this study is 
simple to perform, does not require any chemical restrain, is non-traumatic and causes 
only minimal to none discomfort to the animal. In contrast to other methods used for 
the collection of NS, such as nasal lavage or nasal swabs, which commonly involve 
diluting the fluid in  buffer , this method has the advantage that NS collected is 
undiluted and thus contains high concentrations of biomolecules. 
 
The biochemical analysis of 38 NS samples collected from healthy cattle described in 
Chapter 2 was carried out using an Olympus A640 analyser operated by Veterinary 
Diagnostic Services, University of Glasgow and the results were compare to standard 
bovine serum reference.  Concentrations of total protein, albumin, calcium, phosphate, 
sodium and chloride were lower than the serum reference range while urea, creatinine, 
bilirubin and aspartate transaminase levels were comparable to serum reference ranges. 
Interestingly, 2 notable findings were seen in bovine NS. The mean (±SD) AP activity in 
NS was 1259±520 IU/L and was up to 15.7-fold higher at 80:1259 than the serum 
reference range for AP while the mean GGT activity was 67±21 IU/L and was up to 2.5-
fold higher at 27:67 than the bovine serum GGT reference range. The components of NS 
had generally been associated with plasma exudation from the local blood vessel of 
nasal mucosa as the major source of constituent of its biomolecules. The extensive 
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differences in AP and GGT activity present in NS in compare to serum reference highly 
suggest that these enzymes were locally produced. In addition, since the NS was 
collected from healthy population, those findings reflect the natural composition of 
bovine NS and not a response towards any disease. Additionally, a preliminary study to 
compare the NSAP activity from cattle challenged with intranasal MCF virus (n=4) had 
showed that the mean NSAP activity from pre challenge animal was further increased by 
3-fold in the NS collected post challenged.  
 
There are no previous reports of the activities of these enzymes in NS being greater 
than that found in serum or plasma hence this novel discovery justified a further 
thorough investigation as described in this study. Whether the high activity seen was 
associated with the increase of NS production during disease or AP was being actively 
produced and secreted in response to local nasal stimulation are questions that still 
need to be addressed. The theory suggesting NSAP was a result of leakage from serum is 
not supported by the finding of a higher activity of AP in NS than in serum unless a 
mechanism to export the AP against a concentration gradient is present in this tissue.  
Subsequently, the molecular nature of nasal AP and whether this enzyme has the same 
characteristic and physiological function with the well-known bovine IAP would be 
addressed in Chapter 3 and 4. 
 
This chapter have established a reference range of analytes that are present in the NS 
of healthy cattle. This data should lay the groundwork for future investigation on BRD 
such as studies on biomarker discovery involving bovine NS as the source of biological 
samples. The next logical step in this thesis was to examine the source of high AP 
activity reported in bovine NS. 
 
Chapter 3 specifically dealt with the investigation of AP that was found to be present in 
bovine NS. The objectives were to 1) Determination of the tissue responsible for 
producing and secreting NSAP by histochemistry, 2) Comparison of nasal AP activity with 
other relevant bovine tissue, 3) Detection and quantification of AP concentration in NS 
and nasal mucosa and 4) Characterization of nasal AP isoenzyme with electrophoresis 
and isoelectric focusing (IEF). 
 
Histochemistry using an AP specific stain showed strong AP activity was present in the 
luminal and basal ends of nasal epithelium and serous glands. Control experiments also 
confirm the findings where AP activity staining was abolished in the presence of 
levamisole which is a known non-specific AP inhibitor. Therefore, this finding confirmed 
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that the respiratory cell and the serous glands of the nasal mucosa are responsible for 
producing and secreting AP hence the presence of strong AP activity seen in NS. Apart 
from the findings shown in 3.3.3, there have been few studies involved in localising AP 
in the nasal mucosa or other respiratory tissue. Only two studies have identified the 
presence of AP in the respiratory cells. Bourne (1948) found AP in human nasal mucosa 
and it has also been found in the nasal epithelium of guinea pigs (Gawin et al., 1991).  
Conversely, in a histochemistry study involved isolating enzymes in the nasal mucosa, 
Shapiro (1968) showed that in embryonic stage of the rodents, only basal portions of 
olfactory epithelium stained positively for AP which was not present in other respiratory 
cells. Staining became more intense in older embryos, but continued to be localized in 
the basal one-third to one half of the olfactory epithelium. He concluded that the 
presence of this hydrolytic enzyme suggested AP involvement in the mechanism of 
olfaction.  
 
From this histochemistry study it was apparent that the NSAP was produced locally. The 
author believed that the discovery of nasal mucosa as the production source of bovine 
NSAP is a novel finding in research on AP.  Previously nasal mucosa unlike liver, bone 
and intestine was not identified as the site of AP production in mammals. Although the 
source of NSAP have been successfully localised in the nasal mucosa, the precise mRNA 
location of this protein in the respiratory cells and the actual enzyme production 
pathway are yet to be studied and determined. Future work in this area should employ 
in situ hybridisation to define those matters.  Unfortunately, due to lack of time and 
resources, the investigation of GGT that was also showing high activity in the bovine NS 
was not performed. It would be of great interest to determine whether GGT in NS is also 
produced locally by the respiratory cells. 
 
Another notable finding in this chapter is that the distribution of AP activity in the cells 
of nasal epithelium and mucosa. Following the discovery that the NSAP was produced by 
the cells of the nasal mucosa, an objective in Chapter 3 was to measure and compare 
the AP activity from nasal mucosa to bovine tissue known to produce this enzyme, 
looking mainly at the liver, intestine and kidney. The AP extraction method used was 
similar to a method described by Rudolph et al. (1997) and result shown in activities per 
gram of wet tissue used.  The AP derived from the nasal mucosa extracts (n=6) have a 
highest mean of activity followed by liver, kidney and extracts from intestinal mucosa, 
but this findings was not statistically difference. However, all of these extracts had 
significantly higher AP activities compared with the heart tissue that served as a 
negative control. It was concluded that although the AP activities between nasal 
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mucosa and AP producing tissues were not significantly difference, AP was still actively 
produced and released by the nasal mucosa which justify further investigation on the 
role and purpose of AP present in the bovine NS.  Comparison of AP activity with bone 
extracts was not included in this study due to the lack of fresh bone sample. It would be 
important to include bone tissue in future study of AP activity due to its vital role in 
calcium homeostasis and during skeletal mineralization. 
 
In order to detect AP protein and quantify the concentration of AP in nasal tissue, 
western blot analysis was performed. The antibody used in this study was a monoclonal 
antibody raise in mouse against human bone AP (abcam 17272) and was conjugated with 
HRP using a commercial conjugation kit. However, although it was a monoclonal 
antibody, the western blot with anti AP revealed four visible protein bands at 
approximately 30, 55, 70 and 150 kDa in nasal mucosa and liver extractions (Figure 3.4).  
Further western blot analysis to determine the specificity of antibody used was carried 
out in NS and in various tissues extracts including BSA as a negative control but have 
resulted the antibody binds with bovine albumin at approximately 70 kDa.  The findings 
were discussed in detail in section 3.4 of this thesis. It was concluded that the antibody 
used in this study was not specific in detecting AP protein hence restricting further 
analysis and quantification of the AP concentration in nasal mucosa and other related 
tissues.  Further study with antisera specific for bovine AP from NS is warranted. 
 
An initial attempt to stain for AP following native PAGE was not successful, possibly the 
AP did not enter the gel without the reduction that usually is involved in SDS-PAGE. A 
study for AP separation using agarose gel electrophoresis was undertaken to compare 
the electrophoretic mobility of bovine AP isoenzymes from NS and nasal mucosa with 
other bovine tissues.  After stained with AP specific substrate, results have shown that 
AP from NS and nasal extracts has the same size and is clearly travelled slower than the 
liver extract (Figure 3.9). However, the AP bands from other tissue extracts (bone, 
kidney and intestine) show no clear difference in electrophoretic mobility with NS and 
nasal mucosa. Therefore, AP extracts from the various bovine tissues were subjected for 
separation by IEF according to pIs to aid in identification of relative isoenzymes.   
 
Thus IEF was able to separate the AP and allowed the enzyme activity to be detected by 
AP activity staining. Although similar AP activity was loaded on to the IEF gel (Figure 
3.10), inspection revealed notable differences in the band intensities. This difference 
was possibly due to differences in the ability of the AP enzyme to penetrate the 
polyacrylamide gel which was especially evident in the NS samples. This could be due to 
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the formation of aggregates, possibly with high molecular weight and complex 
proteoglycans contained in nasal mucus remaining at the sample well. Smearing was 
also seen on one of the IEF track from NS sample and its greater activity compared to 
sample the other NS sample may be due to partial degradation of AP molecules during 
sample preparation which could allow greater penetration of the gel by smaller AP 
forms.  
 
Staining was carried out at pH 9.2 and as there is a possibility that different AP 
isoenzyme would optimally stain at different pHs and this may also contribute to the 
variation seen in AP activity on the IEF gel. Nevertheless, the AP isoenzyme in NS had 
pIs in the same region as those of the nasal mucosa extracts (pH 4.2-6.8) but was clearly 
different from the extracts of other tissues. The differences in IEF migration of the AP 
extracts is likely to be due to PTMs such as glycosylation or phosphorylation, the 
elucidation of which would be the subject of further investigation. 
 
Chapter 4 investigated assessed the genomic part of nasal AP using advance molecular 
methods; endpoint RT-PCR to detect the AP gene expression in nasal tissue and gene 
sequencing to compare its nucleotides with other tissues known to produce AP mainly 
from the liver and intestine. Database and literature searches suggest that the only 
known gene that expressed AP in bovine tissue were the tissue non-specific AP gene 
(ALPL; NM_176858) and intestinal AP gene (ALPI; NM_173987). Preliminary work 
successfully generated primer sequences (Table 4.1) to differentiate between the 
bovine ALPL and ALPI genes for the amplication of bovine AP present in nasal, liver and 
intestinal tissues. The analysis at mRNA levels from nasal mucosa by endpoint RT-PCR 
and PCR product sequencing confirmed that the AP was locally produced and has 
homology at the nucleotide level to the tissue non-specific AP splice variant gene found 
in bovine liver, bone and kidney. Another potential study that would be worthwhile is to 
quantify the nasal AP gene expression by qPCR which would be significant in 
determining the rate of expression in nasal mucosa and comparison with other relevant 
AP producing tissues and assess changes during BRD. 
 
The specific reason and precise location in the respiratory cells that express the mRNA 
encoding tissue non-specific AP genes within the nasal tissues is unclear, but the 
induced expression probably results from the reaction of certain cytokines or hormones 
with their cellular receptors in response to invading pathogens and inflammatory 
signals. The difference in pIs that has been demonstrated in Chapter 3 strongly suggests 
PTMs of the nasal derived AP hence increasing the functional diversity of the enzyme.  
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In addition, although non-specific AP and IAP were expressed by different gene, both of 
the AP genes encode enzymes with well conserved catalytic activities hence is possible 
to have the ability to dephosphorylate LPS endotoxin as was described in detail in 
section 1.3.4. 
 
Apart from the reported ability of IAP to dephosphorylate LPS, Picher et al. (2003) have 
suggested that AP present within the respiratory cell is capable to dephosphorylate ATP 
to AMP and to adenosine, a molecule that is important for maintaining mucociliary 
clearance rate. Furthermore in this species, NS is commonly transferred to the mouth as 
cattle have the tendency to lick their muzzle and nostrils so that the nasal AP could be 
effective in the rumen as an anti-endotoxin with a dephosphorylation activity (Lalles, 
2014).  Although it was speculated and liken the nasal AP function with the ability of IAP 
to dephosphorylate LPS, the definitive role of nasal AP and how it participates in the 
nasal innate response could be a very important and interesting area to explore in the 
future and definitely beneficial to the diagnosis and control of BRD. 
 
The research was also driven by the rapid advancement and the easy accessibility of the 
various proteomic technologies. The main objective in Chapter 5 was to identify the 
proteome of healthy bovine NS in the awareness that it is vital to define a “normal” 
profile of NS proteins so that the usual function of this secretion can be well-
determined and disease-specific changes can be identified.  For this chapter,   
conventional 1-DE was used to conduct a preliminary investigation on the protein 
contents in NS. Prior to that, the protein concentrations of 38 NS samples collected 
from healthy cattle were determined resulted with a mean of 15±6.7 g/L (±SD).  On 1-
DE a total of 13 distinct protein bands were visible after NS protein was separated 
according to Mw.  
Initial application of 2-DE on six individual NS samples showed a similar spot pattern 
with little variation observable. Subsequently 2-DE of pooled NS (n=6) produced a gel 
with well separated protein spots. Thirty apparent protein spots were selected and 
process for identification.  Protein identification by using ESI-MS/MS analysis on proteins 
bands from 1-DE and spots from 2-DE have identified similar proteins within the gels 
consist of vascular derived proteins involve mainly in regulatory and innate immunity 
and also glandular derived proteins like OBP and lactoferrin. Interestingly, glutathione-
S-transferase an enzyme capable of detoxifying noxious compounds were detected only 
in 2-DE and was not discovered by other means of protein separation used in this study. 
The proteomic findings on NS were collected later served as a baseline parameter of 
normal bovine NS for comparative proteomic study conducted in Chapter 6. 
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However, although the 2-DE method used in this study successfully isolated and allowed 
identification of protein expression, a series of limitations have to be dealt with when 
using this proteomic approach. For instance preparation of 2-DE needs intensive work 
and not all proteins can be resolved; membrane proteins are not represented because of 
their poor solubility, and low abundant proteins cannot be detected because they are 
often lost during the electrophoretic procedure (Gygi and Aebersold, 2000 and Santoni 
et al., 2000).  In addition, 2-DE also limits the assessment of more than a group of 
sample and analyses of the changes in proteins expression. Therefore, these issues need 
to be solved in order to ensure appropriate comparison between groups and, thus, 
advance identification of any possible markers to differentiate between disease and 
healthy animals. 
Even though 2-DE results can be variable among gels, an accurate comparison requires 
first of all that protein samples are separated via the same electrophoretic system to 
ensure consistency. The system of two-dimensional fluorescence difference gel 
electrophoresis (DiGE) is another variant of 2-DE and would offer the possibility of 
including an internal standard making comparison of gels easier and quantification of 
proteins more accurate (Marouga et al., 2005). 
Chapter 6 aimed to use DiGE as an advance comparative proteomics tool to detail the 
changes in the NS protein profiles from healthy, disease and vaccinated group of 
animals. Nasal secretion used in this study derived from an earlier immunisation study 
against bovine malignant catarrhal fever (MCF; Haig et al., 2008). The selection of NS 
for the disease and vaccinated group were described in detail in section 6.2.6. In 
general, animal given vaccination and booster by intramuscular (IM) and later 
challenged via intranasal route were selected as the ‘vaccinated group’ and those 
challenged without given any protection were selected as the ‘disease group’. 
Difference gel electrophoresis has been used with success to find differentially 
expressed proteins in a number of studies with the major advantage of this technique 
being that it allows the comparison of two protein samples on the same gel. This 
method proved to allow for a more accurate detection of small differences in protein 
levels between samples (Alban et al., 2003). The high sensitivity of this method have 
enabled the detection of more than 500 protein spots per gel and the comparison 
between the 3 different group of NS have identified 23 proteins that were differentially 
expressed. The majority of the NS proteins identified in this study were akin to those 
identified in human NS (Casado et al., 2005) which mainly consists of proteins involved 
in innate and acquired immunity system. These have proved that bovine NS to have a 
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critical role in preventing microbial infections and protecting the LRT from any 
pollutants. 
The most abundant plasma proteins (vascular derived proteins) in NS were albumin and 
immunoglobulins which accounts for more than half of all the protein that were 
differentially expressed between the 3 different groups.  Most of the plasma proteins 
were down regulated in disease and vaccinated group. This is probably proteins such as 
fibrinogen and albumin that were actively involved in innate immune processes by 
forming a coagulated mass of mucins (Lindahl et al., 2001 and Ghafouri et al., 2002).  
However, proteins such as serotransferrin, cathelicidin and complement factor C3 which 
are important for bacterial inactivation and immune complex formation decreased in 
expression whereas in the vaccinated group were observe to be highly expressed. The 
difference of expression was possibly due to the ability of host immune system to fully 
respond to vaccination hence providing protection to the host prior to challenge. 
Cellular proteins like lactoferrin, an antimicrobial protein commonly present in mucosal 
secretions were also down regulated in disease and increased in expression within the 
vaccinated groups. This situation might relate to its antiviral activity by actively being 
secreted and binds lipoproteins of cell membranes hence preventing the virus to 
penetrate into the cells (Nozaki et al., 2003). 
On the other hand, immunoglobulins were up regulated in the disease and vaccinated 
group possibly as an acquired immune response to the intranasal challenge which could 
actively infiltrate from serum into the NS through an increase in vascular permeability 
during inflammation (Casado et al., 2005). In addition, another high abundance plasma-
derived protein that is up regulated is the α-2-macroglobulin. This very high molecular 
weight protein is capable of passing through the molecular weight sieve created by the 
nasal epithelial basement membrane and together with α-2-microglobulin and β-2-
microglobulin forms the MHC class I complex (Svensson et al., 1995).   
The function of OBP, apart being known to be involved in scent recognition, is also 
likely involves in protecting airways from lipid peroxidation (Grolli et al., 2006). 
However in this study, the increase in expression in disease and vaccinated group were 
still not clearly understood.  Mitchell et al. (2011) have shown in immunochemistry that 
OBP was produced locally within the nasal mucosal glands and also show high expression 
in the tracheal and bronchial mucosal glands. However, Mitchell also reported that OBP 
does not become involved in host defence mechanism or alter bacterial growth. 
Previous work from the same group reported increased levels of OBP in the lung of 
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dexamethasone-treated calves suggesting that this may be one mechanism by which 
corticosteroids modulate pulmonary inflammatory responses, which implicates OBP as a 
moderator of inflammation that may influence the outcome of many pulmonary disease 
conditions (Mitchell et al., 2007). 
In summary, Chapter 6 concluded that DiGE analysis has been able to detect several NS 
proteins which were differentially expressed in cattle under disease and vaccinated 
condition. Nevertheless the inherent drawbacks of DiGE that is present including limited 
sample capacity, insufficient detection of very acidic and basic proteins as well as 
hydrophobic membrane proteins and low visualization sensitivity were considered and 
look upon (Monteoliva and Albar, 2004). The application of a non-gel based technique 
could be a productive alternative to overcome many 2-DE limitations.  
Shotgun proteomics (bottom-up strategy) is used to identify highly complex peptide 
fractions, generated after protein proteolytic digestion. This method is able to resolve 
peptides using different fractionation strategies, which offer high-throughput analyses 
of the sample proteome and provide a snapshot of the major protein constituents 
(Abdallah et al., 2012). This technology is also able to identify low-abundance proteins 
as well as highly acidic and basic proteins (Washburn et al., 2001).  However, most of 
the shotgun methodologies are non-quantitative hence for quantification of potential 
biomarkers and assessment of protein expression between groups, quantitative methods 
based on protein labelling (such as SILAC and iTRAQ) or on unlabelled approaches to 
increase the coverage of all differentially expressed proteins present in NS should be 
considered for future studies. 
There is a vital need for the discovery of markers that will detect BRD at an earlier 
stage. The discovery of potential biomarkers like AP in bovine NS would be a very 
desirable achievement due to the ease with which this secretion can be collected and 
has now been biochemically and molecularly characterized for future reference.  All of 
the work detailed within this thesis strives towards this similar goal. The emergence of 
new methodologies for the large-scale analysis of differentially expressed proteins in 
body fluids is presenting opportunities in the search for novel diagnostic markers of 
disease. The development and application of proteomic technologies with improved 
sensitivity could be applied to identify potential biomarkers of respiratory disease in NS, 
hence linking the major findings in this thesis. 
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7.1   Conclusion 
In conclusion, the studies in this thesis have contributed significantly to the 
understanding of biochemical composition and protein expression in bovine NS and thus 
to the understanding possible mechanism by which NS is involved in bovine innate 
protection against respiratory diseases. The novel discovery of that AP is present in 
bovine NS is not fully understood which makes investigation of this secretion more 
challenging. Nevertheless, the establishment of a practical method of collecting NS and 
establishing its biochemical profiles enables studies of this fluid to be made in more 
depth, especially the more undiscovered areas including the biological function of nasal 
AP.  
 
Additionally, the protein profiling as well as analysis of differentially expressed nasal 
proteins has provided information in the response of the animal under stress situation 
such as in post-vaccinated or disease state which has not been reported before. The 
proteins catalogued were also an important resource for the comparison of future 
proteomics studies involving NS as well as quantifying responsiveness to vaccine hence 
contributing to the control and prevention of respiratory diseases in cattle. 
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Appendix A 
 
Publication 
MF Ghazali, HHC Koh-Tan, M McLaughlin, P Montague, NN Jonsson and PD Eckersall 
‘Alkaline phosphatase in nasal secretion of cattle: biochemical and molecular 
characterisation’ BMC Veterinary Research. 2014, 10 (1), 204. 
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Appendix 2.1 (section 2.2.3) 
 
Bradford reagent (5X concentrate) 
100 mg  Coomassie Brilliant Blue G-250 
47 ml   Methanol (100%) 
100 ml  Phosphoric Acid (85%) 
QS to 200 ml with H2O 
NOTE: Coomassie must be dissolved in the methanol first before the other ingredients 
are added. 
 
Appendix 2.2 (section 2.2.4) 
 
Albumin 
 
A coloured complex is formed when bromocresol green (BCG) reacts with albumin. The 
absorbance of the albumin-BCG complex is measured bichromatically at 600/800 nm and 
is proportional to the albumin concentration in the sample. 
Reaction principle: 
Albumin + BCG        pH 4.2 Green complexes 
 
Calcium 
 
Calcium ions react with o-Cresolphthalein-complexone (Ca-oCPC) in an alkaline medium 
to form a purple coloured complex. In this method the absorbance of the Ca-oCPC 
complexis measured bicromatically at 570/660 nm. The resulting increase in absorbance 
of the reaction mixture is directly proportional to the calcium concentration in the 
sample. 
Reaction principle: 
Ca2+ + oCPC       8-Hydroxyquinolone  Ca-oCPC Complex2+  
                                           pH 10.6 
 
Sodium, Potassium and Choloride 
 
The Ion selective electrode (ISE) for sodium (Na+), potassium (K+) and chloride (Cl-) 
employs crown ether membrane electrodes for Na+ and K+ and a molecular oriented PVC 
membrane for Cl- that are specific for each ion of interest in the sample. An electrical 
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potential is developed according to the Nernst Equation for a specific ion. When 
compared to an internal reference, this electrical potential is translated into voltage 
and then into the ion concentration of the sample. 
 
Creatinine 
 
Creatinine forms a yellow-orange coloured compound with picric acid in an alkaline 
medium. The rate of change in absorbance at 520/800 nm is proportional to the 
creatinine in the sample. 
Reaction principle: 
Creatinine + picric acid                    Creatinine picrate complex 
 
Phosphate 
 
In plasma, serum and bodily fluids the majority of phosphate exists in the inorganic 
form (Pi), approximately 15% bound to protein and the remainder in complexes and free 
forms. Inorganic phosphate reacts with molybdate to form a heteropolyacid complex. 
The asorbance at 340/380 nm is directly proportional to the inorganic phosphorous 
concentration in the sample. 
Reaction principle: 
7 H3PO4 + 12 (Mo7O24)
6- + 72 H+                     7 H3PO4(MoO3)12 + 36 H2O 
 
Total bilirubin 
 
A stabilised diazonium salt, 3,5-dichlorophenyldiazonium tetrafluoroborate (DPD), 
reacts with conjugated bilirubin directly and with unconjugated bilirubin in the 
presence of an accelerator to form azobilirubin. The absorbance at 540 nm is 
proportional to the total bilirubin concentration. A separate sample blank is performed 
to reduce endogenous interference. 
Reaction principle: 
Bilirubin + DPD        Caffeine         Azobilirubin 
                                             Surfactant 
Total Protein 
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Cupric acid in an alkaline solution react with proteins and polypeptides containing at 
least two peptide bonds to produce a violet coloured complex. The absorbance of the 
complex at 540/660 nm is directly proportional to the concentration of protein in the 
sample.  
Reaction principle: 
Protein + Cu2+          OH - Blue violet complex  
Urea 
 
Urea is hydrolysed in the presence of water and urease to produce ammonia and carbon 
dioxide. The ammonia produced in the first reaction combines with 2-oxoglutarate and 
nicotinamide adenine dinucleotide (NADH) in the presence of glutamate-dehydrogenase 
(GLDH) to yield glutamate and NAD+. The decrease in NADH absorbance per unit time is 
proportional to the urea concentration. 
Reaction principle: 
Urea + 2 H2O        
Urease 2 NH4
+ + CO3
2-  
2-Oxoglutarate  + 2 NH4+ + 2 NADH         GLDH        2 L-Glutamate + 2 NAD+ + 2 H2O  
 
Aspartate transaminase 
 
Aspartate transaminase (AST) catalyses the transamination of aspartate and 2-
oxoglutarate, forming L-glutamate and oxaloacetate. The addition of pyridoxal 
phosphate to the reaction mixture ensures maximum catalytic activity of AST. The 
oxaloacetate is reduced to L-malate by malate dehydrogenase (MDH), while NADH is 
simultaneously converted to NAD+. The decrease in absorbance due to the consumption 
of NADH is measured at 340 nm and is proportional to the AST activity in the sample. 
Endogenous pyruvate is removed by the LDH-reaction during the incubation period. 
Reaction principle: 
2-Oxoglutarate  + L-Aspartate          AST   L-Glutamate + oxaloacetate  
Oxaloacetate + NADH + H+         MDH          L-Malate + NAD+ 
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Appendix 2.3 (section 2.2.6.1) 
 
Coating buffer 
0.05 M  Carbonate-Bicarbonate 
Adjust pH to 9.6 with 1M sodium hydroxide (NaOH) 
 
ELISA wash and blocking solution 
50 mM  Tris 
0.14 M  NaCl 
0.05%   Tween 20 
Adjust pH to 8.0 with 1M sodium hydroxide (NaOH)  
 
Sample and conjugate diluent 
50 mM  Tris 
0.14 M  NaCl 
0.05%   Tween 20 
Adjust pH to 8.0 with 1M sodium hydroxide (NaOH) 
 
ELISA Stop Solution 
0.18 M  H2SO4  
 
Appendix 2.4 (section 2.2.8.1) 
 
 
SDS-PAGE Running Buffer 
144 g  Glycine 
30.3 g  Tris 
10 g  SDS 
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Add the glycine to 700ml of distilled water, once dissolved add Tris and SDS and finally 
made up the volume of 1L with dH2O. 
 
 
Appendix 3.1 (section 3.2.1.1) 
 
 
10% buffered neutral formaldehyde 
162.5    disodium hydrogen orthophosphate  
87.5 g  sodium dihydrogen phosphate  
2.5 L  37% formaldehyde.  
Add dH2O to give final volume of 25 L and adjust pH to 7.4 with 1M hydrochloric acid 
(HCl). 
 
Appendix 3.2 (section 3.2.1.4) 
 
 
70% absolute alcohol 
140 ml  100% alcohol  
60 ml   dH2O  
 
70% methylated spirit  
70 ml  100% ethanol  
30 ml   dH2O 
 
Appendix 3.3 (section 3.2.1.4) 
 
 
1% acid alcohol 
990 ml  70% ethanol 
10 ml  Concentrated HCl 
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Appendix 3.4 (section 3.2.1.4) 
 
 
Scott’s tap water substitute 
8.25 g  Sodium bicarbonate 
50 g  Magnesium sulphate 
2500 ml Tap water 
2 crystals Thymol 
Bring to a total volume of 2.5 L 
 
Appendix 3.5 (section 3.2.1.5) 
 
 
VECTOR® Red AP enzyme staining procedure 
Step 1: Add 2 drops of Reagent 1 to 5 ml of 100 mM Tris-HCl, at pH 8.2 - 8.5 buffer*.  
Step 2: Add 2 drops of Reagent 2 and mix well. 
Step 3: Add 2 drops of Reagent 3 and mix well. 
Step 4: Incubate tissue sections with the substrate at room temperature until suitable 
staining develops (generally 20-30 minutes provides good staining intensity). 
Step 5: Wash sections in assay buffer for 5 minutes. Rinse in water. 
* Make the working solution in 100 mM - 200 mM Tris-HCl, pH 8.2 - pH 8.5. 
 
Appendix 3.6 (section 3.2.3.3) 
 
 
Transfer buffer (1X) 
6.06 g  Tris 
28.8 g  Glycine 
1600 ml dH2O 
400 ml  Methanol 
Mix well and adjust pH to 8.0 with 1M sodium hydroxide (NaOH) 
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Appendix 3.7 (section 3.2.3.3) 
 
 
5% skimmed milk  
5 g  skim milk powder  
100 ml  1X Tris-buffered saline containing Tween 20 
 
Appendix 3.8 (section 3.2.3.3) 
 
 
TTBS (10X) 
60.2 g  Tris-base 
87.6 g  Sodium Chloride (NaCl) 
10 ml  Tween 20 
700 ml  dh2O.  
Adjust pH to 7.4 with 1M hydrochloric acid (HCl) and make the volume up to 1L. 
 
Appendix 3.9 (section 3.2.4) 
 
 
2% Agarose gel 
0.8 g  Agarose powder (Sigma-Chem Co, Poole, UK) 
40 ml  TAE buffer (1X) 
4 ml  dH2O 
Dilute solution in microwave for 1-2 min then add 15 µl of Ethidium bromide after 30 
sec. 
TAE buffer (1X) 
4.8 g  Tris-base 
1.1 ml  Acetic acid 
2 ml  0.5M EDTA 
Adjust pH to 8.6 with 1M sodium hydroxide (NaOH) and make the volume up to 1L.
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